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Central motor conduction was assessed as a predictor of mortality and 
functional outcome in a longitudinal study of 118 patients with first-ever stroke. 
Investigations commenced 12-72 hours after stroke and were repeated up to death 
or 12 months. The results were compared with normal data, validated 
assessments of motor function, detailed neurological examinations and CT scans. 
Responses were recorded in the surface electromyogram from proximal and 
distal muscles of both upper limbs following percutaneous electromagnetic 
stimulation of the motor cortex (muscles contracted) and spinal motor roots 
(muscles relaxed). Central Motor Conduction Time (CMCT) was estimated by 
subtracting the latencies of spinal root evoked responses from those of cortical 
evoked responses. The durations and thresholds of the responses were recorded. 
Investigations 12-72 hours after stroke identified patients with 1) normal 
CIVICT, 2) delayed CIVICT, and 3) absent responses. Sequential investigations up 
to 12 months after stroke revealed 1) CIVICT may remain unchanged, 2) delayed 
CIVICT may become normal 3) responses may reappear with shortened duration, 
with delayed or normal CIVICT, 4) responses were lost if the stroke extended, 5) 
initially high thresholds to stimulation decreased. 
Absent responses 12-72 hours after stroke initially correlated with reduced 
power, hand dexterity and functional ability, and with large infarctions, mass effect 
and cortical lesions on CT scans. Normal CIVICT correlated with a high probability 
of survival and significantly better functional recovery at 12 months. Absent 
responses correlated with a high probability of stroke-related death. Survivors had 
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poor outcome for muscle power, hand dexterity, activities of daily living, functional 
outcome and duration of stay in hospital. 
Results from the thenar muscles alone provided accurate prognostic 
information. If results from all the muscles were considered and the test repeated 
seven days after the first assessment, the sensitivity of the test increased. 
Electromagnetic stimulation is a safe prognostic investigation that is 
complementary to clinical examination and imaging patients with stroke. 
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ABBREVIATIONS AND DEFINITIONS 
CIVICT Central motor conduction time 
CT Computerised tomography 
EMG Electromyograrn 
EMS Electromagnetic stimulation 
ES Electrical stimulation 
Kruskal-Wallis Kruskal-Wallis one-way analysis of variance 
LACS Lacunar syndrome 
MEP Motor evoked potential 
Mann-Whitney Mann-Whitney U- Wilcoxon rank sum W test 
MRI Magnetic resonance imaging 
NR No response 
NS Not significant 
PACS Partial anterior circulation syndrome 
POCS Posterior circulation syndrome 
SEP Sensory evoked potential 
SD Standard deviation 
TACS Total anterior circulation syndrome 
Wilcoxon Wilcoxon matched pairs signed ranks test 
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Paretic side of body: 
Side of greater motor impairment. 
Non-paretic side of body: 
Side contralateral to paretic side. 
Damaged hemisphere: 
Hemisphere contralateral to paretic side. 
Undamaged hemisphere: 
Hemisphere contralateral to non-paretic side. 
Normal Response Group: 
Group of patients who showed normal CIVICT values obtained with respect 
to responses in thenar muscles. 
Delayed Response Group: 
Group of patients who showed delayed CIVICT values obtained with respect 
to responses in thenar muscles. 
No Response Group: 
Group of patients with no responses in thenar muscles to maximal 
electromagnetic stimulation of the cortex. 
Patients with responses: 
Patients who have responses in the target muscles following 
electromagnetic stimulation of the motor cortex. (Normal 
and Delayed Response Groups combined). 
Immediate post-stroke period: 
Within 72 hours of the first symptom due to the stroke. 
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INTRODUCTION 
1.1 THE INDIVIDUAL AND FINANCIAL COST OF STROKE 
Stroke is a clinical syndrome of rapidly developing clinical signs of focal or 
global disturbance of cerebral function, lasting more than 24 hours or leading to 
death, with no apparent cause other than of vascular origin (Aho et al., 1980). 
Stroke is the third commonest cause of death in the United Kingdom (Wolf et al., 
1986) with an annual death rate of approximately 100 per 100,000 of the general 
population (Kurtzke, 1986) and an incidence of approximately 200 per 100,000 
per year (Sandercock and Warlow, 1983). Stroke is a major cause of physical and 
psychological disability in the community. 
In terms of the financial cost to the health service, stroke is the third 
commonest cause for hospital admission (Garraway, 1976) and it has been 
estimated to consume 6% of all hospital costs and 4.6% of all NHS costs 
(Carstairs, 1976). The expenditure is due to the resources needed in the initial 
treatment and support of patients with stroke and the long hospitalisation that 
follows the acute event. The costs remain high for survivors in terms of the 
long-term commitment during rehabilitation and continuing care in the community. 
Individuals with stroke therefore represent a major financial burden to the National 
Health Service. 
The personal cost to the individual with stroke is high. A stroke may 
restrict the blood supply to any part of the brain and produce neurological damage 
resulting in loss of function and disability for the individual. A wide range of 
impairment follows stroke including problems with cognition, communication and 
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motor and sensory loss. The functional consequences are many and include 
restriction of activities of daily living, social functioning, loss of employment, 
sexual and psychological problems. The survivors of stroke have a lower quality 
of life and have to face numerous problems from the social and financial 
consequences of their disability. The disruption of normal lifestyle is not restricted 
to the individual patient with stroke but also affects their family, caregivers and 
dependents. 
The physical problems that follow stroke are diverse, but the paralysis of the 
limbs and loss of the ability to perform skilled motor activities is perhaps the most 
salient feature of stroke. Impairment of motor function in the upper limb is 
particularly disabling in view of man's highly evolved use of the hand in the use of 
tools, machines, communication skills and leisure activity. Although some degree 
of recovery can be expected after a stroke, complete recovery is uncommon. Only 
4-9% of stroke patients can be expected to regain normal sensorimotor function 
in an arm that was originally completely paralysed (Adams and McComb, 1953; 
Twitchell 1951; Moskowitz et al., 1972). Up to 30% of patients with stroke do 
not recover any useful function of the upper limb (Bard and Hirschberg, 1965; 
Newman, 1972). The residual motor impairment in the upper limb represents a 
major cause of disability for patients with stroke. 
The costs of stroke are high both in terms of the financial cost to the 
community and the constraints on health care resources, and due to the suffering 
and reduced quality of life experienced by the individual. Scientific research, to 
evaluate new treatment strategies, and methods of investigation to provide more 
accurate assessment of prognosis, are required to improve the care of patients 
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with stroke. This study has assessed the prognostic value of a relatively new 
neurophysiological method of investigating the function of the central motor 
pathways. The study focused upon motor function in the upper limb and how 
measurements of central motor conduction immediately after stroke relate to 
mortality and the recovery of motor function at 12 months. The value of this test 
of neurophysiological function needs to be viewed in relationship to pre-existing 
methods of assessing mortality and motor outcome after stroke. At the onset of 
the study the prognostic value of electromagnetic stimulation (EMS) of the brain 
following acute stroke was not established. 
1.2 PREDICTORS OF OUTCOME AFTER STROKE 
Prognostic information following stroke is important to determine the 
patient's individual need for physiotherapy and rehabilitation, and to give the 
patient and the relatives a more accurate indication of possible recovery. 
Advances in neuroscience have lead to the use of pharmacological agents in the 
acute stroke situation, for example thrombolytic agents such streptokinase, the use 
of aspirin or heparin, and neuroprotective drugs such as calcium antagonists and 
glutamate receptor blockers. Accurate prognostic information at the earliest 
possible stage after stroke would provide valuable data, which could be used to 
identify the patients requiring acute medical therapy and who might benefit from 
intensive rehabilitation. The information would assist in the planning and the 
costing of rehabilitation services and predicting the need for continued 
hospitalisation and nursing care. Early and accurate prognostication is needed in 
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order to enhance the care and management of the individual with stroke. 
Diagnosis of stroke is achieved by careful clinical examination and is assisted 
by computerised tomography (CT) and, where available, magnetic resonance 
imaging (MRI). Clinical examination assesses the neurological impairment and 
function of the patient. Imaging the brain provides anatomical information 
regarding the site of the damage and pathological information by establishing if the 
stroke is due to haemorrhage or infarction. However, both clinical assessment and 
imaging provide limited prognostic information in the immediate post-stroke period 
(up to 72 hours after the onset of symptoms). Certain clinical syndromes and 
features on CT scans are associated with an increased risk of death but neither 
method is highly accurate in the immediate post-stroke period to predict the 
prospects for recovery of motor function in the upper limb. 
1.2.1 Clinical findings of prognostic value 
Certain physical signs following stroke are known to correlate with increased 
risk of death and thus are of prognostic value. Dysconjugate eye movements 
(Rankin, 1957; Oxbury et al., 1975; Allen, 1984), the presence of a full 
hemianopia (Gray et al., 1989), reduced level of consciousness (Marquarsden, 
1983), leg weakness (Chambers et al., 1987) urinary incontinence (Wade et al., 
1985) and swallowing difficulty (Wade and Hewer, 1987a) all correlate with 
mortality. Recently, Bamford et al. (1991) reported the use of a clinical 
classification of physical signs that correlated with mortality. 
In the first 72 hours after stroke the clinical signs may be of limited value in 
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predicting the return of motor function in the upper limb of survivors. Clinical 
evaluation is unable to distinguish neurological deficit due to neuronal death leading 
to permanent damage and loss of function, from signs due to reversible 
dysfunction of neural tissue and the effects of cerebral oedema where good 
functional recovery may develop. A further problem with clinical assessment 
leading to an overestimate of impairment is that objective assessment of motor 
function is difficult if the subject has cognitive impairment, psychological problems 
or sensory deficits as a result of stroke. 
In the immediate post-stroke period, assuming that no other pathology 
occurs, the clinical signs can be used to predict good motor recovery in a fully 
conscious patient with a completed stroke where there is only mild impairment of 
motor function (Bonita and Beaglehole, 1988), assuming no further deterioration 
occurs. However, the converse is not so simple. Immediately after a stroke the 
severity of clinical signs in the upper limb may be of value in predicting the 
functional outcome of survivors (Wade and Hewer, 1987b; Prescott et al., 1982). 
However, some patients who initially exhibit severe motor impairment may 
eventually achieve good motor skills, despite the early clinical picture suggesting 
the contrary (Wade and Hewer, 1987b; Biller et al., 1990; Prescott et al., 1982). 
The time elapsed before recovery begins may be more significant as a prognostic 
indicator than the initial severity of the motor deficit (Marquarsden, 1983). As 
recovery evolves during the first few weeks after stroke, the presence of severe 
residual motor impairment becomes more accurate in predicting the final functional 
outcome. The clinical prognostication becomes more reliable when based upon 
clinical observations performed two to three weeks after a stroke, or even later. 
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Clinical assessment of the severity of paralysis can be imprecise and misleading 
and thus the relationship of clinical signs immediately after stroke to prognosis is 
ambiguous (Jongbioed, 1986). 
1.2.2 CT scan features immediately after stroke 
Imaging techniques such as MRI and CT scanning provide valuable 
anatomical and pathological information in stroke. MRI is not universally available 
in the U. K. or as sensitive at identifying haemorrhage as CT scanning. CT scanning 
is very accurate for identifying intracerebral haemorrhage (Paxton and Ambrose, 
1974). The possibility of identifying cerebral infarction at an early stage after 
stroke has greatly improved with machines of higher resolution. However, 
hypodensity, the hallmark of infarction may take several days before it is well- 
defined and in the first 72 hours after stroke less than 60% of infarcts are evident 
as hypodensity (Mohr, 1986). Quantitative measurement of a visible lesion is 
difficult due to the influence of mass effect and cerebral oedema both of which 
may lead to an overestimate of the dimensions of the lesion due to poor definition 
of its boundaries. Later, as the lesion matures fogging may lead to disappearance 
of the lesion or if it remains visible it may lead to an underestimate of its size 
(Becker et al., 1979; Scriver and Olsen, 1981). The accuracy of anatomical and 
pathological information from imaging is variable in the very early stages after 
stroke and subsequently only provides subjective prognostic information in some 
patients. 
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1.2.3 The need for further research into methods of prognostic value 
In the immediate post-stroke period clinical signs and CT scans are not 
accurate in predicting motor outcome. Anatomical information from CT scans is 
complementary to the assessment of functional activity of the individual derived 
from history and neurological examination, however, no single group of 
observations taken within 72 hours of stroke is accurate enough to predict the 
functional recovery of the individual patient at 12 months. What is presently 
lacking is objective neurophysiological assessment of the function and integrity of 
the central motor pathways. Further research is needed to establish objective 
neurophysiological methods of predicting outcome. The aim would be to combine 
the neurophysiological data with anatomical and clinical data to provide a more 
reliable prediction of the prospects for recovery of individual patients. 
Damage to the motor cortex and the corticospinal tracts leads to loss of 
function of the contralateral limbs after stroke (Bach-y-Rita, 1980). It is therefore 
logical to evaluate the prognostic value of any method capable of assessing the 
integrity and function of the central motor pathways in a patient with stroke. Such 
a procedure would have to be safe, non-invasive and practicable. If observations 
of neurophysiological function are compared to validated clinical assessments of 
motor function and the tests are repeated sequentially during the recovery phase 
it may be possible to assess the relationship of how the function of the central 
motor pathways relates to the recovery of motor function. If correlations were 
found between measures of central motor conduction immediately after stroke and 
risk of death and clinical measures of outcome at 12 months once recovery has 
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ceased, it should be possible to assess the prognostic value of a new technique. 
The neurophysiological mechanisms that underlie intrinsic neurological 
recovery of motor function after stroke are insufficiently understood. The 
relationship of the integrity of the central motor pathways to recovery of motor 
function is not defined. A number of procedures already exist for assessing the 
function of the central sensorimotor pathways. Direct and percutaneous electrical 
stimulation of the motor cortex, somatosensory evoked potentials (SEPs) and 
percutaneous electromagnetic stimulation (EMS) of the central motor pathways 
provide direct information and their use in studies in animals and patients with 
cerebral ischaemia, suggest that neurophysiological function of the central motor 
pathways is likely to correlate with functional outcome. 
1.3 ELECTRICAL STIMULATION OF THE BRAIN 
Electrical stimulation (ES) of the motor cortex to activate the motor 
pathways has been shown to produce movements in the contralateral limbs. This 
method is capable of assessing the integrity of the central motor pathways and 
thus providing prognostic information after stroke. Unfortunately the method is 
painful. The earliest investigations of motor function using ES involved direct 
stimulation of the exposed brains of animals. Electrical stimulation of the exposed 
motor cortex in the dog to produce movements in the contralateral limb was first 
achieved by Fritsch and Hitzig in 1870. Ferrier in 1875 observed contralateral 
movement of muscles during ES of the exposed monkey motor cortex. The first 
description of electrical methods to stimulate the human brain appears to be that 
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of Bartholow in 1874 (See Rothwell et al., 1991) who produced movements of the 
contralateral muscles during faradic stimulation of the exposed parts of a human 
brain. The anatomical and functional importance of these observations in man 
were defined in the work of Penfield and Jasper (1964). 
However, for ethical and safety reasons neurophysiological investigation of 
the corticospinal pathway in man depends on the ability to stimulate the neurones 
of the motor cortex through the intact skull. Gualtierotti and Paterson (1954) first 
reported percutaneous ES of the motor cortex in baboons and human subjects 
using repetitive electrical shocks. In 1980 Merton and Morton succeeded in 
activating muscles in the hand and upper limb by applying a single, short (50us), 
high voltage electrical pulse to the scalp above the contralateral motor cortex. This 
report was followed by the use of ES over the cervical and lumbar spine by Merton 
et al. (1982). Despite the brief stimulus the technique remains unpleasant and 
painful. It is because of the discomfort produced during ES that researchers such 
as Barker, Jalinous and Freeston in 1985 developed electromagnetic neural 
stimulators using the principles of electromagnetic induction (Faraday, 1839) to 
excite neural tissue indirectly through the intact skull without causing pain. 
1.4 ELECTROMAGNETIC STIMULATION OF NEURAL TISSUES 
1.4.1 Development of electromagnetic neural stimulators 
The origin of using magnetic fields to stimulate neural tissues dates back to 
the end of the last century. In 1896 D'Arsonval first demonstrated how a 
changing magnetic field could stimulate neural tissue. His observations that 
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phosphenes could be produced by stimulation of the retina or visual cortex were 
independently reported by Beer in 1902. A number of investigators were able to 
reproduce the phenomenon (Thompson, 1910; Dunlap, 1911; Magnusson and 
Stevens 1911,1914). It was not until 1965 that Bickford and Freming 
demonstrated muscle contraction could be produced using magnetic fields to 
stimulate the sciatic nerve in the frog and rabbit. Investigations using 
electromagnetic induction to produce a response in superficial peripheral human 
nerve were performed by Irwin et al. in 1970 and in human nerve and muscle by 
Halgren in 1973, followed by Polsen et al. in 1982(a). It was almost a century of 
intermittent interest and investigation before technological advances allowed the 
human motor cortex to be indirectly stimulated using a time-varying magnetic field. 
Painless excitation of the human motor cortex was first achieved by Barker 
and his colleagues using electromagnetic induction (Barker et al., 1985,1987). 
A magnetic field was generated with an induction coil placed above the scalp. 
Following the discharge of energy from an electrical capacitor a brief pulse of 
current flowed through the coil. The current rose and fell rapidly in its flow 
through the coil resulting in a time-varying magnetic field. This action follows the 
principle of electromagnetic induction whereby an electric current is induced in a 
conductor that lies within a time-varying magnetic field. The result in the brain 
was a motor evoked potential (MEP) that traversed the motor pathways and was 
detected in muscles of the upper limb as a change in the electromyogram. The 
technique is painless and non-invasive. The magnetic field passes through the 
body structures without significant attenuation. Thus, the skull is not a barrier to 
EMS and it is straightforward to produce responses to cortical stimulation in both 
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relaxed and voluntarily contracted muscles in both the upper and lower limbs. The 
lack of discomfort makes cortical stimulation both practical and acceptable to all 
age groups. The painless and non-invasive nature of the test is tolerated 
remarkably well by severely ill patients such as those with acute stroke. 
1.4.2 Safety of electromagnetic stimulation of the brain 
Safety must be a major consideration before using a new technique in 
human subjects whether they are normal individuals, patients with chronic 
neurological disorders or acutely ill patients with evolving stroke. Prior to the 
commencement of our project EMS of the brain was under close scrutiny regarding 
its safety. No serious adverse effects had been reported and the information 
available suggested the technique was safe. More recent studies and extensive 
use of EMS in thousands of patients of all age groups with many different 
neurological conditions have not revealed any immediate or medium-term adverse 
effects. Some individual researchers have received several thousand cortical 
stimuli with no apparent adverse effects (Barker, 1991). The Human Motor 
Research group in Newcastle has now tested several hundred babies, children and 
adults with no adverse effects (Eyre and Miller, personal communication). EMS of 
the human brain does appear to be safe. However at the onset of the present 
study there was very little information available regarding the safety of stimulating 
the brain of patients with evolving cerebral damage after acute stroke. As a 
consequence of this we adopted a very cautious approach to its use and applied 
rigorous safety criteria (See: 2.1 Structure of the project - Inclusion Criteria). 
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The physical effects of imparting energy to the brain 
The energy absorbed by the cortex of the brain during EMS is only 
1/100,000 the magnitude of the inducing current (Cadwell, 1990). The strength 
of the magnetic field of up to 2 Tesla, although more focused and time-variable, 
is of similar strength to the uniform fields used in MRI. Using electroconvulsive 
therapy as an analogy, the stimulus used in EMS is 1000 times smaller than that 
used for electroconvulsive therapy and the energy is about 10' ' smaller. The total 
energy delivered to the brain using EMS at maximal stimulus is approximately only 
0.1% of the basal metabolic rate of the brain itself (Jalinous, 1992). 
If metal objects are present within the brain they will be subjected to 
mechanical forces due to the induced currents. The effect upon small metallic 
objects is minimal but large metallic objects can be moved and much depends upon 
the dimensions of the object and its relative conductivity particularly if it is 
ferromagnetic (Jalinous, 1992). The induction of an electric current in a 
conductive material can produce heat and care must be taken if skin electrodes lie 
within the path of the magnetic field. During rapid-rate EMS specially designed 
electrodes with gaps cut in the electrode should be used. This simple measure 
interrupts the induced eddy currents and reduces heating in the electrode and 
lessens the risk of burns to the skin (Roth et al., 1992). 
The presence of cardiac pacemakers or electronic implants in the brain e. g. 
hearing aids, must be considered as a contra ind icatio n lest the induced currents 
lead to malfunction. 
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Cardiovascular considerations 
Electromagnetic stimulation of the motor cortex is unlikely to produce 
cardiovascular problems. Cardiac muscle has a high threshold to stimulation and 
is difficult to stimulate with EMS (Geddes, 1991). This is partly due to the 
distance that cardiac muscle lies from the skin and due to the exponential fall in 
magnetic field with distance. The net result is that very powerful EMS is required 
to interfere with the function of cardiac muscle. Experiments with EMS in rats and 
an anaesthetized dog have failed to cause ventricular ectopic beats (Polsen et al., 
1982b; Bourland et al., 1990). Similarly no significant changes in cardiovascular 
function in terms of heart rate, blood pressure or focal cortical blood flow were 
observed following repeated EMS in cats, even under conditions of severe cerebral 
anoxia (Eyre et al., 1990). It is therefore highly unlikely that EMS of the brain 
could directly interfere with cardiac function. 
The risk of provoking epileptic seizures 
The risk of provoking an epileptic seizure from EMS is low. The use of EMS 
appears to be safe in patients with seizures despite the fact that cortical 
excitability is increased with generalised untreated epilepsy (Reutens and Berkovic, 
1992). Kindling is the phenomenon whereby an epileptic focus is induced by a 
stimulus. Goddard et al. (1969) were unsuccessful at inducing kindling using ES 
in experimental animals at stimulus frequencies of less than 3 Hz, irrespective of 
the total number of stimuli given. Most electromagnetic stimulators have a 
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maximum discharge rate of less than 0.5 Hz, hence no danger of kindling should 
exist (Barker, 1991). In patients with epilepsy, although it is possible to provoke 
electroencephalographic evidence of seizure activity, it has been very difficult to 
produce a clinical seizure. Hufnagel (1990a) was only able to provoke a clinical 
seizure in 1/13 patients with complex partial seizures. Tassinari (1990) only 
provoked one clinical seizure in f if ty-eight patients with epilepsy and did not record 
any change in seizure frequency or type of attack during a three months follow-up. 
Isolated seizures occurring during EMS have been reported. A focal seizure 
occurred in a normal subject when using rapid-rate EMS at 1OHz at 100% of 
maximum output (Pascual-Leone et al., 1992a). It is widely assumed that single 
stimuli repeated at less than 0.5 Hz are safe but, it remains possible that rapid-rate 
stimuli of high intensity and frequency may produce a seizure in predisposed 
individuals. H6mberg and Netz (1989) reported a single seizure in a stroke patient 
with a massive hemispheric infarction. Following this event the authors suggested 
that patients with large ischaernic lesions may be more vulnerable to seizures and 
EMS should be avoided in patients with large areas of damage. There is also a 
report of a focal seizure provoked by EMS in a subject with a large hemispheric 
infarction who was investigated 10 months after stroke (Fauth et al., 1992). 
However, in view of the number of subjects investigated using EMS and only 
isolated reports of seizures these were likely to have been incidental occurrences. 
Recent studies in stroke patients did not observe a worsening of the neurological 
deficit or secondary effects following stimulation of the motor cortex (Kandler, 
1990; Escudero et al., 1992). Experiments in animals with ischaemia did not 
reveal any abnormality in cerebral blood flow or cortical activity nor any increased 
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risk of kindling during stimulation at the time of anoxia (Eyre et al., 1990) 
(See: Discussion - 4.10 Safety of EMS of the brain after stroke). 
Effect upon cognitive function 
Recently, transient changes in cognitive function occurring during EMS have 
been reported by Levy et al. (1990). The changes were within a narrow time range 
and were probably due to a short-lived and focal interference of cognitive 
processing. Delayed execution of voluntary movement has been observed after 
EMS of the brain in man (Day et al., 1989; Ammon and Gandevia, 1990; Andrews 
et al., 1992) and delayed perception of a transient visual stimulus after stimuli 
were given over the occipital regions (Amassian et al., 1988). In both cases, it 
was likely to be due to a temporary interference of processing and planning. 
Psychometric testing has not shown any significant changes in relation to 
stimulation (Rossini et al., 1987; Bridgers and Delaney, 1989) and longer term 
interference of cognition has not been reported. Histopathological study of 
surgically removed temporal lobes from patients investigated with EMS prior to 
surgery did not show any lesions attributable to EMS, despite the fact that the 
brain had been subjected to approximately 2000 stimuli (Gates et al., 1992). 
Hormonal changes 
No significant changes in cortisol or prolactin were observed following 
excitation of the human brain using EMS (Levy et al., 1990, Thomas et al., 199 1). 
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Acoustic hazards 
Finally, a more insidious hazard from EMS was suggested by Counter et al. 
(1990) who found the discharge noise from the magnetic coil to be surprisingly 
loud. Brief clicks of up to 157dB were recorded close to the ears of rabbits. The 
brevity of the sound and the relatively long time constant of the human auditory 
perception means that damaging effects could go unnoticed. Barker et al. 1991, 
and Boyd et al. 1991, concluded that the magnetic nerve stimulators they 
examined did not produce a significant acoustic hazard in normal use. A further 
study by Pascual-Leone et al. (1992b) did not reveal any hearing loss in human 
subjects but did recommend the use of earplugs for subjects and investigators. 
1.5 THE USES OF ELECTROMAGNETIC STIMULATION OF THE BRAIN 
In neurological conditions with motor impairment 
Electromagnetic stimulation of the human motor cortex to produce MEPs 
recorded from the surface EMG in skeletal muscle has developed into a widely 
used, non-invasive technique for evaluating descending motor pathway function 
in man (Rothwell et al., 1987; Rossini et al., 1987; Mills et al., 1987; Koh and 
Eyre, 1988; Eyre et al., 1991). Abnormalities in central motor conduction have 
been observed in a wide variety of disorders including patients with multiple 
sclerosis (Hess et al., 1986), motor neurone disease (Ingram and Swash, 1987), 
degenerative ataxic disorders (Claus et al., 1988), hereditary motor and sensory 
neuropathies (Hess et al., 1987a), Parkinson's disease (Kandler et al., 1990) 
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hereditary spastic paraplegia (Schady et al., 1991) and Retts disease (Eyre et al., 
1990). The technique has also been used to help distinguish psychogenic paralysis 
from organic disease (Pillai et al., 1992). 
EMS has great potential as a method for monitoring the function of the 
central motor pathways during surgery for scoliosis (Shields et al., 1990) and 
cervical spondylosis (Jaskolski et al., 1989), and to investigate the basis of mirror 
movements (Britton et al., 1991). EMS has been used to map the human cortex 
(Ueno et al., 1990) and to predict the outcome of coma (Ying et al., 1992). In 
addition to investigations of the central motor pathways the technique has been 
used to investigate patients with epilepsy (Hufnageletal., 1990b). Thetechnique 
has also been used in a wide variety of conditions affecting the peripheral nervous 
system. 
Experience of the use of EMS in the human subject of all ages is now 
extensive. The safe and painless stimulation of the central motor pathways and 
spinal motor roots is of proven value in the investigation of many motor disorders 
in human subjects. The production of MEPs provides a novel solution to the 
problem of non-invasive and painless investigation of the function of central motor 
pathways. The technique allows the estimation of CMCT and the measurement 
of the amplitude and duration of responses and the threshold to stimulate 
responses. MEPs can be used to analyse the relationship of a wide range of 
neurological disorders to motor function in the same way in which sensory and 
visual evoked potentials have improved our diagnostic skills. The success of using 
EMS in conditions with motor impairment suggest that the technique may have an 
important role in the investigation of cerebrovascular disease. 
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What neural elements are excited by electromagnetic stimulation? 
There are a number of projects that have shed light on which neural 
elements are stimulated and how EMS compares to ES of the brain, a technique 
which has now become almost obsolete in human experiments with the advent of 
the painless method of EMS. In studies in the monkey EMS and percutaneous ES 
of the scalp have been shown to evoke activity exclusively in the corticospinal 
pathway (Edgley et al., 1989,1990 a and b, 1992). Rothwell et al. (1991) 
suggested the site of stimulation from EMS was trans-synaptic with no evidence 
for direct stimulation of the Betz cell. However, using recordings from the 
pyramidal tracts in anaesthetized monkeys Edgley et al. (1 990b) have suggested 
that the Betz cell is directly excited by EMS at threshold. At higher intensities of 
stimulation, the initial segment of the corticospinal neurones are activated. 
Anatomical imaging performed in conjunction with EMS suggests the site of 
stimulation is at the junction of grey and white matter (Epstein et al., 1990). By 
comparison, ES may directly stimulate the pyramidal tract cells (Day et al., 1989) 
but this form of stimulation may deeply penetrate the brain and is capable of 
exciting the corticospinal pathway as distal as the medullary pyramids when 
suprathreshold stimulation is used (Edgley et al., 1990b). This model has been 
assumed to apply to human studies (Burke et al., 1990). 
Electromagnetic stimulation can be used to excite the spinal motor nerves 
as they emerge from the vertebral column, which enables the peripheral motor 
conduction time to be estimated in the upper limb (Barker et al., 1986; Ugawa et 
al., 1989). Subtraction of the latencies from motor root responses from those 
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following cortical stimulation, estimates Central Motor Conduction Time (CMCT) 
of the fastest conducting corticospinal pathway fibres (Merton et al., 1982). 
The evidence in both human and non-human primate studies support the 
concept that EMS excites the corticospinal pathway. The technique therefore has 
great potential for investigating motor changes following stroke. 
1.6 N EURO PHYSIOLOGICAL INVESTIGATIONS AFIFER STROKE 
Electrical stimulation of the brain 
A number of studies have used ES to assess the function of the motor 
pathways following stroke. In a study of 20 patients one to 22 months after 
stroke Berardelli et al. (1987) used percutaneous ES of the motor cortex and 
observed the absence of MEPs in 17 patients and prolongation of latency in three 
patients. Dominkus et al. (1990) observed similar abnormalities in 33 patients 
within three days of acute stroke. Fourteen patients had absent responses, 13 had 
delayed CIVICT and six patients had normal CIVICT. Two months after stroke, the 
initial abnormalities of central motor conduction correlated with poor recovery of 
motorskills. By contrast, Abruzzesse et al (1991) studied 32 patients one to 60 
days after lacunar stroke. Only 1 subject had absent responses in two of the three 
muscles tested, 18 had delayed CIVICT in one or more muscles and 14 had no 
change in CIVICT in all three target muscles. 
These studies suggest the assessment of the central motor pathways after 
stroke may reveal information of prognostic value. Percutaneous ES of the brain, 
however, is painful and therefore, there are ethical questions surrounding its use 
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in patients following stroke, particularly within hours of the ictus when the subject 
may be very ill. Alternative methods to investigate the function of the central 
motor pathways after stroke therefore have been explored in the present study. 
Sensory evoked potentials 
As an alternative to ES other investigators have used SEPs to assess damage 
of the sensorimotor pathways in ischaemic models and patients with stroke. SEPs 
in animal models of ischaemia are abolished once the cerebral blood flow falls 
below 12 ml/100g/minute (Branston et al., 1974). Prolongation in latency of 
evoked potentials (Hargadine et al., 1980; Meyer et al., 1985), was only observed 
in white matter damage by Lesnick et al. (1984). In adult humans with stroke, 
depression of SEPs was observed in 24 patients (Larson et al., 1966) and 
Kussofsky et al. (1982) obtained similar results in 16 patients. Unfortunately both 
these studies do not state clearly how long after stroke the tests were performed. 
Zeman and Yiannikas (1989) assessed 35 patients and demonstrated that 
abnormalities in SEPs correlate with functional outcome, measured by length of 
stay in hospital and Barthel index at the time of discharge from hospital, but they 
did not state exactly the interval after stroke at which the tests were performed. 
La Joie et al. (l 982) investigated 68 patients on an average of 36 days after stroke. 
Absent SEPs were found to correlate with poor recovery. However, the SEP 
assesses the integrity of the sensory component of the sensorimotor pathways, 
and is not a direct test of the corticospinal pathways. 
When MEPs, produced by percutaneous ES of the motor cortex were 
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compared to SEPs in 19 patients an average of eight days after stroke (Macdonell 
et al., 1989), central motor conduction was observed to be within the normal 
range or delayed, or no responses were obtained. MEPs were found to have 
slightly better predictive value for motor recovery compared to SEPs. 
Electromagnetic stimulation of the motor cortex 
Most studies using EMS after stroke have investigated patients in the 
chronic phase, weeks to months after stroke and there are only a few reports of 
relatively small numbers of patients tested within days of the onset of symptoms. 
At the time of commencing the present study there was no study of a large 
number of patients examined within 72 hours of the ictus. The relationship of the 
neurophysiological findings to initial clinical assessments and anatomical and 
pathological information from CT scans was unclear. No study had been 
performed using sequential clinical and neurophysiological assessments and 
documented the changes that occur in the central motor pathways and how the 
changes relate to probability of death and functional outcome at 12 months when 
further recovery is unlikely. 
In a preliminary study using EMS of the brain in 10 hemiparetic patients in 
the non-acute period Bridgers (1990) demonstrated three groups of patients, 
characterised by absent responses, or responses with prolonged or normal CIVICT. 
Similar observations were made by Berradelli et al. 0 99 1) on 20 patients one to 
54 weeks following stroke. H6mberg et al. 0 99 1) investigated 51 patients with 
residual disability ranging from one to 53 months following stroke. 27% of 
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patients had no responses following EMS and the MEPs demonstrated a wide range 
of latency and amplitude. Kandler et al. (1991) made similar observations in 22 
patients four days after acute stroke and suggested that the amplitudes of the 
MEPs may relate to outcome. Since the present project was completed, Escudero 
et al. (1992) have reported the findings in 62 patients with acute stroke assessed 
at some time within the first week after stroke. Responses were absent from the 
upper limb in 35% of cases. The presence or absence of MEPs correlated with 
muscle power and function. Finally, Chu and Wu 0 992) tested 28 patients one 
to five days after acute stroke. Using an unusual empirical method for grouping 
patients with absent or delayed responses and combining the results from the 
upper and lower limbs, they concluded that if MEPs were present the prognosis 
was good and if MEPs were absent the outcome was more variable. Both these 
last two papers studied patients with acute stroke but failed to assess large 
numbers of patients in the first 72 hours following the onset of symptoms. In 
keeping with the others studies already cited, they failed to correlate the 
neurophysiological findings with functional outcome at 12 months. 
The studies described so far all support the view that EMS is potentially a 
useful method for determining prognosis after stroke but that systematic studies 
of large numbers of subjects, first investigated within 72 hours following the onset 
of symptoms are required. To clearly evaluate the prognostic value of the 
technique, the initial central motor conduction findings need to be compared to 
mortality and a comprehensive assessment of functional outcome at 12 months 
whereupon functional motor recovery should be complete. How far the technique 
might also help to monitor the progress of motor recovery also needs to be defined. 
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1.7 AIMS OF THE PROJECT 
No longitudinal study so far reported has reinvestigated sequentially a large 
number of patients with stroke at fixed time intervals and observed the changes 
in conduction in the central motor pathways. No definitive study has compared 
abnormalities in central motor conduction in the first 72 hours after the onset of 
symptoms of the stroke to mortality and to functional outcome at 12 months. At 
the time of writing this thesis, the prognostic value of using EMS in the acute 
stroke period to determine mortality and functional outcome at 12 months was not 
clearly defined. The present study was therefore undertaken in order to establish 
the prognostic value of EMS after stroke, with the following aims: 
(1) to conduct a longitudinal study on a large number of subjects following 
their first stroke and to make serial observations up to 12 months, starting within 
12-72 hours of the onset of symptoms of stroke and thus document the natural 
history of conduction in the motor pathways after stroke. 
(2) to compare neurophysiological measurements of conduction in central 
motor pathways controlling the upper limb with validated assessments of motor 
function, the results of detailed neurological examinations and the anatomical and 
pathological findings of CT scans. 
(3) to assess the neurophysiological measurements as an early predictor of 
mortality and functional recovery at 12 months and the duration of stay in hospital. 
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METHODS AND MATERIALS 
2.1 STRUCTURE OF THE PROJECT 
The study was designed as a prospective longitudinal project and followed 
patients with their first-ever stroke over a 12 month period or to death, if this 
occurred earlier. The choice of 12 months as the outcome was based upon the 
observation that motor recovery after stroke is largely completed by six months 
(Fugel-Meyeretal., 1975). After 12 months further major functional improvement 
was unlikely to occur and the impairment of motor function was expected to be 
permanent. Survivors of the first 60 patients were also reassessed at 18 months 
after stroke to ensure that no further neurophysiological or functional changes 
continued beyond the accepted period of motor improvement. The project was 
preceded by a small cross-sectional pilot study in which 18 patients with their 
f irst-ever stroke were investigated at different stages of recovery. The project was 
approved by the Newcastle Upon Tyne University Joint Ethics Committee. 
2.1.1 Normal subjects 
53 healthy subjects, 20 male and 33 female, aged 47-87 years, of a similar 
age to the stroke patients (See below) were studied to provide normative data. 
(Table 1). All the subjects gave written, informed consent. These healthy 
volunteers were recruited from hospital visitors. Posters were placed in prominent 
positions within the hospital requesting the assistance of healthy subjects for 
stroke research. 
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NORMAL SUBJECTS PATIENTS 
Total number 53 118 
Males 20 (38%) 63 (53%) 
Females 33 (62%) 55 (47%) 
Age range, years 47-87 40-98 
Mean age, years 66.5 70.8 
Mean age of males 68.1 66.7 
Mean age of females 65.5 75.5 
Table 1. Details of the age and sex of normal subjects and patients. 
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2.1.2 Patients 
118 patients, 63 male and 55 female, aged 40 to 98 years with first-ever 
stroke were recruited over a 15 month period (Table 1). The patients were 
recruited from the Royal Victoria Infirmary, Newcastle General Hospital and 
Freeman Hospital, Newcastle upon Tyne. All consultant physicians in the three 
hospitals gave permission to approach the patients. The patients were admitted 
as acute medical emergencies. Each morning, for the duration of the recruitment 
period, the resident medical officer for each hospital was asked about all patients 
admitted with the diagnosis of acute stroke. The patients were interviewed at the 
first possible opportunity, preferably with their relatives present. The medical 
notes were reviewed for evidence of previous stroke or any contraindication to 
EMS of the brain (See below). The purpose of the project was explained and if the 
patient or their relatives gave informed consent, a detailed clinical history of their 
symptoms was taken. Once the details of the history were available, particularly 
when accompanied by the account given by a relative or witness, it became 
apparent that many patients had sustained previous strokes and others did not 
have a history compatible with stroke. These patients were not recruited. 
Documentation of the details of the illness was followed by neurological 
examination. The examination identified further patients who had not sustained 
a stroke. Either no signs were present, suggesting a diagnosis of transient 
ischaernic attack, or signs not compatible with stroke were found. A wide 
spectrum of non-stroke disease was discovered including simple falls in the elderly, 
hypotensive episodes, brain tumours, or collapses due to cardiac events or seizure. 
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2.1.3 Definition of stroke 
Stroke was defined by the World Health Organisation criteria as a clinical 
syndrome of rapidly developing clinical symptoms and/or signs of focal or global 
loss of cerebral function with symptoms lasting more than 24 hours or leading to 
death, with no apparent cause other than that of vascular origin (Aho et al., 1980). 
Infarction was not distinguished from haemorrhage using clinical criteria. 
2.1.4 Inclusion criteria 
Patients who had sustained a stroke were considered suitable for recruitment 
to the study if they met the following inclusion criteria: 
1. The patient must be admitted as an acute medical admission, and must not have 
sustained the stroke whilst in hospital. 
2. The patient must have sustained a first-ever stroke: The patient and his/her 
family were questioned, but if there was any ambiguity, the patient's general 
practitioner was consulted. If a history of a previous stroke or transient ischaernic 
attack was discovered the patient was not recruited. 
3. The patient must not be moribund: The fitness of the patient was based upon 
my own observations, or those of senior medical staff responsible for the patient. 
4. No history, or evidence of previous central neurological disease must exist: This 
was to ensure that any neurological features were a consequence of stroke, and 
that no "contamination" from other disorders would distort the findings of the 
study. The only exception was migraine, assuming that no neurological deficit had 
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remained following the resolution of any attack. 
5. No history of epileptic seizure or febrile convulsion: Seizures may reflect 
underlying, but clinically, covert neurological abnormalities of the brain. Excluding 
these patients reduced the theoretical possibility of a seizure during EMS. 
6. No serious head injury or blow to the head causing a loss of consciousness: 
Hidden neurological damage may exist following a significant head injury and thus 
produce misleading and inaccurate signs. There may also be an increased risk of 
epileptic seizures if brain damage was present. 
7. No operations that involved either a craniotomy or access to the spinal cord: 
This avoided the influence of post-surgical neurological damage. Also, metallic 
materials may have been left in-situ and, if ferromagnetic, these would have the 
potential for movement and heating when subjected to the time-varying magnetic 
field. Anatomical damage caused by these events would be potentially dangerous. 
8. No atlanto-axial joint instability, e. g. from rheumatoid arthritis of the neck: 
Electromagnetic stimulation to the spinal roots in the cervical spine causes sudden 
and involuntary muscle contraction of the neck muscles. This could be potentially 
harmful in the presence of atlanto-axial joint instability. 
9. No cardiac pacemaker or intracranial hearing devices: Such devices might 
malfunction in the presence of powerful electromagnetic fields and this could 
present a risk to the patient. 
10. No history of damage to the eyes or face from metal fragments, either from 
shrapnel injuries or due to occupational injuries e. g. splinters from metal work: 
This was to avoid any potential anatomical damage to tissues. If the metal was 
ferromagnetic it might be displaced by the presence of the magnetic stimulus. 
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11. No prostheses in the head or neck e. g. in the middle ear: To avoid malfunction 
of electronic or electrical devices and potential movement if ferromagnetic. 
12. Written informed consent must be given by the patient or from a close relative, 
in whose opinion it was felt that the patient would wish to participate, if he/she 
were able to communicate. 
13. All patients must enter the study and complete their investigations within 72 
hours after the onset of symptoms. 
The first neurological symptom was regarded as the onset of the stroke. 
Patients were only recruited if the first set of investigations could be completed 
within 72 hours after the onset of symptoms, designated as Day 1. This was a 
reasonable delay during which investigations might still yield valuable and, 
hopefully, evolving neurophysiologicalfindings. It allowed for the practical aspects 
of transporting either the equipment to the patient or the patient to the 
neurophysiological laboratory. 
Following the initial interview and examination, if all the criteria for 
recruitment were met, the practical details of the project were explained to both 
the patient and where possible, the spouse or a close relative. If the patient 
demonstrated language difficulties, or problems of comprehension, e. g. confusion, 
the details of the project were always discussed with the next of kin or a close 
relative. Written consent was taken only if the patient understood or a relative 
was in agreement that the patient would, in their opinion, be willing to participate. 
If written consent could not be obtained from the patient e. g. if the patient was 
unable to sign their consent form, the consent was given by proxy. 
45 
I spent a lot of time explaining the details of the project to avoid 
misunderstandings. It was emphasized that the investigations would be repeated 
over a period of 18 months and at no time would these investigations hinder any 
treatment received whilst in hospital, nor would the tests interfere with the 
patients subsequent discharge from hospital, or their future placement or 
management. The project involved only diagnostic methods and that no 
therapeutic value was to be expected. There was no evidence to indicate EMS 
was not a safe procedure, but it was emphasised that no guarantee could be given 
regarding the remote possibility of unknown side effects occurring at a later date. 
2.1.5 Clinical details recorded 
The medical history and clinical examination findings were documented on 
a precoded questionnaire to allow easy transfer of the data for computing and 
statistical analysis. Background information about next of kin, address, general 
practitioner were taken and details about the onset and symptoms of the stroke, 
past medical history, current medications, family history, occupational history, 
smoking and alcohol consumption. Handedness was assessed by asking about 
hand preference for activities involving a high degree of dexterity such as writing, 
use of tools, racket games etc. The findings of the examination of the 
cardiovascular system were documented along with the results of a detailed 
neurological examination including aspects of cognitive function such as language 
and visual attention, fundoscopy, visual fields, the cranial nerves, sensation, 
muscle tone, tendon and frontal release reflexes and plantar responses. 
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2.1.6 The timing of investigations after stroke 
The first clinical and neuro physiological investigations were completed within 
12-72 hours of the onset of symptoms (Day 1). Investigations were repeated at 
set time intervals after Day 1, viz. 3,7 and 28 days, 3,6 and 12 months (Table 
2), and at 18 months for the survivors of the first 60 patients recruited. 
Neurological assessments preceded EMS of the brain and were blind to information 
from CT scans. Patients too ill to be moved were assessed at the bedside since 
the equipment was mobile. 
t 
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TIMING OF THE INVESTIGATIONS 
Day 1 within 72 hours of onset of symptoms. 
Day 3 48 hours after first test. 
Day 7 seven days after first test. 
Day 28 28 days after first test. 
Month 3 three months after first test. 
Month 6 six months after first test. 
Month 12 12 months after first test. 
Month 181 18 months after first test. 
TABLE 2. Timing of the neu ro physiological and clinical observations. 
' Only the survivors from the first 60 patients recruited were investigated at 18 
months. 
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2.2 RADIOLOGICAL, CLINICALANDNEUROPHYSIOLOGICAL ASSESSMENTS OF 
PATIENTS WITH STROKE 
2.2.1 Initial and sequential assessments 
A wide variety of clinical and neurophysiological measures of motor function 
and activities dependent upon motor function were assessed at Day 1 (Table 3). 
The details of symptoms, a complete neurological examination and the Bamford 
classification of stroke were only documented at the time of recruitment. When 
possible all other measurements were repeated at every test session. This 
provided a sequential record of clinical and neurophysiological change during the 
first 12 months of recovery. 
2.2.2 Outcome assessments at 12 months 
In order to define the clinical, functional and neurophysiological status of the 
survivors at 12 months, a range of outcome measures were used including clinical 
examination of tone and reflexes, assessment of muscle power in the upper and 
lower limbs, hand dexterity, the activities of daily living and level of independent 
function (Table 4). Estimates of various measures of central motor conduction 
were made using EMS of the brain. The number of patients who died was 
recorded and defined as either dying of stroke-related causes or of non-stroke 
death. The period of time to death and the period a patient spent in hospital were 
recorded. The survivors of the first 60 patients in the study were reviewed at 18 





Bamford clinical classification of stroke. 
Examination of muscle tone and tendon reflexes. 
Motricity Index to assess limb power. 
Nine-hole Peg Test of hand dexterity. 
Barthel scale of the activities of daily living'. 
Estimates of central motor conduction. 
TABLE 3. Initial assessments at Day 1. 
' The assessment made at, Day 7 was used for comparison with central motor 
conduction since the Barthel Scale is not reliable until about seven days. 
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OUTCOME MEASURES AT 12 MONTHS 
Examination of muscle tone and tendon reflexes. 
Motricity Index to assess limb power. 
Nine-hole Peg Test of hand dexterity. 
Barthel scale of the activities of daily living. 
Rankin scale to assess functional outcome. 
Estimates of central motor conduction: 
1. CMCT 
2. duration of response 
3. threshold to stimulation 
Mortality. 
Period of time to death. 
Duration of stay in hospital. 
TABLE 4. Outcome measures at 12 months. 
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2.2.3 Radiological assessments 
Scanning was performed at Newcastle General Hospital (IGE 9800 CT 
scanner) and at the Royal Victoria Infirmary (Shimadzu 3000TX). An attempt was 
made to obtain a CT scan in every patient, but eleven patients were not scanned: 
three patients were too ill to travel to another hospital, four patients died prior to 
the scan, three could not be transported for scanning due to a national ambulance 
strike and a further patient left hospital and did not return for a scan. 
The CT scans were reviewed by two consultant neurologists and a 
consultant neuroradiologist who made their observations in the absence of any 
clinical data and the results of neurophysiological and functional assessments. The 
type of stroke was defined as haernorrhage if blood was visible as an area of high 
attenuation. Infarction was defined as a region of low attenuation. If 
haemorrhagic transformation of an infarction was present, the type of stroke was 
regarded as an infarction. If no abnormality was seen the scan was defined as 
, normal. 
If a lesion was visible its size and volume were estimated. The largest 
horizontal diameter in any direction of any single scan slice was measured. An 
approximation of the volume of the lesion was derived from multiplying the anterior 
to posterior depth of the lesion by its largest horizontal diameter and multiplying 
by the height of the lesion. This defined a cube of tissue which was approximated 
to spherical volume by dividing the volume by two. The final result was the 
approximate spherical volume of tissue affected by the lesion, the units being mm' 
(Nelson et al., 1980). 
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The presence of ventricular rupture or hydrocephalus was noted. Mass 
effect was defined as displacement of anatomical structures in any plane and 
included sulcal effacement. The site of the lesion was identified as cortical, 
subcortical or both cortical plus subcortical. Laterality of lesion was defined as 
left, right, midline or left plus right. The pattern of the lesion was defined as 
confluent or patchy. The arterial territory was defined using the scheme given by 
Savoiardo (1986). All the features that were assessed on the CT scans are given 
in Table 6. 
2.2.4 Clinical assessments 
Symptoms 
The patient or his/her carers were asked about the following symptoms: 
awareness of weakness in arm, leg or face, problems of swallowing, vision, 
speech, alteration in sensation, loss of urinary and bowel continence, loss of 
consciousness and headache. The side of the body affected was noted where 
appropriate. 
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FEATURES ON CT SCANS 











Laterality of lesion: 
Pattern of lesion: 
Cortical 
Subcortical 




Left + Right 
Confluent 
Patchy 
Arterial territory: Posterior inferior cerebellar artery (PICA) 
Basilar artery (BA) 
Anterior inferior cerebellar artery (AICA) 
Superior cerebellar artery (SPA) 
Posterior cerebral artery (PCA) 
Anterior choroidal artery (AChA) 
Anterior cerebral artery (ACA) 
Middle cerebral artery (MCA) 
Perforating lenticulostriate arteries (PLA) 
More than one territory involved 
Size of lesion: Largest horizontal diameter 
Approximate spherical volume 
Table 5. Features identified and recorded from CT scans. 
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The Bamford Classification of stroke 
The neurological examination findings at Day 1 were used to assign patients 
into four clinically defined subgroups, using the classification of Bamford et al. 
(1991) (Table 6). Patients were classified using this method irrespective of the 
type of stroke. At the time of recruitment, the nature of the insult whether 
infarction or haemorrhage was not defined, and only became apparent after 
subsequent CT scanning. Classification could be amended at Day 3 in order to 
accommodate any progression of signs that might have occurred. The 
classification was not changed at subsequent dates nor in the light of the results 
of the CT scan. 
Examination of tone and tendon reflexes 
Tone was assessed in the arms and legs for both sides of the body. The 
results were described as either normal, or abnormal if the tone was increased or 
decreased. The tendon reflexes in the upper limbs of supinator, biceps brachii and 
triceps brachii and in the lower limbs at the knee and ankle were assessed and 
were recorded as normal, or abnormal if exaggerated or absent. Plantar responses 
to stimulation were recorded as normal if flexor, or abnormal if extensor. 
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BAMFORD CLASSIFICATION OF STROKE (Bamford et al. 1991). 
Total Anterior Circulation Syndrome (TACS) 
Includes all the following: 
1) Higher cerebral dysfunction 
(e. g. dysphasia, dyscalculia, visuo-spatial problems). 
2) An homonymous visual field defect. 
3) An ipsilateral motor and/or sensory deficit involving at least 
two out of three areas of the face, arm and leg. 
Partial Anterior Circulation Syndrome (PACS) 
1) Only two of the three components of the TACS syndrome. 
or 2) Higher cerebral dysfunction alone. 
or 3) A motor/sensory deficit more restricted than those classified as 
LACS (e. g. confined to only one limb, or to face and hand but 
not to the whole arm). 
Posterior Circulation Syndrome (POCS) 
1A combination of the ipsilateral cranial nerve palsy and 
contralateral motor and/or sensory deficit. 
or 2) Bilateral motor and/or sensory deficit. 
or 3) Disorder of conjugate eye movement. 
or 4) Cerebellar dysfunction without ipsilateral long tract deficit. 
or 5) Isolated homonymous visual field defect. 
Lacunar Syndrome (LACS) 
1) Pure motor stroke. 
or 2) Pure sensory stroke. 
or 3) Sensori-motor stroke. 
or 4) Ataxic herniparesis, where ipsilateral cerebellar and 
corticospinal tract signs are present, with or without 
dysarthria, in the absence of higher cerebral dysfunction, 
or visual field deficit. 
Table 6. The Bamford clinical classification of stroke (Bamford et al. 1991). 
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The Motricity Index of muscle power 
Muscle power was recorded with the patient either seated or lying down 
using the Motricity Index (Demeurisse et al., 1980). This is derived from the 
Medical Research Council scale of power testing and uses weighted scores to 
assess power for six specific movements in the upper and lower limbs - pinch grip 
of index finger to thumb, elbow flexion, shoulder abduction, dorsiflexion of the 
foot, knee extension and hip flexion (Table 7). Both sides of the body were 
assessed at each test session. 
Two principles underlie the Motricity Index, first, the strength of any one 
movement about a joint is similar to the strength of all other movements about the 
joint, and so only the strength of one movement is assessed for each joint. 
Second, the proportion of total recovery is represented by each change of grade, 
and thereby the significance of change is given by the weighted score. The 
weightings represent the difficulty experienced by the patient to progress from one 
stage to the next with the total difficulty experienced in progressing from stage 0 
to stage 6. The use of weighted scores allows the calculation of a score out of 
100 to represent the power at a joint, in a limb, or in the whole side. 
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MOTRICITY INDEX (Derneurisse et al., 1980). 
Pinch grip - 2.5cm cube held between thumb and index finger. 
O= no movement. 
11 = any movement of finger or thumb. 
19= grips cube, but unable to hold against gravity. 
22= cube held against gravity, but not against weak pull. 
26= grips cube against gravity, but weaker than the other side. 
33 = normal pinch grip. 
Elbow flexion: elbow flexed at 901, forearm horizontal and upper arm 
vertical. Patient attempts to flex arm against resistance. 
Shoulder abduction: with the elbow fully flexed and against the chest 
wall the patient abducts the arm against resistance. 
Ankle dorsiflexion: patient is asked to dorsiflex the foot against 
resistance from a relaxed plantar flexed position. 
Knee extension: extend the knee against resistance from a flexed 
position of 900. 
Hip flexion: flexion of the hip from a position of 9" flexion against 
resistance. 
The assessments above are scored according to the following scale: 
O= no movement. 
9= powerful contraction in muscle, but no movement. 
14= movement, but not full range and not against gravity. 
19= full range of movement against gravity, but unable to move 
against minimal resistance. 
25= full range of movement against resistance, but weaker than 
the other side. 
33= normal power. 
Upper limb total (Pinch grip)+ (Elbow flexion)+ (shoulder abduction) +1 
Lower limb total (Ankle dorsif lexion) + (Knee extension) + (Hip flexion) +1 
ide total = (Upper limb total)+ (Lower limb total) 
2 
Table 7. The Motricity index of muscle power (Derneurisse et al., 1980). The 
scores are weighted according to the difficulty of the required movement. 
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The Nine Hole Peg Test of hand dexterity 
This is a performance test of hand function (Sharpless, 1982). The subject 
was asked to place nine cylindrical pegs of wood, 9mm diameter, 32mm long, into 
a peg board with a 3x3 array of holes spaced 60mm apart (Fig. 1). Patients 
performed the test using the non-paretic hand followed by the paretic hand. The 
time taken to position correctly all nine pegs for each hand was recorded. A time 
limit of 50s was applied. Less than all nine pegs may be positioned in this time or 
no pegs at all. The test is expressed as the rate of positioning of pegs per second. 
A normal range was provided by testing the normal group of 53 healthy subjects. 
The rules of the procedure were explained and the method demonstrated to 
the patient. A practice attempt was allowed. Only the hand under investigation 
must pick-up the pegs. Only one peg at a time must be manipulated and it must 
be fully placed into a hole. If a peg was dropped, then the patient had to restart 
the test from the beginning with 9 pegs. 
Non-motor problems may negatively influence the test and had to be 
compensated, e. g. positioning the peg board to one side of the midline for better 
performance, if hemianopia interferes with the test. If shoulder weakness limited 
hand positioning, the patient was allowed to lift the paretic arm into position with 
the non-paretic hand, but the pegs had to be grasped using the paretic hand alone. 
If a cooperative patient was unable to attempt the test with the paretic hand 
because of other impairments (e. g. visual or cognitive) and the patient only had a 
flicker of movement, or no movement at all in the pinch grip component of the 
Motricity Index, an arbitrary score of zero pegs per second was recorded. It would 
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Figure 1. The Nine-hole Peg Test assesses hand dexterity. The nine wooden pegs 
are placed in the peg board as quickly as possible. The time taken to correctly 
position all nine pegs is recorded. If all the pegs are not in position within the time 
limit of 50 seconds the number of correctly positioned pegs is recorded. The test 
is expressed as the rate of peg positioning i. e. pegs/second. 
II 
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seem reasonable to assume that with no useful movement in pinch grip, the hand 
could not be used to grasp pegs and therefore no score would be achieved. The 
same rule was not applied to the performance of the non-paretic hand. If 
movement was present, but the patient was unable to execute a skilled movement 
e. g. due to dyspraxia, it would not be correct to make the same assumption that 
the hand was incapable of achieving a score, in the absence of the neurological 
deficit preventing the test. 
The Barthel Scale of the activities of daily living 
The Barthel scale (Mahoney and Barthel, 1965) was used to assess ten 
different aspects of daily activity, most of which relate indirectly to motor function 
(Table 8). Points were awarded for different levels of achievement in each 
category and the scores were added together to provide a total score ranging from 
0-20. The level of achievement reported by the carer, appears to be the most 
accurate assessment (Wade, 1985) and the activities reported by the patient tend 
to be less accurate and more variable. Therefore the information was obtained 
from the principal carer not the patient. 
The activities assessed were very dependent upon motor function. This can 
be a weakness of the Barthel scale, but given that this study focused on motor 
function, the motor bias was an advantage. A disadvantage of the Barthel scale 
is the saturation effect of a score with a maximum of 20. The score of 20 does 
not equate with "normal" function and does not necessarily reflect a lack of 
disability, for example a problem with language secondary to a stroke can be quite 
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BARTHEL SCALE OF THE ACTIVITIES OF DAILY LIVING 
(Mahoney and Barthel, 1965) 
Bowel control O= incontinent 
1= occasionally incontinent 
2= continent 
Bladder control O= incontinent/catheterised & unable to cope 
1= occasionally incontinent 
2= continent 
Grooming O= dependent 
1 independent for washing face; combing hair; 
cleaning teeth; shaving 
Toilet use O= dependent 
1= requires some help 
2= independent 
Feeding 0= dependent 
1= requires help 
2= independent 
Transfer O= dependent 
1= requires major help, but can sit unaided 
2= minor help 
3= independent 
Mobility O= immobile 
1= independent with use of wheelchair 
2= walks with the help of one person 
3= independent (but may use stick or walking aid) 
Dressing O= dependent 
1= requires help with some items 
2= fullyindepenclent 
Stairs O= unable to climb or descend stairs 
1= requires help on stairs 
2= independent and able to climb or descend stairs 
Bathing 0= dependent 
1= independent 
Total = maximum of 20 
Table 8. Barthel scale of the activities of daily living (Mahoney and Barthel, 1965). 
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disabling, but the individual can score full marks on the Barthel scale. The score 
must not be considered as necessarily indicative of the patient's absolute 
A10, performance level - this is not possible to measure. A further potential 
disadvantage of the Barthel scale is the even spacing of the intervals used to 
measure performance. In order to lessen any adverse effects this might have on 
the statistical analysis of the results, non-parametric statistics have been used 
through the study. However, the Barthel score is a validated and useful method 
of assessing the activities of daily living. 
At the initial interview the patient's score prior to their stroke was 
established. This was not necessarily the maximum of 20 points due to pre- 
existing problems, e. g. arthritis, or amputation of a limb. The Barthel score was 
assessed at every test session but the assessments at Day 1 and Day 3 have only 
limited value. Assessments made in the first few days are often incomplete. 
Patients may not have been given the opportunity to attempt some components 
of the scale e. g. they may have not been mobilised and therefore ability to walk 
and climb stairs can not be assessed, or they may have not wanted to eat, or 
bladder continence may be unknown. In order to allow time to assess the patient's 
capabilities and to provide a more accurate assessment of function, the first Barthel 
assessment used in any statistical comparisons was the Day 7 test. At each test 
session the Barthel score was expressed empirically as a score out 20. 
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The Barthel scale of the activities of daily living at 12 months 
In addition to recording the score out of 20 at 12 months the patients were 
arbitrarily divided into two outcome groups - "good" (scores of 13 - 20) or "poor" 
(12 or less). Patients with scores of 13 or more tend to be only mildly disabled 
and independent of a carer for activities of daily living whereas those with scores 
of 12 or less tend to be dependent (Wade and Hewer, 1987b). 
The Rankin Scale of functional outcome at 12 months after stroke 
At 12 months functional outcome was assessed using a modified version of 
the Rankin scale (Rankin, 1957; Bamford et al., 1989). Six categories are 
recognised, ranging from 0 (no disability or symptoms and independent) to 5 
(bedridden and totally dependent). Patients were assigned to different categories 
on the basis of their functional capacity (Table 9). Patients were also designated 
as independent (categories 0,1 or 2), or dependent (categories 3,4 or 5). 
2.2.5 Mortality after stroke 
If the patient died within the study, the death certificate was reviewed. 
Death caused by the original stroke, its extension or by further stroke was defined 
as stroke-related, and, unless an independent cause was identified, included death 
from stroke-related problems such as pneumonia, pulmonary embolus and 
septicaernia. Non-stroke death encompassed all other causes of death. 
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RANKIN SCALE (Rankin, 1957; Bamford et al., 1989). 
Grade: 
0= No disability related to stroke. 
1= No significant disability. 
Symptoms may be present but able to complete all usual duties. 
2= Slight disability. 
Unable to complete some of previous activities, but able to look 
after own affairs without assistance. 
3= Moderate disability. 
Requires some help, but able to walk without assistance. 
Moderately severe disability. 
Unable to walk without assistance and unable to attend to own 
bodily needs without assistance. 
Severe disability. 
Bedridden, incontinent and requiring constant nursing care and 
attention. 
Table 9. The modified version of the Rankin scale of function 
(Bamford et al., 1989). 
65 
2.2.6 Period of time to death 
The number of days that a patient remained alive after stroke was recorded. 
2.2.7 Duration of stay in hospital after stroke 
The number of days that a patient remained in hospital or required nursing 
care outside of their home was recorded for survivors at 12 months. This provides 
a rough measure of the degree of dependence. It is clearly only a reflection of 
severity of stroke and is influenced by many medical, social and health care 
factors. It nevertheless provides information that may be useful regarding 
rehabilitation and medical resource management. 
2.2.8 Neurophysiological assessments 
Electromagnetic Stimulation of the brain 
Electromagnetic stimulation was used to stimulate painlessly and safely the 
brain (Barker et al., 1985). A time-varying magnetic field was produced by rapidly 
discharging a high current through a coil held above the head of the subject with 
the centre of the coil placed over the vertex. The neural tissue of the brain is 
electroconductive and an electrical current was induced in the motor cortex. The 
magnetic field produced an action potential in the neural tissue and an MEP 
traversed the motor pathways and was recorded at the contralateral target muscle 
from the compound surface EMG. The patient was aware of a loud click from the 
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coil held above the head. This was the result of rapid expansion of the coil 
windings and of the gases around. The patient experienced a painless and 
short-lived involuntary twitch of muscles in the upper limbs. 
An explanation and demonstration of the technique was given to each 
patient prior to the investigation and often repeated at subsequent test sessions 
as a reassurance that no changes had been made. Where possible a demonstration 
was given to the patient's relatives and to any nursing or medical staff looking 
after the patient. This proved to be a successful way of improving the quality of 
understanding regarding the technique and it minimised anxiety. 
Electromagnetic Stimulation of the motor cortex 
The subjects were either seated or lying half supine in bed with the particular 
arm being studied supported by pillows. An electromagnetic stimulator (MagStim 
200, MagStim Co. Ltd. ) was used to excite the motor cortex and spinal motor 
roots. To stimulate the motor cortex a circular coil (MagStirn 9cm) was placed in 
the tangential plane above the vertex of the head (Fig. 2). Both sides of the coil 
were able to stimulate either cerebral hemisphere. The left hemisphere was 
stimulated with an anti-clockwise current, viewing the coil from above, and the 
right hemisphere by a clockwise current (Day et al., 1990). The two sides of the 
coil were marked so that the appropriate side was used for each hemisphere. 
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Figure 2. Photograph of a subject under investigation using EMS Of the motor 
cortex. 
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Threshold of stimulation of the motor cortex 
The output of the stimulator is graded as a percentage of maximum voltage 
output. The current induced in the brain is related to the power of the electrical 
pulse through the coil. In view of this the stimulus intensity is expressed as 
percentage power output of the stimulator, i. e. the square of the percentage 
reading of stimulus voltage displayed by the stimulator, divided by 100. 
The stimulus intensity was increased gradually until the threshold level was 
reached, when a response in relaxed biceps brachii could be consistently obtained 
in 50% of trials. The threshold level was documented for both biceps brachii and 
thenar muscles, but not for triceps brachii and pectoralis major in order to reduce 
the total number of stimuli given to a patient. The stimulus intensity was then set 
at a suprathreshold level at 4% power (i. e. 20% voltage) above the threshold for 
biceps brachii, as far as the scale permitted. If the threshold was 100% then this 
was the stimulus level used. If no response was obtained, despite maximum 
stimulation with the target muscle relaxed, no value for the threshold to stimulation 
was given. 
In order to document the presence of responses and to obtain appropriate 
values of CIVICT, facilitation was provided by gentle voluntary contraction of the 
muscle being studied; if no voluntary contraction could be achieved, the subject 
contracted the homologous muscle of the opposite side (Hess et al., 1987b and 
c). An absent response to stimulation was documented if no response was 
obtained after 10 stimuli at maximum output of the stimulator and with facilitation 
from muscle contraction. Eight or more responses were recorded from stimulation 
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of the cortex. The shortest latency in any trial between cortical stimulation and the 
muscle response was noted, since this has been shown to provide the basis for the 
best estimate of central motor conduction time (Hess et al., 1987b and c). Some 
patients were only able to demonstrate responses by the threshold lowering effect 
of attempted ipsilateral or homologous contralateral muscle contraction. 
Recording of the surface electromyogram 
The surface electromyograrn (EMG) was recorded using miniature 
preamplifiers with in-built electrodes applied to the skin (Johnson et al., 1977) over 
the following muscles bilaterally: pectoralis major (electrodes horizontally over the 
clavicular head); biceps brachii (electrodes in the vertical plane over the muscle 
belly); triceps brachii (electrodes in the vertical plane over the belly of the lateral 
head); thenar muscles (electrodes over the thenar eminence in the direction of the 
first metacarpal bone). A virtual earth electrode was applied to the forearm. 
The skin was cleaned with alcohol and the area dried. The preamplifier with 
its two inbuilt electrodes was attached to the skin with double-sided skin- 
compatible adhesive tape with two holes that align with the underlying electrodes. 
Contact between the skin and the electrodes was made with electrode gel placed 
in the holes of the adhesive tape. The electrodes were placed in approximately the 
same position at each test session. Obviously this was not precise. Precise 
positioning could only have been obtained if the skin was indelibly marked to 
ensure the same position for the duration of the longitudinal study. 
The two recording electrodes comprised silver discs of 5mm diameter set at 
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20mm centres. The signals were amplified and filtered with a -3dB bandpass of 
10-1 OOOHz and recorded on magnetic tape (Racal Store 4 recorder) and also using 
a computer (Apricot Xi) running Signal Averager software via a type 1401 interface 
(Cambridge Electronic Design Ltd. ). The signals from the preamplifiers were fed 
through an isolation circuit for safety reasons (B. S. 5247) (Fig 3). 150 
milliseconds of EMG activity was recorded using the stimulus artifact as the zero 
point for time measurements. 
Protocol for electromagnetic stimulation of the motor cortex 
The clinical assessments were carried out prior to EMS. This standardised 
the investigations and eliminated any bias of motor function that stimulation of the 
motor cortex might conceivably produce. EMS was performed at every test 
session assuming the patient was willing, or not deemed too ill. 
In stroke patients EMS of the hemisphere contralateral to the paretic side 
was always studied first - referred to as the damaged hemisphere. This was 
always followed by ipsilateral stimulation of the cervical motor roots to the same 
target muscles. The undamaged hemisphere was then investigated followed by 
stimulation of the appropriate motor roots. 
The patient was repeatedly stimulated with the coil in the same position at 
the vertex at approximately five second intervals. Eight or more well-defined 
responses were recorded, unless the patient showed signs of distress, in which 
case, fewer stimuli were given. Such cases were rare, but if distress was 










Pre amplifier electrodes amplifier 
Figure 3. Diagram of the equipment used for EMS of the brain and spinal motor 
roots and the recording of compound EMG responses from the target muscles of 
the upper limb. 
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Computer 
willing to continue, then four or more responses were recorded. If responses were 
absent after ten stimuli at maximum output of the stimulator and with facilitation 
from muscle contraction a result of "No Response" (NR) was documented. The 
shortest latency of responses following cortical stimulation was used to estimate 
CIVICT (Hess et al., 1987c). 
In order to restrict the total number of stimuli given, recordings from the 
thenar and biceps brachii muscles were recorded simultaneously with the muscles 
contracted - the biceps by attempted flexion of the elbow against resistance, whilst 
simultaneously contracting the thenar muscles by gripping a 3x3cm wooden cube 
between thumb and index finger. The triceps brachii and pectoralis major muscles 
were then stimulated while the patient was instructed to extend simultaneously at 
the elbow and internally rotate the arm against resistance. In both cases if the 
target muscles were paralysed attempts were made to contract the homologous 
muscles of the non-paretic arm using the same manoeuvre outlined above. 
Electromagnetic stimulation of the spinal roots 
To stimulate the cervical motor roots the stimulator coil was applied over the 
cervical vertebrae, centred in the coronal plane over the body of C7. Responses 
were recorded in the surface EMG of the target muscles. Anti-clockwise current 
flow was used to stimulate roots to the left arm and clockwise flow for the right 
arm. During stimulation of the spinal roots the target muscles were relaxed since 
muscle contraction does not affect latency when stimulating the spinal roots. The 
stimulus strength was 100% power for all subjects, irrespective of the threshold 
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of response. The longest latency was noted from eight or more responses. Four 
or more responses were obtained if a patient demonstrated any distress. 
For stimulation of the cervical motor roots, maximum stimulation intensity 
at 100% irrespective of the threshold to stimulation was used for all patients and 
normal subjects. The decision was based upon experience gained from the pilot 
study described below. The use of 100% intensity provided a consistent response 
in the EMG. The use of supra-threshold electrical stimulation of cervical roots has 
been shown, however, to shorten the latency of the muscle response (Plassman 
and Gandevia, 1989). On the other hand supra-threshold EMS has been reported 
to produce responses at less variable latencies (Ugawa et al., 1989). 
Since commencing the present study, further research has shown that EMS 
over the cervical motor roots is most consistent when applied at maximal 
stimulation. The best position for stimulation is to centre the coil over the midline 
of the cervical vertebrae. In fact, EMS appears to stimulate the motor roots more 
proximally than ES thus giving a more accurate estimation of CIVICT (Cros et al., 
1990). The method used in this project was based upon experience gained from 
the pilot cross-sectional study. 
Central Motor Conduction Time (CMCT) 
Subtraction of the longest latency to cervical motor root stimulation from 
that of the shortest latency to motor cortex stimulation provided an estimate of 
CIVICT for each muscle (Hess et al., 1987c) (Fig. 4). Estimations of CIVICT were 
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Figure 4. Diagram to demonstrate how CMCT is calculated. The longest latency 
of evoked potentials following stimulation of the spinal root to a particular target 
muscle is subtracted from the shortest latency of responses following stimulation 
of the cortex to the same muscle. The difference between the two responses is 
an estimate of CMCT. 
Coil stimulating 
over cervical spine 
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Duration of the motor evoked potential 
The durations of the responses were measured from the average of all the 
responses following cortical stimulation. The duration was determined visually by 
noting the onset of the response and where the response returned to the baseline. 
The measurement of duration from an average of single trials may possibly lead to 
a skew of the results by recording the shortest onset latency and the longest offset 
latency, but the inaccuracy is small in relation to the total duration. 
Accuracy and objectivity of estimations of CMCT 
CIVICT values are an approximation of conduction in the central motor 
pathways synapsing with spinal motor neurones. EMS produces a volley in the 
corticospinal pathway (Edgley et al., 1989 a and b, 1990,1992) which in turn 
activates the spinal motor neurones leading to the action potential recorded in 
muscle (Barker et al., 1987). Subtraction of the peripheral component from the 
total cortex to muscle time gives an overestimate of CMCT. EMS and ES over the 
cervical spine both excite the motor roots in the region of the intervertebral 
foramina (Mills and Murray, 1986, Schmid et al., 1990). Thus the time taken for 
the action potential to pass along the ventral root to its emergence from the 
intervertebral foramen and the corticospinal synaptic delay (approximately 1 ms) 
is included within the CIVICT estimation (Murray, 1991). The term CMCT is 
therefore a useful and widely used term but it is inevitably imprecise since values 
of CIVICT include a short peripheral component. 
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The onset of a response was taken as the first deflection from the baseline 
whether this was positive or negative. The responses were very consistent and 
the onset of the waveform could easily be defined and measured. All 
measurements of latency were analysed using a small software programme 
specifically written by Mr. Sean Kelly (Computing Engineer, Human Movement 
Research Group) for this project, which calculated the values of CIVICT and 
duration when analysing the raw data. The longest latency following cervical 
motor root stimulation was subtracted from that of the shortest latency following 
motor cortex stimulation to provide an estimate of CIVICT for each muscle. 
2.3 ASSESSMENTS OF NORMAL SUBJECTS 
The same contra indications for EMS for stroke patients were applied to the 
53 normal subjects (Table 1). These healthy volunteers were investigated to 
obtain comparative data for the Nine-hole Peg Test and central motor conduction 
values (CMCT, duration and stimulus threshold). The nature of the investigations 
was explained to the subjects. All the subjects gave informed written consent. 
The subjects were asked about their medical history, with particular reference to 
cardiovascular and neurological disorders, neurological symptoms, medications, 
family history, smoking and drinking habits. A neurological examination was then 
performed. This included cognitive function; visual fields, acuity and fundoscopy; 
cranial nerves; peripheral sensory system; motor system; tendon reflexes, plantar 
response and primitive reflexes; and ce rebel larfunction and gait. If no neurological 
problem was discovered, and the subjects met the same relevant safety criteria as 
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for the stroke patients, they were enroled in the normal subject group. 
The normal subjects performed the Nine-hole Peg Test with left hand 
followed by right hand. The rate for the two hands was averaged in order to 
eliminate the possible bias of dominance. EMS of the cortex and motor roots for 
both sides of the body followed, using the same methods described for stroke 
patients. The left hemisphere followed by the right motor roots were stimulated 
first, and then the right hemisphere and left motor roots. Recordings were 
obtained from the same four target muscles on the side of the body contralateral 
to the cortical stimulation using the same experimental paradigm described above. 
Estimates of CIVICT, the duration of responses and stimulus thresholds were 
averaged for the homologous muscles of each side since no significant differences 
were identified in the responses from dominant and non-dominant hemispheres. 
2.4 PILOT CROSS-SECTIONAL STUDY 
Prior to the longitudinal study 18 patients with first-ever stroke, were 
studied cross-sectiona I ly at different stages of recovery from 1 to 18 months after 
stroke using EMS of the motor cortex and spinal motor roots. These patients were 
selected from a study investigating risk factors leading to stroke. Their 
presentation and clinical features had been accurately documented by a fellow 
researcher, David Spriggs (Spriggs et al., 1990). All the subjects had originally 
presented with herniparesis. Ten healthy normal subjects with no record of 
neurological disease were also investigated with EMS of the motor cortex. 
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2.5 DATA HANDLING AND STATISTICS 
All data were tabulated on precoded forms and analysed after verification on 
the Northumbrian Universities Multiple Access Computer (NUMAC), using the 
SSPS-X statistical package. Normal ranges derived from investigations of normal 
subjects data are expressed as the mean + 2.58 times the standard deviation 
(99% confidence interval). Results from patients were considered abnormal if no 
recorded response was obtained despite facilitation. Values of CMCT, duration, 
threshold to stimulation and rate of peg positioning in the Nine-hole Peg Test were 
abnormal if they fell outside the 99% confidence intervals for values obtained from 
the normal group of subjects. Absent responses are not regarded as a zero value. 
They are not included in the calculation of any mean values (this applies to CIVICT, 
duration and threshold). They are shown as No Responses (NR) in the figures. 
All statistical comparisons used non-parametric methods. Kruskal-Wallis 
one-way analysis of variance was used to compare three groups of data and Mann- 
Whitney U test to compare two groups of data. Wilcoxon matched pairs signed 
rank test was used to compare paired results. Odds ratios are given as a measure 
of association. Where appropriate a Yates correction was used with the Chi- 
squared test. 
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Validity of measures of CMCT in predicting outcome at 12 months 
The validity of CIVICT in predicting outcome at 12 months has been assessed 
by the following statistical measures in two patient groups: 
1. The No Response Group (No responses despite muscle contraction and maximal 
stimulator output). 
2. Patients with responses (Combining the Normal Response Group and the 
Delayed Response Group - see Results). 
Sensitivity refers to the proportion of patients with no response at Day 1 
whose recovery at 12 months is graded as poor for the various outcome measures. 
Specificity refers to the proportion of patients with responses at normal or delayed 
latencies at Day 1, whose outcome at 12 months is defined as good. Positive 
predictive value refers to the proportion of those with no response at Day 1 whose 
outcome at 12 months is poor, and negative predictive value provides the 
proportion of those with responses at Day 1 whose outcome at 12 months is good 
(See Kramer, 1988). 
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RESULTS 
3.1 PILOT CROSS-SECTIONAL STUDY 
The main observations from the pilot cross-sectional study are listed below: 
1. Following EMS of the cortex responses could always be obtained in relaxed 
muscles at thresholds below maximal stimulator output in normal subjects. 
2. Cortical responses were always recordable in the non-paretic limb following 
stimulation of the non-damaged motor cortex in patients with stroke. 
3. No ipsilateral responses could be evoked in either the normal or stroke subjects. 
4. In more than half the stroke subjects responses in the paretic limb could only be 
obtained at maximal stimulator output (100%) facilitated by muscle contraction. 
6. In three subjects no responses were obtained in the paretic upper limb despite 
maximal stimulation and contraction of the homologous muscles in the non-paretic 
upper limb. 
6. It was confirmed that muscle contraction shortened the latency of the evoked 
response (Hess et al., 1987b). 
7. Responses were always produced following stimulation of the spinal roots in 
both normal and stroke subjects but the stimulus strength varied greatly from as 
low as 16% to 100% of the power output of the stimulator. Subjects with very 
large neck muscles, or excessive obesity, or those with an exaggerated cervical 
lordosis, required maximal stimulation, presumably due to the distance from 
stimulator to the point of stimulation of the spinal nerve root. 
8. The latency of the responses following stimulation of the spinal roots was not 
significantly influenced by the presence of muscle contraction. 
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9. The amplitude of responses were often smaller in stroke patients. 
10. The amplitude of responses varied greatly within a very wide range particularly 
if muscle contraction was present in the limb under investigation. 
11. Measurement of amplitude was very inaccurate since relaxation of muscle was 
particulary difficult if spasticity was present. 
Following experience gained from the pilot study the following methods of 
investigation were chosen for the longitudinal study: 
1. The threshold to stimulation would be determined in relaxed biceps brachii and 
thenar muscles. 
2. The presence or absence of responses would be noted in relaxed muscles and 
in contracted muscles. 
3. All recording of responses would take place during muscle contraction. The use 
of muscle contraction to facilitate a response ensured if a response was produced 
the shortest latency would be recorded. 
4. Responses would be regarded as absent only if they could not be evoked after 
repeated attempts at maximal stimulation and with muscle contraction. This 
manoeuvre avoided inadvertently missing responses that were only obtained with 
the threshold-lowering action of muscle contraction. The use of contraction 
avoided problems relating to the difficulty some patients had relaxing the target 
muscle, particularly if spasticity was present. 
5. Maximal power would be used to stimulate the spinal motor roots in order to 
ensure a response from all subjects. 
6. Stimulation of the spinal roots did not require contraction to facilitate responses 
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and so responses from the motor roots would be recorded in relaxed muscles. 
7. It was difficult to standardise and control the amplitude of responses. From 
initial trials the author concluded that measurement of amplitude was far too 
subjective, with too much inter- and intra-subject variation. 
3.2 NORMAL SUBJECTS 
3.2.1 Handedness 
Handedness in the 53 healthy subjects is shown in Table 10. No correlation 
was found for the differences between CIVICT, duration and threshold to 
stimulation for responses recorded from the dominant compared to non-dominant 
hemisphere. The constancy and reproducibility of CIVICT, duration and threshold 
to stimulation of responses when the two hemispheres were compared meant that 
comparisons could be made with the results from stroke patients, irrespective of 
which hemisphere was affected by the stroke. 
3.2.2 The Nine-hole Peg Test of dexterity in normal subjects 
The peg positioning rates for left and right hands were averaged to allow 
comparisons with stroke patients, irrespective of the hemisphere affected by the 
stroke. The mean value was 0.55 pegs per second, S. D. =+0.07. Any values 
in stroke patients that were outside the normal range were regarded as abnormal. 
Therefore using the results from normal subjects the normal range for the peg test 
rate was regarded as the mean + 2.58 S. D i. e. the 99% confidence interval. 
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HANDEDNESS NUMBER OF SUBJECTS 
(n = 53) 
Left 2 (4%) 
Right 49 (92%) 
Ambidextrous 2 (4%) 
Table 10. Handedness in normal subjects. 
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3.2.3 Bectromagnetic stimulation in normal subjects 
CMCT and duration of response 
Typical EMG responses to EMS of the motor cortex and the cervical motor 
roots are shown in Fig. 5A for normal subjects. Responses could always be 
obtained following EMS of the motor cortex or the spinal motor roots whether the 
muscles were relaxed or contracted. Responses were recorded in contracted 
muscles during cortical stimulation and in relaxed muscles during stimulation of the 
spinal roots. 
The variation in latency of cortical responses to different muscles and the 
differences in CMCTs reflects the different intracranial distance travelled by the 
responses from their origins in the motor cortex to the level where the motor roots 
exit from the spinal cord. The results for individual muscles were very consistent. 
The recordings from the pectoralis major muscles demonstrated the most variation. 
The durations of the cortical responses are very similar for the different muscles. 
The results of CIVICT for all 53 normal subjects for each muscles tested are 
plotted against age in Fig. 6. No statistical relationship to age was found for 
CIVICT or duration, hence all stroke patients could be compared without taking age 
into consideration. The mean values of CIVICT and duration are given in Table 11. 
Therefore using the results from normal subjects the normal range for CIVICT was 
regarded as the mean + 2.58 S. D i. e. the 99% confidence interval. Any values 
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Figure 5. Responses recorded in the EMGs; of different muscles following EMS of 
the motor cortex and spinal motor roots. The responses to cortical stimulation 
were recorded in the presence of muscle contraction or, if no voluntary contraction 
could be achieved, with voluntary contraction of the homologous contralateral 
muscle. The cortical stimulus intensities were set at a value of 4% power above 
the power at threshold for a response. Maximal stimulation was used during 
stimulation of the spinal roots with the target muscles relaxed. 
A Normal subject with responses in all four target muscles with normal CMCT. 
B Stroke patient with responses in all four target muscles with normal CMCT. 
C Stroke patient with responses in all four target muscles with delayed CMCT. 
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Figure 6. Central motor conduction time (CMCT) with respect to age in normal 
subjects. The values were obtained from 53 healthy subjects from recordings in 
the thenar muscle, biceps brachii, triceps brachii and the pectoralis major muscles. 
The broken lines indicate the 99% confidence interval. 
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MUSCLE CIVICT (ms) DURATION (ms) 
Thenar 6.2 + 0.9 41.6 + 6.8 
Biceps brachii 5.1 
_±ý 
0.8 40.9 + 7.5 
Triceps brachii 5.3 + 0.7 39.1 + 7.2 
Pectoralis major 5.6 + 1.2 42.3 + 10.6 
Table 11. Central motor conduction values for CIVICT and duration of response 
(mean + S. D. ) for normal subjects. 
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Threshold to stimulation 
The mean thresholds of the responses to motor cortex stimulation in relaxed 
biceps brachii and thenar muscles are shown in Table 12. The threshold to 
stimulation of the thenar muscles in the hand was slightly lower than the level for 
biceps brachii. The values for left and right hemispheres do not differ significantly 
and the values given are the average for the two hemispheres. Therefore using the 
results from normal subjects the normal range for threshold was regarded as the 
mean + 2.58 S. D. i. e. the 99% confidence interval. Any values for stroke 
patients that lie outside the normal range were regarded as abnormal. 
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MUSCLE THRESHOLD - POWER % 
Thenar 32.7 + 13.2 
Biceps brachii 3 6.7 :E 12.3 
Triceps brachii - 
Pectoralis major 
Table 12. Threshold to stimulation expressed as power (mean :LS. D. ) for normal 
subjects. 
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3.3 STROKE PATIENTS 
Timing of the first investigations after stroke 
All the patients had their first set of investigations completed within 12-72 
hours of the onset of symptoms (Day 1) with a median value of 47.5 hours (mean 
S. D. = 44.8 + 17.1). 
Exclusions prior to entry to study 
Of 327 patients, approached and reviewed in the selection procedure, 206 
patients were not recruited for the reasons given in Table 13A. 
Exclusions following entry to study 
In addition to the 118 f irst-ever stroke patients in the study a further three 
patients were originally recruited. All three patients met the inclusion criteria and 
appeared to have sustained a stroke. In each case a confident clinical diagnosis 
of stroke was made. However, they were excluded after entry when the CT scans 
revealed other types of pathology (Table 1313). CT scanning identified a 
subarachnoid haernorrhage in one patient and bilateral subdural haernatomas in 
another. Multiple areas of infarction with an unusual appearance and widespread 
patchy distribution were observed in the third case. The case notes from another 
hospital of the third case revealed previous neurological disease in the form of 
sarcoidosis. The results from these patients were excluded from the study. 
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EXCLUSIONS TO STUDY (n = 206) 
Wrong diagnosis 24 
Previous stroke 58 
Neurological disease / head injury 13 
Moribund or died prior to EMS 30 
History of epileptic fit 13 
Unstable atlanto-axial joint 4 
Pacemaker 2 
Metal in face or eyes' 1 
No consent given 29 
Too ill to travel or transport problems 15 
Fractured humerus 1 
Outside the 72 hours inclusion period 16 
Table 13A. Reasons for excluding 206 patients from the study. 
' Five patients excluded for other reasons given above, were also aware of the 
presence of metal fragments in the face or eyes as a result of shrapnel injury or 
occupational damage. Hence it is very important to enquire about metal in the 
head before embarking upon the use of EMS of the brain in any patient. 
EXCLUSIONS AFTER ENTRY INTO STUDY (n=3) 
Reason for exclusion Number of patients 
Subarachnoid haemorrhage 1 
Subdural haematoma 1 
Neurosarcoidosis 1 
Table 13B. Reasons for the exclusion of three patients after entry into study. 
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Patient compliance 
All 118 patients were followed to the completion of the study (12 or 18 
months) or to death if this occurred earlier. The neurophysiological assessment at 
12 months was not completed in eight of the 76 survivors. Two patients had left 
the region, therefore excluding assessments of neurophysiological testing, 
examination of tone and reflexes, the Nine-hole Peg Test and the Motricity Index. 
One patient was moribund. Three patients declined further neurophysiological 
testing. Two patients developed seizures not related to EMS. With these 
exceptions the final assessment of all survivors at 12 months was complete 
(Table 14). 
Handedness and side of weakness after stroke 
The details regarding hemispheric dominance and which side was affected 
by stroke are given in Table 15. The presence or absence of responses following 
cortical stimulation, CIVICT, duration of response or threshold to stimulation was 
not related to the affected hemisphere whether dominant or non-dominant. 
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REASONS FOR INCOMPLETE NEUROPHYSIOLOGICAL 
STUDIES AT 12 MONTHS (n = 8) 
Reason for omission Number of patients 
Left region' 2 
Moribund 1 
Refused further tests 3 
Epileptic seizure 2 
Table 14. Reasons for failure to complete sequential neurophysiological 
investigations up to 12 months in eight patients. 
' These two patients moved a considerable distance away from the region and 
although information regarding their functional abilities was obtained by 
telephoning their carers, no data for neurophysiological assessment, examination 
of tone and reflexes, the Nine-hole Peg Test and the Motricity Index was available 
at 12 months. 
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SIDE OF BODY NUMBER OF PATIENTS HANDEDNESS 
(n= 118) left right 
Side of weakness: 
left 63 (53.4%) 2 61 
right 53 (44.9%) 6 48 
left + right 2 (1.7%) 2 
Table 15. Handedness and paretic side of the body in stroke patients. 
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3.4 N EUROPHYSIO LOGICAL RESULTS AT DAY 1 IN STROKE PATIENTS 
3.4.1 CMCT estimated from responses recorded in the paretic arm follovifing EMS 
of the damaged hemisphere at Day 1 
EMG responses to motor cervical root stimulation were always present but 
responses to motor cortex stimulation were more variable or absent. Responses 
in the muscles of the paretic side to contralateral cortical stimulation were only 
obtained in some patients with facilitation by contraction of the target muscle or 
the homologous muscle of the non-paretic side. The use of muscle contraction to 
facilitate responses to cortical stimulation was observed in all patients throughout 
the 12 months of follow-up after stroke. The facilitation of the responses to 
cortical stimulation is important, since 15 patients at Day 1 would otherwise have 
been categorised in the No Response Group with respect to the results from the 
thenar muscles and 19 patients in the No Response Group with respect to the 
results from biceps brachii. Comparable studies by other authors in this field have 
used a similarly powered electromagnetic stimulator, so that it is likely many false 
negative responses have been recorded. Table 16 demonstrates the number of 
patients in whom responses are present without muscle contraction and in those 
patients in whom responses are only present facilitated by muscle contraction. 
Since the thresholds were only measured for the thenar and biceps brachii muscles 
this observation only relates to these two muscles. 
The mean values for CIVICT and the duration of responses for the four target 
muscles of the paretic and non-paretic sides are given in Table 17. 
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RESPONSES IN PARETIC LIMB NUMBER OF PATIENTS 
(n = 118) 
Thenar muscles 
Obtained in relaxed muscle 59 
Obtained in contracted muscle 16 
No response despite contraction 44 
Biceps brachii 
Obtained in relaxed muscle 53 
Obtained in contracted muscle 19 
No response despite contraction 46 
Table 16. The presence of responses in the thenar and biceps brachii muscles for: 
1) relaxed muscles. 
2) only obtained in muscles with contraction of the target muscle or the 
homologous muscle on the non-paretic side. 
3) muscles with no response even at 100% stimulus power with muscle 
contraction. 
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DAY I PARETIC SIDE NON- PARETIC SIDE 
CMCT (ms) Duration (ms) CNICT (ms) Duration (ms) 
Thenar 6.4 + 1.7 38.4 + 14.5 5.7 + 1.4 44.0 + 13.2 
Biceps brachii 5.0+ 1.3 41.3 + 15.0 4.9 + 0.9 48.0 + 14.9 
Triceps brachii 6.1 + 2.0 42.6 + 15.4 5.3 + 1.3 44.5 + 14.9 
Pectoralis major 6.4+ 2.5 44.1 + 16.5 6.0+ 2.0 47.8 + 16.3 
Table 17. Central motor conduction values (mean + S. D. ) and duration of 
responses 
(mean + S. D. ) in the muscles of the paretic and non-paretic upper limbs in stroke 
patients at Day 1. 
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At Day 1 following stroke three groups of patients were identified by 
measurement of CIVICT, calculated by responses in the thenar muscles and by 
comparison of the values with those obtained from normal subjects. Patients 
either had normal CIVICT values (within 99% confidence limits for normal subjects), 
delayed CIVICT values (>99% confidence limits for normal subjects) or no 
responses (See: Figs. 513, C and D, respectively). Hence patients are categorised 
into Normal Response, Delayed Response and No Response Groups. A similar 
grouping could be made using the CIVICT values obtained for each muscle tested. 
At every time of testing during the study some patients could be assigned to each 
group. Table 18 shows the distribution of the categories with respect to the 
different muscles at Day 1. 
The most prolonged CIVICT of 29. Oms was recorded in biceps brachii at Day 
28. This value is considerably longer than the mean CIVICT in normal subjects 
(5.1 ms + 0.77 S. D. ). On the few occasions where CMCTs were short and below 
the normal range, they were regarded as normal, since the functional progress and 
outcome of this small group was the same as for those individuals whose CMCTs 
fell within the normal range. 
Responses to cortical stimulation may be absent from a single target muscle 
in the paretic arm, but usually more than one muscle was observed to have lost 
responses. The number of patients with absent responses in the target muscles 
are shown in Table 19.61 patients had recordable responses in all the muscles 
at Day 1 whereas 57 patients had no responses in one or more target muscles at 
Day 1.32 patients had no responses in all the target muscles following cortical 
stimulation at Day 1. 
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TARGET MUSCLE NORMAL' DELAYED NO RESPONSE 
Thenar 67 7 44 
Biceps brachii 67 5 46 
Triceps brachii 53 14 51 
Pectoralis major' 56 11 45 
Table 18. Number of patients in each CIACT group at Day 1 (n = 118). 
I This contains two values for the thenar muscles and two values for triceps brachii 
which were below the 0.5% confidence limit of the normal range. These results 
were included in the Normal Response Group since the outcome of these patients 
was the same as patients with normal CMCT. 
' Poor quality responses were recorded from pectoralis major in six patients at 
Day 1 and the results were discarded. Therefore n= 112 for pectoralis major. 
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NUMBER OF MUSCLES WITH 
NO RESPONSES AT DAY 1. 
NUMBER OF PATIENTS 
(n = 118) 
One muscle 6 (6.1%) 
Two muscles 6 (4.2%) 
Three muscles 14 (11.9%) 
Four muscles 32 (27.1%) 
Responses in all muscles 61 (51.7%) 
Table 19. The number of muscles in which responses could not be obtained 
following cortical stimulation at Day 1. The number of patients is shown for each 
catagory. 
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3.4.2 CMCT and duration of the response in the non-paretic arm following EMS 
of the undamaged hemisphere at Day 1 
Only two patients did not have responses in relaxed muscles of the 
non-paretic limb at 100% stimulation at Day 1. All patients had responses in the 
muscles of the non-paretic limb following stimulation of the undamaged hemisphere 
with the target muscles contracted. Responses could always be obtained following 
stimulation of the spinal motor roots. Values of CMCT and the duration of the 
responses obtained from the responses of muscles in the non-paretic arm following 
stimulation of the undamaged hemisphere were all within the normal range 
(See Table 17). 
3.4.3 Threshold of responses following EMS of the damaged and non-damaged 
hemispheres at Day 1 
The mean thresholds for evoking responses in biceps brachii and the thenar 
muscles in both the paretic and non-paretic limbs for all patients demonstrating 
responses in relaxed muscles at Day 1 are shown in Table 20. It should be noted 
that patients who did not have responses even at 100% stimulation are not 
included in the calculation of means, i. e. the thresholds are not regarded as 
zero %. Hence only the results of patients who demonstrated responses in relaxed 
muscles are included in the calculations. In keeping with the findings in normal 
individuals, the thresholds to cortical stimulation were lower for the thenar muscles 
in the hand compared to biceps brachii. 
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SUBJECTS BICEPS BRACHII THENAR MUSCLES 
Normal subjects' 36.7 + 12.3 32.7 + 13.2 
Stroke patients 
Day 1 respondere: 
Paretic limb 51.3 + 20.8 47.4+ 20.0 
Non-paretic limb 38.9 
.: E 
15.5 34.9 + 13.3 
All stroke patients' 
Non-paretic limb 41.9 + 17.5 38.1 + 15.6 
Table 20. Thresholds of responses in relaxed biceps brachii and thenar muscles 
at Day 1 (mean + S. D. ). The results for normal subjects are also given for 
comparison. 
1n= 53. 
n= 53 for biceps brachii, n= 59 for thenar muscles. 
n= 116. Responses were only obtained in two patients following EMS of the 
undamaged hemisphere when the target muscles were contracted. 
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3.5 CENTRAL MOTOR CONDUCTION IN THE FIRST 12 MONTHS AFTER STROKE 
3.5.1 Changes in CMCT from responses recorded in the paretic arm during the 
first 12 months after stroke 
The results of CIVICT for all target muscles at each test from Day 1 to 12 
months are shown in Fig. 7. The 12 months following stroke represent a period 
in which major changes occur in clinical signs and sensorimotor abilities. 
Sequential neurophysiological investigations also revealed marked changes in the 
CIVICT. The changes observed were similar for all the muscles tested and included: 
1. Responses may remain unchanged with normal CIVICT, delayed CIVICT or no 
response. 
2. Patients with no responses may gain responses with either normal or delayed 
CMCT. 
3. Delayed CIVICT may become normal. 
4. Responses may be lost if the stroke evolves. 
The majority of patients with normal CIVICT at Day 1 retained normal 
conduction throughout the 12 month period. 16 of the 44 patients with no 
responses in thenar muscles at Day 1 survived and were investigated at 12 months 
(See: 3.3 Stroke patients - Patient compliance, for reasons why some of the 
survivors did not receive EMS). The majority of patients with no responses at 
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Figure 7. Central motor conduction time (CMCT) for thenar, biceps brachii, triceps 
brachil and pectoralis major muscles at each test session following stroke. The 
values for each stroke patient are shown individually. Measurements were made 
on 118 patients at Day 1 and the subsequent reduction in numbers result from the 
42 deaths during the study. The stippled areas indicate the normal range (99% 
confidence interval) for each muscle. MTH, month. 
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Three patterns of change were observed. Responses remained absent 
(n = 4), responses returned by 12 months with delayed CIVICT (n = 7), or responses 
returned with normal CIVICT (n = 5). These patterns are illustrated in Fig. 8 using 
results from the thenar muscles and five representative case histories. The same 
patterns of change were observed in the 24 patients who died by 12 months who 
originally had no responses in the thenar muscles at Day 1. The same changes 
were observed in all target muscles. 
The number of patients in the No Response Group following cortical 
stimulation at Day 1 had reduced considerably at 12 months. The reduction in 
numbers is due to the high mortality of patients in the No Response Group. Most 
of the survivors from the No Response Group gain responses. Of the responses 
that appear most have delayed CMCTs, which explains the wider spread of CIVICT 
values and the increased number of patients with delayed responses at 12 months. 
Some patients lost responses after Day 1. On clinical grounds 14 patients 
extended their stroke during the first seven days after entry to the study. The 
clinical deterioration coincided with the loss of responses in some target muscles 
even though responses had been observed previously at Day 1. 
Table 21 compares the distribution of the three response groups with 
respect to the different muscles at Day 1 and at 12 months. The reduction in 
numbers of patients tested at 12 months was due to the death of 42 patients and 
a further eight patients who could not be tested (See: 3.3 Stroke patients - Patient 
compliance). Although observations were made on four different muscles, the 
responses in the thenar muscles have been taken as the most representative and 











Time after onset of stroke. 
Figure 8. Patterns of change in central motor conduction time (CMCT) illustrated 
by data from five stroke patients obtained from recordings in thenar muscles. 
no response to cortical stimulation throughout the study. 
0 initially no response, but delayed CIVICT appearing at three months. 
delayed central motor conduction throughout the study. 
initially no response, but normal central motor conduction in first week 
following stroke and maintained throughout the study. 
normal central motor conduction throughout the study. 
Stippled areas indicate normal range (99% confidence interval). 
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DAY1 DAY3 DAY7 DAY28 3MTH 6MTH 12MTH 
DAY 1 NORMAL' DELAYED NO RESPONSE 
Thenar 67 7 44 
Biceps brachii 67 6 46 
Triceps brachii 53 14 51 
Pectoralis majoi-2 56 11 45 
12 MONTHS NORMAL' DELAYED NO RESPONSE3 
Thenar 49 14 5 
Biceps brachii 52 13 3 
Triceps brachii 44 20 4 
Pectoralis major 52 13 3 
Table 21. Number in each patient group at Day 1 (n = 118) and for survivors 
studied at 12 months (n = 68). 
' This also contains two sets of values for the thenar muscles and two sets of 
values for triceps brachii which fell below the 0.5% confidence limit of the normal 
range. Where CMCTs were short and below the normal range, they were regarded 
as normal, since the functional progress and outcome of this small group proved 
to be the same as for those individuals whose CMCTs fell within the normal range. 
' Poor quality responses recorded from pectoralis major in 6 patients lead to the 
results being discarded, therefore n= 112. 
Included patients in whom absent responses did not return and patients whose 
stroke extended causing subsequent loss of responses that did not return. 
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The variation in the different conduction groups, in particular the greater 
number and spread of CMCTs in patients with delayed conduction, accounts for 
the greater value of the mean CMCTs for the patients tested at 12 months. The 
Day 1 CIVICT values are compared to the CMCTs at 12 months in (Table 22). 
From this point onwards in the thesis any reference to central motor 
conduction results will refer to those obtained from recordings taken in the thenar 
muscles (unless other muscles are specifically named). The principles apply to all 
the target muscles. The results from the thenar muscles have been chosen since 
they represent the best observation of how n eu ro physiological changes relate to 
clinical state and the recovery of motor function. 
3.5.2 Evolution and severity of stroke 
Stroke often evolves over a period of days, and although some physical 
signs rapidly become established it is often a few days before the neurological 
damage is complete. A second group of patients has therefore been defined with 
no response following cortical stimulation on one or more occasions on Days 1-7. 
The two patient groups of no responders are: 
1) Patients with no response to cortical stimulation at Day 1 (The No Response 
Group). 
2) Patients with no response to cortical stimulation on one or more occasions at 
Day 1, Day 3 or at Day 7 (Days 1-7). 
These groupings can be used to refer to the results from one target muscles 
or to the absence of responses from one or more target muscle. 
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DAY I PARETIC SIDE NOW PARETIC SIDE 
CMCT (ms) Duration (ms) CNICT (ms) Duration (ms) 
Thenar 6.4+ 1.7 38.4 + 14.5 5.7 + 1.4 44.0+ 13.2 
Biceps brachii 5.0+ 1.3 41.3 + 15.0 4.9 + 0.9 48.0 + 14.9 
Triceps brachii 6.1 + 2.0 42.6 + 15.4 5.3 + 1.3 44.5 + 14.9 
Pectoralis major 6.4 + 2.5 44.1 + 16.5 6.0+ 2.0 47.8 + 16.3 
12 MONTHS PARETIC SIDE NOW PARETIC SIDE 
CMCT (ms) Duration (ms) CMCT (ms) Duration (ms) 
Thenar 7.4+ 2.4 44.7 + 15.7 6.0+ 1.3 43.1 + 12.6 
Biceps brachii 6.2 + 2.4 43.1 + 13.4 5.1 + 0.7 45.9 + 12.4 
Triceps brachii 6.9 + 3.1 43.3 + 14.4 5.3 + 1.2 46.4 + 12.6 
Pectoralis major 6.8 + 2.9 50.6 + 17.7 5.9 + 1.9 49.7 + 16.6 
Table 22. Central motor conduction values (mean + SD) in paretic and non-paretic 
sides in stroke patients at Day 1 and at 12 months. 
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Regrouping the patients with no responses on one or more occasions on 
Days 1-7 includes patients whose stroke has progressed and who have 
subsequently lost responses. The reason for making this additional group is that 
the results suggest that absent responses are of great prognostic importance. 
Hence the absence of responses in any muscle on one or more occasions in any 
of the first three test sessions (Days 1-7) merits further consideration. 
3.5.3 Changes in the duration of responses recorded in the paretic arm during the 
first 12 months after stroke 
The mean values for duration of the responses following cortical stimulation 
obtained in all muscles of both the paretic and non-paretic sides in the stroke 
patients at any test session were not significantly different from the normal 
subjects (Table 22). However, the duration of responses that reappeared in the 
patients with no responses on Days 1-7 were shorter for thenar muscles 
(p=0.007), biceps brachii (p=0.01) and pectoralis major (p=0.04) than in those 
patients who had not lost responses on Days 1-7. The results for triceps were not 
significant (p>0.05). (All tests used the Mann-Whitney U test) 
3.5.4 Threshold to electromagnetic stimulation of the motor cortex after stroke 
The thresholds to cortical stimulation were only assessed in the relaxed 
biceps brachii and thenar muscles (See: 3.1 Pilot cross-sectional study). Table 23 
compares the thresholds for normal subjects with different groups of patients at 
ill 
NORMAL SUBJECTS 
BICEPS BRACHII THENAR MUSCLES 
36.7 + 12.3 32.7 + 13.2 
11 
STROKE PATIENTS. DAY 1 RESPONDERS (Normal and Delayed Response Groups). 
SIDE OF 
BODY 
BICEPS BRACHII THENAR MUSCLES 
Day 1 Month 12 p value Day 1 Month 12 p value 












ALL STROKE PATIENTS. 
SIDE OF BICEPS BRACHII THENAR MUSCLES 
BODY 
Day 1 Month 12 p value Day 1 Month 12 p value 
Non- 41.9 29.4 38.1 27.3 
paretic 
Table 23. Thresholds of responses in relaxed biceps brachii and thenar muscles 
expressed as % of maximal power output. The results for individuals at Day 1 are 
compared to the corresponding values for the same surviving patients at 12 
months. *=p <0.0001. (Wilcoxon matched pairs signed rank test). 
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Day 1 and at 12 months. In normal subjects the mean threshold for biceps brachii 
was 36.7% of maximum power output and for thenar muscles 32.7%. For all 
patients with responses at Day 1 (Normal and Delayed Groups), who continued to 
demonstrate responses at subsequent test dates, the means at Day 1 were 5 1.3% 
for biceps brachii and 47.4% for thenar muscles; they decreased to 29.6% and 
30.4%, respectively, at 12 months. The threshold values for patients with 
responses although starting at levels significantly above normal values decreased 
over 12 months to values that were significantly lower than normal values. 
The group of patients without responses (No Response Group) did not have 
recordable thresholds at Day 1 and, upon gaining responses, invariably did so at 
maximum stimulus power (100%). To include the values for this group of patients 
in any calculation of threshold value would lead to an overestimation and skew the 
mean value for the entire group investigated at 12 months. This would effectively 
obscure the changes in thresholds for the patients with responses at Day 1. 
Therefore, the threshold values of patients who gained responses have been 
omitted from the calculation of mean values of threshold for the responses 
recorded in the paretic limb. 
In the patients who had responses at Day 1 on the paretic side, a similar 
decrease in threshold was also observed in muscles of the non-paretic side 
(Table 23). The threshold for muscles on the non-paretic side also fell for the 
entire group of patients, whether responses could be recorded or not at Day 1 in 
muscles of the paretic side. The reduction in threshold from Day 1 to 12 months 
was significant for values obtained from both the damaged or undamaged 
hemispheres. 
113 
3.6 SAFETY OF ELECTROMAGNETIC STIMULATION FOLLOWING STROKE 
Symptoms following EMS of the brain 
No complications occurred during, or directly following the use of EMS. No 
healthy volunteer or stroke patient, even those with very extensive areas of brain 
damage complained of any symptoms. This was despite the fact that sequential 
investigations were repeated over many months, often using the maximum power 
output of the stimulator. A few patients did comment upon the loud click that the 
coil produces during the emission of the magnetic field. The small number of 
patients who declined further neurophysiological tests after commencing the study, 
did not do so because of adverse effects from the test. 
Incidence of epileptic seizures 
Only 2 (1.7%) patients experienced a seizure during the whole project. In 
both cases this did not occur for more than four weeks after EMS. No seizures 
were observed at the time of cortical stimulation. 
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3.7 RADIOLOGICAL AND CLINICAL ASSESSMENTS AFTER STROKE 
3.7.1 CT scanning after stroke 
Three of the 121 patients originally entered into the study were excluded 
after entry when other pathology was identified on CT scans. 118 patients 
remained in the study and 107 patients received scans, all of which had features 
compatible with stroke (Table 24). Three of the 11 patients who were not 
scanned were examined at autopsy and had evidence of stroke. Therefore, 110 
patients had additional radiological or pathological evidence to support the clinical 
diagnosis of stroke. 
100 patients were scanned within 14 days of onset of symptoms, four were 
scanned between 15 and 30 days and three after 30 days. The median time to 
scanning was 6 days (mean = 9.0 days + 12.0 S. D. ). 85 of the 107 scans of 
patients identified lesions compatible with stroke. There were 17 patients with 
haernorrhage, 68 with infarction, of which six had signs of haernorrhagic infarction. 
A further 22 patients had a normal CT scan. The mean horizontal diameter of the 
lesions was 58.1 + 35.0 mm, the mean approximate spherical volume was 
66,287 + 76,472 MM3 . Approximately half the lesions seen had mass effect. 
More lesions were seen in the right hemisphere. In most cases the lesions were 
confluent. Most lesions involved cortical and subcortical structures. Damage to 
subcortical structures alone was seen on 32 scans, but only three scans 
demonstrated purely cortical lesions. The most consistent arterial territory causing 
stroke was the middle cerebral artery. 
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CT FEATURE NUMBER OF PATIENTS 




Horizontal diameter mm (mean) 58.1 + 35.0 
Volume mm' (mean) 66287.0 + 76472 
Ventricular rupture 3 
Hydrocephalus 0 
Mass effect' 42 
Site: Cortical 3 
Subcortical 32 
Cortical + subcortical 50 
Laterality of lesion: Left 32 
Right 50 
Midline 0 
Left + Right 3 
Pattern of lesion: Confluent 74 
Patchy 11 
Arterial territory: 
Posterior inferior cerebellar artery (PICA) 0 
Basilar artery (BA) 1 
Anterior inferior cerebellar artery (AICA) 0 
Superior cerebellar artery (SPA) 0 
Posterior cerebral artery (PCA) 12 
Anterior choroidal artery (AChA) 7 
Anterior derebral artery (ACA) 7 
Middle cerebral artery (MCA) 66 
Perforating lenticulostriate arteries (PLA) 5 
More than one territory involved 13 
Table 24. Neuroradiological features identified on CT scans. 
' Includes 6 patients with infarction plus haernorrhage. 
85 patients had visible lesions, 42 had mass effect, 42 had no mass effect and 
in one patient the opinion of the clinicians who reported the scans was divided. 
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The relationship of CT scan features to central motor conduction 
No correlation to CIVICT was found for ventricular rupture, hydrocephalus, 
laterality or pattern of lesion and arterial territory. Correlations with CIVICT were 
found for type of stroke, horizontal diameter, volume of lesion, mass effect and 
site of lesion. The results of the CT scan features and the relationship to central 
motor conduction are shown in Tables 25 and 26. 
When haemorrhage and infarction were compared with the presence or 
absence of responses on Days 1-7, a larger proportion of patients with infarction 
had no responses to cortical stimulation (54.4%). Patients with infarction 
accounted for the majority of those with no response following EMS. Only 23.5% 
of patients with haemorrhage had no responses. Most patients with normal scans 
retained cortical responses, however, five patients out of 22 (22.7%) with a 
normal scan had absent responses. 
The size of the lesion was important in terms of the largest single diameter 
on any CT scan view and the approximate spherical volume. The larger the lesion 
the greater the probability of no responses following cortical stimulation. 
The relationship of absent responses in the presence of mass effect was the 
least clear. The majority of patients with no response on Days 1-7 (62.5%) have 
evidence of mass effect on their scans. However 15 patients with no visible mass 
effect from the lesion also had no responses following EMS. 
Lesions involving the cortex were more likely to be associated with absent 
responses. 64% of patients with cortical lesions lost responses, whereas only 
22% of patients with purely subcortical lesions had no responses following EMS. 
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CT SCAN FEATURE PATIENTS WITH PATIENTS WITH 
RESPONSES PRESENT (n=61) NO RESPONSE (n=46) 
Day 1 Days 1-7 Day I Days 1-7 
Haemorrhage (n = 17) 14 13 3 4 
Infarction (n = 68) 37 31 31 37 
Normal scan (n = 22) 17 17 5 5 
Horizontal diameter' (mean) 44.9 39.9 78.7 78.2 
Spherical volume' (mean) 35,253 25,617 112,837 109,932 
Mass effect' (n = 42) 22 17 20 25 
No mass effect (n = 42) 29 27 13 15 
Cortical lesion (n = 3) 2 2 1 1 
Subcortical lesion (n=32) 26 25 6 7 
Cortical + subcortical (n = 50) 23 17 27 33 
Table 25. The most important CT scan features and their relationship to central 
motor conduction. The patients are subdivided on the basis of having no response 
on Day 1 or no response on one or more occasions on Days 1-7. The central 
motor conduction results pooled for Days 1-7 are more representative than Day 1 
results in view of the fact that the CT scans were performed at various times after 
the onset of stroke and hence did not correspond to a particular test day. 
' Horizontal diameter in mm. 
Spherical volume in mm'. 
n=84 for the presence or not of mass effect. The scan of one patient was 
regarded as "not sure" by the three clinicians who interpreted the scans. 
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CT SCAN FEATURE CORRELATION WITH ABSENCE OF RESPONSES 
Day 1 Days 1-7 
Type of stroke P<0.05 P<0.05 
Horizontal diameter P=0.001 P<0.0001 
Spherical volume P=0.0001 P<0.0001 
Mass effect NS p<0.05 
Site p<0.005 P<0.0005 
Table 26. The following scan features correlated with loss of responses on 
Day 1 and on Days 1-7 after stroke: 
1. Infarction was more likely to be present if responses were absent (Chi-Square). 
2. The larger the horizontal diameter or spherical volume of the lesion the greater 
the probability of no response to cortical stimulation (Mann-Whitney U test). 
3. Response were likely to be absent if mass effect was present (Chi-Square). 
4. Purely subcortical lesions were more likely to lead to loss of responses compared 
to lesions that included the cortex (Chi-Square). 
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No correlation was found between delayed CIVICT and CT scan appearances. 
Of the seven patients with delayed responses in the thenar muscles on Day 1, one 
patient had a normal scan, six patients had visible lesions of which five had mass 
effect. In two patients the lesions were purely subcortical but in the other four 
scans both the cortex and subcortex were involved. 
3.7.2 Symptoms after stroke 
The neurological symptoms reported by patients between the onset of stroke 
to the first assessment at Day 1 are recorded in Table 27. Awareness of upper 
limb weakness was a common feature. Although not all patients were initially 
aware of weakness in the limbs, all 118 patients in the study demonstrated signs 
of motor weakness at Day 1. Sensory symptoms in the limbs were less common. 
The relationship of symptoms with central motor conduction 
Symptoms at the onset of stroke that correlated with no response in a target 
muscle at any time on Days 1-7 are shown in Table 28 (applies to all four target 
muscles). A correlation with absent responses in the target muscles was found to 
exist for the presence of weakness in hand, arm or leg on the paretic side of the 
body (p<0.05); swallowing problems (p<0.05); visual problems (p<0.05); and 
the loss of urinary continence (p<0.005). No relationship was found for the 
following symptoms: speech problems; facial weakness; loss of consciousness at 
onset of stroke; headache; sensory disturbance; loss of bowel continence. 
120 
SYMPTOM DUE TO STROKE NUMBER OF 
PATIENTS 
(n= 118) 
Speech problem' 72 (61.0%) 
Swallowing problem 37 (31.4%) 
Weakness of facial muscles: 
Left side 26 (22.0%) 
Right side 24 (20.3%) 
Both sides 0 
Weakness of hand muscles: 
Left side 60 (50.8%) 
Right side 39 (33.1%) 
Both sides 1 (0.8%) 
Weakness of arm muscles: 
Left side 60 (50.8%) 
Right side 37 (31.4%) 
Both sides 1 (0.8%) 
Weakness of leg muscles: 
Left side 45 (38.1%) 
Right side 28 (23.7%) 
Both sides 4 (3.4%) 
Loss of consciousness 16 (13.6%) 
Visual disturbance 25 (21.2%) 
Headache 40 (33.9%) 
Sensory disturbance: 
Left side 27 (22.9%) 
Right side 22 (18.6%) 
Both sides 2 (1.7%) 
Loss of urinary continence 28 (23.7%) 
Loss of bowel continence 4 (3.4%) 
Table 27. Number of patients who reported neurological symptoms at Day 1. 
I Speech problems refers to any difficulty with speech encountered by the patient 




Weakness in hand, arm or leg p<0.06 
on the paretic side of the body. 
Swallowing problems. P<0.05 
Visual problems. p<0.05 
Loss of urinary continence'. p<0.005 
Table 28. The relationship of symptoms to absence of responses following cortical 
stimulation. The results apply to all the target muscles demonstrating no 
responses on one or more occasions on Days 1-7 after stroke. (Chi-square with 
Yates correction when appropriate). 
I No correlation existed for absence of responses observed in biceps brachii. 
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3.7.3 The Bamford clinical classification of stroke 
The examination findings at Day 1 were used to allocate patients into four 
different clinical categories using the Bamford classification (Table 29A). The 
commonest clinical presentation was a lacunar syndrome (LACS). Slightly less 
than one third of patients had a total anterior circulation syndrome (TACS), and the 
same number had a partial anterior circulation syndrome (PACS). Only two 
patients were categorised as having a posterior circulation syndrome (POCS). Two 
patients could not be categorised to a particular group with certainty. 
The relationship of the Bamford classification of stroke with central motor 
conduction 
The relationship of the Bamford classification to central motor conduction 
is shown in Table 29B. 56.8% of patients with TACS had no responses in the 
thenar muscles at Day 1, compared to 46% of PACS and 15% of LACS. 43.2% 
of TACS and 64.1 % of PACS had responses (Normal and Delayed Groups 
combined) following EMS compared to 85% of LACS. Patients with TACS were 
by definition, those with extensive hemispheric damage and a wide spectrum of 
clinical signs. Patients with TACS were the most likely to have no response 
following cortical stimulation. Only a small proportion of patients with LACS had 
no responses following cortical stimulation. When patients in the different Bamford 
categories with responses (Delayed or normal) were compared to patients without 
responses a correlation was found (p = 0.007, Chi-Sq) (Table 2913). 
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BAMFORD CLASSIFICATION NUMBER OF PATIENTS (n=118) 
TACS 37 (31.4%) 
PACS 37 (31.4%) 
POCS 2 (1.7%) 
LACS 40 (33.9%) 
Unclassifiable 2 (1.7%) 
Table 29A. The number of patients in each catagory as defined by the Bamford 
classification (Bamford et al., 1991). 
TACS total anterior circulation syndrome. 
PACS partial anterior circulation syndrome. 
POCS posterior circulation syndrome. 
LACS lacunar syndrome. 
RESPONSES TACS PACS POCS LACS 
No response 21 17 - 6 
Normal 14 18 2 32 
Delayed 2 2 - 2 
Table 29B. Patients (n = 116) subdivided into the different Bamford categories. 
Different response groups (thenar muscles) at Day 1 are shown. When the group 
patients with responses (Delayed or normal) were compared to patients without 
responses in the different subgroups a correlation was present (p = 0.007, Chi-Sq) 
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3.7.4 Muscle tone and tendon reflexes after stroke 
Examination of muscle tone and tendon reflexes at Day 1 
At Day 1 all patients had evidence of changes in muscle tone and tendon 
reflexes. In some patients the abnormalities were not restricted to just the paretic 
side but were present on the non-paretic side. Presumably this was due to a 
number of factors affecting the undamaged hemisphere such as oedema, altered 
haemodynamics, mass effect and possibly secondary ischaemic damage. The 
changes in tone and tendon reflexes in the upper and lower limbs observed at Day 
1 are given in Table 30. One patient had an above-knee amputation on the paretic 
side of the body and therefore it was not possible to assess changes in tone in the 
muscles acting about the knee or ankle, their associated reflexes or the plantar 
responses. 
Examination of muscle tone at 12 months after stroke 
The number and proportion of patients who demonstrated alterations of 
muscle tone at 12 months are shown in Table 31 (the two patients who left the 
Region were not assessed at 12 months). A considerably smaller number of 
patients demonstrated abnormal muscle tone at 12 months. This was partly due 
the resolution of abnormal tone and due to reduced patient numbers at 12 months 
due to the death. 
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ABNORMAL TONE NUMBER OF PATIENTS 
(n = 118) 
Upper limbs 102 (86.4%) 
Lower limbs 72 (61.5%) 
ABNORMAL TENDON REFLEXES NUMBER OF PATIENTS 
(n= 118) 
Biceps reflex 83 (70.3%) 
Triceps reflex 57 (48.3%) 
Supinator reflex 79 (66.9%) 
Knee reflex 76 (64.1%) 
Ankle reflex 61 (43.6%) 
Extensor plantar response 102 (87.2%) 
Table 30. The number of patients with clinical evidence of abnormal tone (either 
increased or decreased) in limbs of the paretic side of the body at Day 1. The 
lower part of the table also shows the number of patients with abnormal tendon 
reflexes (exaggerated or absent) and extensor plantar responses on the paretic side 
of the body at Day 1. 
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TONE AT DAY 1 
ABNORMAL NUMBER OF PATIENTS WITH PATIENTS WITH 
TONE PATIENTS NO RESPONSES RESPONSES 
(n = 118) (n = 53) (n = 65) 
Upper limbs 102 (86.4%) 51 51 
L Lower limbs 72 (61.5%) 43 29 
NORMALTONE NUMBER OF PATIENTS WITH PATIENTS WITH 
PATIENTS NO RESPONSES RESPONSES 
(n = 118) (n = 53) (n = 65) 
Upper limbs 16 (13.6%) 2 14 
Lower limbs 45 (38.5%) 9 36 
TONE AT 12 MONTHS 
ABNORMAL NUMBER OF SURVIVORS WITH SURVIVORS WITH 
TONE PATIENTS NO RESPONSES RESPONSES AT 
AT DAY 1 DAY1 
(n = 74) (n = 20) (n = 52) 
Upper limbs 29 (39.2%) 18 11 
Lower limbs 24 (32.4%) 16 8 
NORMALTONE NUMBER OF SURVIVORS WITH SURVIVORS WITH 
PATIENTS NO RESPONSES RESPONSES AT 
AT DAY 1 DAY1 
(n = 74) (n = 20) (n = 52) 
Upper limbs 45 (60.8%) 4 41 
Lower limbs 50 (67.6%) 6 44 
Table 31. Changes in tone in the upper and lower limbs of the paretic side of the 
body at Day 1 and for the survivors at 12 months. The number of patients with 
responses or absence of responses following cortical stimulation are shown. 
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The relationship of muscle tone with central motor conduction 
Following cortical stimulation the absence of responses in any of the target 
muscles on one or more occasions on Days 1-7, correlated with abnormalities in 
muscle tone (increased or decreased) in the arm (p<0.05) and leg (p=0.0001) on 
the paretic side of the body at Day 1. At 12 months 29 patients had abnormal 
tone in the upper limbs and 24 in the lower limbs on the paretic side of the body. 
The absence of responses following cortical stimulation after stroke on Days 1-7 
correlated with abnormal tone in the arm (p<0.0001) and in the leg (p<0.0001) 
at 12 months. Patients with no responses in a target muscle at any time on Days 
1-7 were more likely to demonstrate abnormal changes in tone, in both the upper 
and lower limbs on the paretic side at 12 months. Most patients with responses 
at Day 1 had normal tone at 12 months. The correlations between absence of 
responses and abnormal tone are shown in Table 32. 
Examination of tendon reflexes at 12 months after stroke 
The number of patients with abnormal tendon reflexes and plantar responses 
at 12 months was less than Day 1. This was due to clinical improvement and 
reduced number of patients due to death. Table 33 shows the number of patients 
with abnormal reflexes on the paretic side of the body at Day 1 and 12 months 
compared to the presence of responses (the two patients who left the Region were 
not assessed at 12 months). At both Day 1 and 12 months there are almost equal 
numbers of patients with or without responses who had abnormal reflexes. 
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ABNORMAL TONE STATISTICAL SIGNIFICANCE 
Days 1-7 
In the paretic arm P<0.05 
In the paretic leg P=0.0001 
At 12 months 
In the paretic arm P<0.0001 




Table 32. The absence of responses following cortical stimulation in any of the 
target muscles after stroke on any occasion on Days 1-7, correlated with abnormal 
muscle tone (Chi-Sq). 
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PATIENTS WITH NO 
RESPONSES 
(n = 53) 
PATIENTS WITH 
RESPONSES 
(n = 65) 
Biceps reflex 83 (70.3%) 39 44 
Triceps reflex 57 (48.3%) 31 26 
Supinator reflex 79 (67.0%) 34 45 
Knee reflex 75 (63.6%) 35 40 
Ankle reflex 51 (43.2%) 27 24 
Plantar response 102 (86.4%) 50 52 
REFLEXES AT 12 MONTHS 
ABNORMAL NUMBER OF SURVIVORS WITH NO SURVIVORS WITH 
REFLEXES PATIENTS RESPONSES AT DAY I RESPONSES AT DAY I 
(n = 20) (n = 52) 
(n = 74) 
Biceps reflex 42 (56.8%) 19 23 
Triceps reflex 29 (39.2%) 15 14 
Supinator reflex 44 (59.5%) 20 24 
Knee reflex 44 (59.5%) 20 24 
Ankle reflex 23 (31.1%) 12 11 
Plantar response 50 (67.6%) 20 30 
Table 33. Abnormal reflexes in the upper and lower limbs on the paretic side of 
the body at Day 1 and for the survivors at 12 months. The number of patients 
with responses or absence of responses following cortical stimulation are shown. 
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The relationship of tendon reflexes with central motor conduction 
There was no correlation between absent responses following cortical 
stimulation after stroke on Day 1 or Days 1-7 and tendon reflexes on the paretic 
side of the body at Day 1, or between absent responses on Day 1 and tendon 
reflexes at 12 months. However, abnormal tendon reflexes on the paretic side for 
survivors at 12 months did correlate with absent responses on Days 1-7 for all 
reflexes and for all the target muscles (all p<0.0001) (Table 34). There was no 
correlation between absent responses at Day 1 and extensor plantar responses at 
Day 1. The absence of responses from any of the target muscles following cortical 
stimulation on any occasion on Days 1-7 correlated with an extensor plantar 
response on the paretic side at Day 1 (p<0.01) and at 12 months (p<0.0001). 
3.7.5 The Motricity Index of muscle power after stroke 
The Motricity Index at Day 1 
Voluntary muscle strength was assessed by clinical examination and given 
weighted scores using the Motricity Index. There was a wide spectrum of scores 
at Day 1. All patients demonstrated some degree of motor impairment. Mild 
transient weakness was identified in the non-paretic limbs for some patients 
presumably due to bilateral damage and the factors mentioned above (See: 3.7.4 
Muscle tone and tendon reflexes after stroke - Examination of muscle tone and 
tendon reflexes at Day 1). Apart from a few individuals with transient mild muscle 
weakness, muscle power on the non-paretic side fell within the normal range 
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ABNORMAL REFLEX STATISTICAL SIGNIFICANCE 
Day 1 
Tendon reflexes in the paretic arm NS 
Tendon reflexes in the paretic leg NS 
(except ankle jerk) 
Ankle jerk P<0.01 
Plantar response P<0.01 
At 12 months 
Tendon reflexes in the paretic arm P<0.0001 
Tendon reflexes in the paretic leg P<0.0001 
Plantar response P<0.0001 
Table 34. The correlations between absence of responses following cortical 
stimulation in any of the target muscles after stroke on any occasion on Days 1-7 
with abnormal tendon reflexes and plantar responses on the paretic side of the 
body at Day 1 and at 12 months (Chi-Sq). 
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irrespective of abnormalities of central motor conduction and the weakness of 
muscles on the paretic side. The mean scores for the paretic side are shown in 
Table 35. 
The Motricity Index at 12 months after stroke 
The mean scores for the Motricity Index for all survivors tested at 12 months 
are given in Table 36 (the two patients who left the region were not assessed at 
12 months). The recovery of pinch grip, which is a movement with some 
contribution from the thenar muscles, was the movement that demonstrated the 
least recovery of power. On the whole, the return of power in the lower limb was 
better than in the upper limb. Most patients showed some improvement in muscle 
power of the paretic side at 12 months. Only a few patients achieved complete 
recovery of muscle power for all movements on the paretic side, most patients 
continuing to demonstrate weakness of some movements. A small number of 
patients remained completely paralysed in the upper limb with no improvement nor 
return of muscle power for certain movements. The slight reduction of power seen 
in some patients in the non-paretic side had completely resolved by 12 months 
with the exception of one rather frail patient. 
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MOTRICITY INDEX SCORES FOR PARETIC SIDE 
FOR ALL PATIENTS AT DAY 1 (n= 118) 
Pinch grip 13.5 + 12.5 
Elbow flexion 15.0 + 12.6 
Shoulder abduction 14.6 + 13.0 
Ankle dorsiflexion 17.2 + 14.1 
Knee extension 19.8 + 127 
Hip flexion 18.3 + 12.8 
Upper limb total 43.9 + 36.9 
Lower limb total 56.0 + 38.2 
Side total 50.2 + 35.7 
Table 35. The Motricity Index scores (mean + S. D. ) for all 118 patients at 
Day 1. 
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MOTRICITY INDEX SCORES FOR PARETIC SIDE 
FOR PATIENTS AT 12 MONTHS ( n= 74) 
Pinch grip 25.7 + 10.2 
Elbow flexion 27.0 + 9.4 
Shoulder abduction 26.5 + 9.9 
Ankle dorsiflexion 27.2 + 10.2 
Knee extension 29.5 + 5.9 
Hip flexion 29.0 + 6.9 
Upper limb total 80.4 + 28.8 
Lower limb total 86.6 + 21.6 
Side total 83.6 + 24.5 
Table 36. The Motricity Index scores (mean + S. D. ) for the 74 patients examined 
at 12 months. 
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The relationship of the Motricity Index with central motor conduction 
All patients were able to contract voluntarily target muscles of the non- 
paretic limb irrespective of the degree of paresis of the paretic limb. If a response 
was present in the target muscles of the paretic limb following cortical stimulation, 
whether the CIVICT was normal or delayed, voluntary movement of the muscle was 
usually present. However, the presence of a response in a target muscle did not 
correlate with normal power and the muscle was often profoundly weak. In 
contrast, 12 patients with no movement of pinch grip at Day 1 did have recordable 
responses in the thenar muscles, 10 with normal CMCTs and two with delayed 
CMCTs. Similar absence of movement but with preservation of responses was 
seen in all the target muscles on Days 1-7. 
Patients with no responses recorded in a target muscle following EMS of the 
cortex, invariably demonstrated either absolutely no movement or occasionally a 
flicker of movement in the muscle. Two individuals appeared to be exceptions to 
this observation, both had slightly more than a flicker of movement in the target 
muscles despite the absence of recordable responses following cortical stimulation. 
The patients were divided into three groups using the results of CIVICT 
recorded from the thenar muscles. Patients were divided into Normal, Delayed and 
No Response Groups. The median scores on the paretic side for the pinch grip, the 
arm as a whole, the leg as a whole and for the paretic side (arm and leg together) 
are shown in Fig. 9. Significant differences were found when the three groups 
were compared for all measures of strength. The No Response Group of patients 
always demonstrated the lowest scores. 
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Figure 9. Comparison of Motricity scores for the three groups of patients at Day 
1 and 12 months. Kruskal Wallis analysis of variance identifies differences 
between the three groups at each time of testing. 
N Normal Response Group 
D Delayed Response Group 
NR No Response Group 
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When the three conduction groups were compared there was a significant 
difference for median pinch grip strength at Day 1. The No Response Group had 
a median value of zero. Four patients in the No Response Group had a flicker of 
muscle activity and a further two subjects had some very weak movement. Similar 
results were obtained when the strength of the other muscles in the upper limb 
was compared. The lower limb muscles retained more power (Fig. 9Q. 
At 12 months most the patients had regained some muscle strength in both 
upper and lower limbs. The improvements in power at 12 months for patients in 
both the Normal Response and the No Response Groups were significant 
(Wilcoxon, p<0.005). The improvement seen in the Delayed Response Group did 
not reach statistical significance, but only five of the seven patients in the Delayed 
Response Group survived to 12 months, and so the result may be skewed. When 
muscle strength for all the movements tested in the Motricity Index were compared 
for the Normal Response and Delayed Response Groups at 12 months there were 
no significant differences. The presence of delayed CIVICT at Day 1 did not 
influence the outcome of recovery of power at 12 months. 
At 12 months the outcome strengths were compared for the surviving 
patients from each of the Day 1 conduction groups. In each case patients were 
allocated to their original groups, irrespective of any changes that may have 
occurred in CMCT by 12 months. Despite an improvement in the median scores 
for each group, the No Response Group had significantly lower scores compared 
to the Normal and Delayed Response Groups. The same differences in muscle 
strength between the three groups were present using the results from any of the 
target muscles to formulate the three conduction groups. The most significant 
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differences were seen when the results of CMCTs for the thenar muscles were 
divided into the three conduction groups and the groups were compared. 
Therefore, when the three conduction groups are compared the differences 
in muscle strength at Day 1 are significant. Differences between the groups were 
still present at 12 months. Both at Day 1 and at 12 months the No Response 
Group achieved the lowest scores. The results for Day 1 CMCTs of any of the four 
target muscle can be used to divide the patients into the three conduction groups. 
Similar correlations were seen for each of the target muscles. The No Response 
Group had the lowest scores at Day 1 and the survivors of this group made the 
least recovery of muscle power. Significant differences were present when the 
median values of scores for the whole arm, or for the power of the whole of the 
paretic side of the body were compared for the three conduction groups at Day 1 
and for the survivors at 12 months. The power of triceps brachii and pectoralis 
major were not assessed as part of the Motricity Index. However, if the results 
from these muscles were used to subdivide the patients into the three conduction 
groups, if responses were absent at Day 1 the outcome was poor at 12 months. 
3.7.6 The Nine-hole Peg Test of hand dexterity after stroke 
The Nine-hole Peg Test at Day 1 
The mean rate for the Peg Test for normal healthy subjects was 0.65 + 0.07 
S. D. pegs per second. The scores for the Peg Test at Day 1 using the patients 
paretic and non-paretic hands are given in Table 37A. 90 patients were able and 
28 patients were unable to attempt the test at Day 1.21 patients with no useful 
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0.07 + 0.12 pegs/sec 
0.33 + 0.1 pegs/sec 
Table 37A. The peg test rate (mean + S. D. ) for the 111 patients assessed at 
Day 1. The results for the paretic hand includes the 21 patients who were 
assigned scores of zero. 
PEG TEST RATE FOR PATIENTS AT 12 MONTHS (n=73) 
Paretic hand 0.28 + 0.21 pegs/sec 
Non-paretic hand 0.45 + 0.13 pegs/sec 
Table 37B. The peg test rate (mean + S. D. ) for the 73 surviving patients assessed 
at 12 months. 
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pinch grip in the affected hand (Motricity scores of zero or nine) were unable to 
make any attempt to perform the peg test at Day 1. In the absence of no useful 
hand movements it was assumed that a number of non-motor deficits e. g. visual 
or cognitive were adversely inhibiting the patients from attempting the test. The 
21 patients were assigned scores of zero i. e. no pegs positioned (See: 2.2.4 
Clinical assessments - The Nine-hole Peg Test of hand dexterity). The patients 
were unable to perform the Peg Test with their non-paretic hand. However, 
because muscle strength was not lost in the non-paretic hand, they were not 
assigned scores of zero. It was therefore not correct to make the same 
assumption that the non-paretic hand was incapable of achieving a score if the 
particular neurological deficit that prevented the test had been removed. 
A further seven patients who could not attempt the test, were not assigned 
scores of "no pegs positioned". These patients had neurological problems that 
limited hand dexterity but they had preservation of power of pinch grip greater than 
no movement or a flicker of movement and so potentially may have been able to 
grasp the pegs if the other inhibitory defects had not been present. 
The Nine-hole Peg Test at 12 months after stroke 
Three patients were unable to perform the test at 12 months, one was 
moribund and two patients had moved from the Region. Most Patients 
demonstrated some improvement of hand dexterity at 12 months. No patients had 
arbitrary scores of zero assigned to them since all the patients could attempt the 
test. The results at 12 months are shown in Table 37B. 
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The relationship of the Nine-hole Peg Test to central motor conduction 
In the No Response Group at Day 1 only six patients had voluntary 
movement of the muscles used in the pinch grip test of the Motricity Index. Only 
one of the six patients was able to place a single peg in the 50s allowed. The 
scores for the remaining patients of the No Response Group were zero (Fig. 10). 
The one patient able to perform the test was one of two patients who had more 
than just a flicker of movement in the Motricity Index assessment of pinch grip but 
no responses in the thenar muscles following cortical stimulation at Day 1. At 12 
months 16 out of the 19 surviving patients of the No Response Group were 
available to attempt the test. Only two achieved scores in the normal range. 
These were the same two patients, who demonstrated muscle movement but had 
no recordable responses (See: 3.7.5 The Motricity Index of muscle power after 
stroke - The relationship of the Motricity Index with central motor conduction). 
When the median rates of peg positioning at Day 1 for the three conduction 
groups defined by the thenar muscles were compared the results were significant. 
Despite improvements in muscle power and hand dexterity for each group, the 
surviving patients from the No Response Group continued to demonstrate 
significantly lower levels of performance at 12 months. Patients with no responses 
following cortical stimulation at Day 1 (the No Response Group) appear to have a 
poor prognosis for manual dexterity. 
For those patients in the Normal or Delayed Response Groups the initial 
performance is similar but they recover to different levels of performance. At Day 

































Figure 10. Comparison of the Nine-hole Peg Test rate for the three groups of 
patients at Day 1 and at 12 months. Kruskal Wallis analysis of variance identifies 
differences between the three groups at each time of testing. 
N Normal Response Group 
D Delayed Response Group 
NR No Response Group 
143 
ND NR 
By 12 months significant improvement has taken place with the median value of 
the Normal Response Group within the normal range and that of the Delayed 
Response Group remaining just outside. Using a Mann-Whitney test to compare 
the differences in performance at 12 months between the Normal and Delayed 
Response Groups the results were not significantly different. However, the median 
score for the five surviving patients of the original seven patients of the Delayed 
Response Group was below the normal range. The results are based upon a very 
small group of patients and may not be accurate, but they suggest that abnormal 
central motor conduction resulting in a delay in CIVICT identifies a group of patients 
in whom the recovery of hand dexterity is likely to be less complete than patients 
with normal conduction values. 
3.7.7 The Barthel scale of the activities of daily living after stroke 
The Barthel scale at Day 7 
At Day 7,106 patients were alive and 12 had died. The surviving patients 
were assessed using the Barthel scale. The patient's carer was questioned 
regarding all aspects of the activities of daily living. The individual's ability to 
perform many activities was unknown. This was due to the fact that the patient 
had remained ill in bed and had not been given the opportunity to try certain 
activities. The activities most frequently not known were the ability to climb stairs 
and bathing. Incomplete scores were surprisingly frequent despite the fact the 
patient had been in hospital for seven or more days by the time the first 
assessment was made. 
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A wide range of scores were present at Day 7, with some patients scoring 
full marks in some categories, others had scores of zero. The median Barthel score 
for patients at Day 7 was 9.0 + 6.7 S. D. (Table 38). 
The Barthel scale at 12 months after stroke 
Details on all 76 surviving patients were available at 12 months and provided 
a final Barthel score. The median score for the survivors at 12 months was 19.5 
4.4 S. D. (Table 39). Most patients demonstrated some improvement in the 
ability to perform the activities of daily living. Bathing, the use of stairs, grooming 
and dressing were the activities least likely to improve. 
The relationship of the Barthel scale at 12 months after stroke to central motor 
conduction 
The surviving patients were subdivided arbitrarily into poor and good 
outcome groups at 12 months. There were 64 patients with good outcome 
(scores of 13-20) and 12 with poor outcome (scores of 0-12) (Table 40). 58% of 
the patients with poor outcome originally had no responses at Day 1 whereas 42% 
of patients with poor outcome were patients who did have responses at Day 1 
(Delayed and Normal Groups combined). Proportionally more surviving patients 
with no responses at Day 1 (35%) had a poor outcome at 12 months compared 
to the proportion of survivors from patients with responses at Day 1 (9%). The 
number of patients with no responses at Day 1 in the poor outcome group at 12 
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BARTHEL SCALE OF THE ACTIVITIES OF DAILY LIVING AT DAY 7. 
Score Patients (n 106) 
Bowel control 0= 14 (11.9%) 
1=- 3 (2.5%) 
2= 74 (62.7%) 
Bladder control 0= 27 (22.9%) 
1= 2 (1.7%) 
2= 64 (54.2%) 
Grooming 0 46 (39.0%) 
1 47 (39.8%) 
Toilet use 0= 36 (30.5%) 
1= 26 (22.0%) 
2= 31 (26.3%) 
Feeding 0= 8 (6.8%) 
1= 56 (47.5%) 
2= 29 (24.6%) 
Transfer 0= 9 (7.6%) 
1= 49 (41.5%) 
2= 3 (2.5%) 
3= 32 (27.1%) 
Mobility 0= 47 (39.8%) 
1= 1 (0.8%) 
2= 16 (13.6%) 
3= 29 (24.6%) 
Dressing 0= 41 (34.7%) 
1= 31 (26.3%) 
2= 21 (17.8%) 
Stairs 0= 2 (1.7%) 
1= 3 (2.5%) 
2= 23 (19.6%) 
Bathing 0= 38 (32.2%) 
1= 25 (21.2%) 
Median total 9.0 + 6.7 S. D. 
Table 38. The Barthel scores for the surviving 106 patients assessed at Day 7. 
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BARTHEL SCALE OF THE ACTIVITIES OF DAILY LIVING AT 12 MONTHS. 
Score Patients (n = 76) 
Bowel control 0= 1 (1.3%) 
1= 0 (0%) 
2= 75 (98.7%) 
Bladder control 0= 2 (2.6%) 
1= 4 (5.3%) 
2= 70 (92.1%) 
Grooming 0= 15 (19.7%) 
1= 61 (80.3%) 
Toilet use 0= 7 (9.2%) 
1= 9 (11.8%) 
2= 60 (79.0%) 
Feeding 0= 3 (4.0%) 
1= 27 (35.5%) 
2= 46 (60.5%) 
Transfer 0= 0 (0%) 
1= 10 (13.1%) 
2= 5 (6.6%) 
3= 61 (80.3%) 
Mobility 0= 2 (2.6%) 
1= 4 (5.3%) 
2= 8 (10.5%) 
3= 62 (81.6%) 
Dressing 0= 10 (13.1%) 
1= 22 (29.0%) 
2= 44 (57.9%) 
Stairs 0= 17 (22.4%) 
1= 7 (9.2%) 
2= 52 (68.4%) 
Bathing 0= 32 (42.1%) 
1= 44 (57.9%) 
Median total = 19.5 + 4.4 S. D. 
Table 39. The Barthel scores for the surviving 76 patients assessed at 12 Months. 
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BARTHEL NORMAL DELAYED NO 
OUTCOME RESPONSE RESPONSE RESPONSE 
GROUP GROUP GROUP 
Poor outcome 4 1 7 
Good outcome 47 4 13 
Table 40. The Barthel scores for surviving patients at 12 months divided into good 
(scores 13-20) and poor (0-12) outcome groups. 
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months might have been even greater if more than 50% of them had not died (See: 
3.7.9 Mortality after stroke). The surviving patients who originally had responses 
at Day 1 (the Delayed and Normal Groups combined) had a low probability of poor 
outcome and the probability of good outcome was high. 
Fig. 11 shows that the No Response Group had very low Barthel scores at 
Day 7 and, although the subjects had improved by 12 months, they did not 
achieve maximal scores. Once again the scores of the Normal and Delayed 
Response Groups are similar and start at Day 7 significantly better than those of 
the No Response Group. Both improve to reach maximal median scores at 12 
months. The differences at Day 7 between the three groups of subjects are still 
present and remain significant at 12 months. 
Unlike the other functional assessments the Barthel score utilised the 
information obtained at Day 7. A period of time was required to assess whether 
the subject could perform many of the activities. If the Barthel score was assessed 
earlier after stroke it was not reliable. It should be noted, however, that the 
patients were still grouped according to central motor conduction at Day 1. Since 
12 patients had died before their Day 7 test the influence of this subgroup with 
exceptionally poor prognosis is unknown. A further reason for error when 
comparing Day 7 scores was the surprisingly incomplete assessment given by the 
carers of the patient's ability to perform the activities of daily living. 
The Barthel score, subdivided arbitrarily into good and poor outcome groups 
(Table 40) is expressed as an odd's ratio in Fig. 12. The surviving patients from 
the No Response Group at Day 1 compared to the patients with responses, 
























Figure 11. Comparison of Barthel scores for the three groups of patients (using the 
Day 1 conduction results) at Day 7 and at 12 months. Kruskal Wallis analysis of 
variance identifies differences between the three groups at each time of testing. 
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D Delayed Response Group 
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Figure 12. Graphical representation of odds ratio with respect to poor outcome at 
12 months assessed by the Barthel score and Rankin scale. Patients in the No 
Response Group at Day 1 are compared with those of the combined Normal and 
Delayed Responses groups at Day 1. The diamond with the value above gives the 
odds ratio and the horizontal line the 95% confidence interval. The significance 
is given by the Chi-squared test. 
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3.7.8 The Rankin scale of functional outcome at 12 months after stroke 
At 12 months the 76 surviving patients were allocated a level of functional 
outcome using the modified version of the Rankin scale. At 12 months only three 
patients (2.5%) were completely free of symptoms and had no impairment of 
function resulting from their stroke. The patients were also divided into two 
groups, those who were independent (categories 0,1 and 2) and those who were 
dependent upon the care of others (categories 3,4 and 5). 69% of patients had 
achieved a level of independence as measured by the Rankin scale and 41 % 
remained dependent upon the care of others. The results are shown in Table 41 A. 
The relationship of the Rankin scale to central motor conduction 
At 12 months the modified Rankin Scale was used to assess functional 
outcome in relation to the three patient conduction groups with respect to the 
thenar muscles as defined at Day 1. Table 41B demonstrates the number of 
patients in each grade of the Rankin scale for each of the original conduction 
groups. Fig. 13 shows the results graphically for all the survivors from each 
conduction group for each Rankin grade. 
The No Response Group had the worst outcome with 76% (16/21) of the 
survivors remaining dependent. A smaller proportion of patients with no responses 
at Day 1 (11 % i. e. 5/44) achieved independence compared to the 54% (40/74) 
who survived from the combined Normal and Delayed Response Groups at Day 1 
who achieved independence. 
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RANKIN OUTCOME GROUP RANKIN SCALE NUMBER OF PATIENTS 
Independent Grade =0 3 
(n = 45) Grade =1 23 
Grade =2 19 
Dependent Grade =3 14 
(n=31) Grade =4 15 
Grade =5 2 
Table 41A. The number of patients in each grade of the Rankin scale at 12 
months. The number in each Rankin outcome group is also given. 
RANKIN NORMAL DELAYED NO RESPONSE 
0 3 
1 20 2 1 
2 13 2 4 
3 9 5 
4 5 1 9 
5 1 1 
Table 41B. The surviving patients (n=76) from the original conduction groups 
(thenar muscles) from Day 1 in each Rankin catagory at 12 months. 
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Figure 13. Distribution of Rankin scale scores among the Normal Response Group, 
Delayed Response Group, No Response Group and all three Groups combined. The 
open bars indicate independence and the hatched bars dependence as assessed by 






The value of subdividing the Rankin Scale into dependent and independent 
groups is expressed as an odd's ratio in Fig. 12. The No Response Group 
compared to those with responses, whether normal or delayed, have a higher 
probability of poor outcome and remaining dependent. 
3.7.9 Mortality after stroke 
At the end of 12 months 42 (36%) patients were dead and 76 patients 
(64%) were alive. 24 (20%) patients died within 28 days of recruitment to the 
study and a further 18 died after 28 days. 36 patients died of stroke-related 
causes, and six patients died of causes not related to stroke. Non-stroke deaths 
were unusual in the first 28 days following stroke. The relationship of causes 
related to stroke and to non-stroke death is given in Table 42. 
The relationship of mortality after stroke to central motor conduction 
23 stroke-related deaths occurred in the first 28 day period after stroke, of 
which 15 patients had shown no responses in the thenar muscles following cortical 
stimulation at Day 1. There were a total of 36 stroke-related deaths at 12 months, 
of which 23 patients had shown no responses in the thenar muscles following 
cortical stimulation at Day 1 (Table 43). 
When patients with no responses in the thenar muscles on one or more 
occasions on Days 1-7 were reviewed, they were found to account for 18 of the 
23 deaths in the first 28 days, and 28 of the 36 stroke-related deaths by 12 
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TIME OF DEATH STROKE-RELATED DEATH NON-STROKE DEATH 
Within 28 days 23 1 
Between 28 days 
an 12 months 
13 6 
Table 42. Timing of death whether within 28 days or between 28 days and 12 
months after stroke and the relationship to the cause of death. 
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MORTAUTY AT 28 DAYS 
MUSCLE WITH NO STROKE-RELATED DEATH ALIVE 
RESPONSE DEATH UNRELATED TO 
(n = 23) STROKE (n = 94) 
(n= 1) 
Thenar. Day 1 15 1 28 
(n = 44) 
Thenar. Days 1-7 18 1 34 
(n = 53) 
Any muscle. Days 1-7 20 42 
-(n 
: HL. 
MORTALITY AT 12 MONTHS 
MUSCLE WITH NO STROKE-RELATED DEATH ALIVE 
RESPONSE DEATH UNRELATED TO 
(n=36) STROKE (n = 76) 
(n = 6) 
Thenar. Day 1 23 1 20 
(n = 44) 
Thenar Days 1-7 28 1 24 
(n = 53) 
Any muscle. Days 1-7 31 4 28 
(n = 63) 
Table 43. The number of patients who died at 28 days and at 12 months are 
given with the numbers dying of stroke-related and unrelated causes for patients 
with absent responses divided into the following groups: 
1. No Response in the thenar muscles at Day 1- 
2. No responses in the thenar muscles on one or more occasions on Days 1-7. 
3. No responses in any one or more than one target muscle, on one or more 
occasions on Days 1-7. 
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months. More significantly, when the patients who demonstrated no responses 
in any one or more than one target muscle, on one or more occasions on Days 1-7 
were considered, they accounted for 20 of the 23 stroke-related deaths occurring 
in the first 28 days and 31 of the 36 stroke-related deaths at 12 months. 
Therefore, of the 36 stroke-related deaths at 12 months only five deaths were in 
patients who demonstrated responses in all of the target muscles on Days 1-7. Of 
these five patients, responses in relaxed muscles were recorded in only three 
patients. In both cases where responses could not be obtained in relaxed muscles, 
a response was possible with muscle contraction. Therefore only three patients 
(8%) out of 36 who died of stroke-related causes had entirely normal central motor 
conduction. 33 (92%) out of the 36 deaths occurred in patients with conduction 
abnormalities. It is also worth noting that four out of the six patients who died of 
causes defined as unrelated to stroke did not have responses in any one or more 
than one target muscle, on one or more occasions on Days 1-7. 
A total of 24/53 patients (45%) with absent responses in the thenar muscles 
at Days 1-7 survived to 12 months and a similar proportion of the 28/63 patients 
(44%) with no responses in any one or more than one target muscle, on one or 
more occasions on Days 1-7. In contrast 48/65 patients (87%) with responses 
always present in all target muscles on Days 1-7 survived to 12 months and only 
five (9%) of this group died of stroke-related causes by 12 months. The chances 
of dying increase when responses are absent in one, or more than one target 
muscle on Days 1-7 after stroke compared to abnormalities identified at Day 1 (Fig. 
14). The Day 1 test is highly predictive of outcome but if the stroke extends the 




THENAR DAY 11 
7.58 P<0.001 
NO RESPONSE 
THENAR DAY 1-7 




10 20 30 
ODDS RATIO 
Figure 14. Graphical representation of odds ratio with respect to stroke-related 
death, illustrating three different No Response Groups: 
1. No response in the thenar muscles at Day 1. 
2. No responses in the thenar muscles on one or more occasions on Days 1-7. 
3. No responses in any one or more than one target muscle, on one or more 
occasions on Days 1-7. 
The diamond with the value above gives the odds ratio and the horizontal line the 
95% confidence interval. The significance is given by the Chi-squared test. 
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The absence of responses in the thenar muscles (or any single muscle) 
within 72 hours of stroke, in the thenar muscles (or any single muscle) on one or 
more occasions on Days 1-7, or the absence of responses in one or more muscle 
on one or more occasions on Days 1-7 correlated with an increased probability of 
death. Absent responses following cortical stimulation increases the risk of death. 
If the damage evolves in the first few days after stroke, resulting in further loss of 
responses in more than one muscle, the probability of death increases. 
3.7.10 The period of time after stroke to death 
Surprisingly all the patients who died of stroke-related causes died in 
hospital. The mean time to death was 57.9 days. The six patients who died of 
causes unrelated to stroke did so much later, mean = 157.7 days. The period of 
time after stroke to death was not significantly different when patients with no 
responses following cortical stimulation were compared to those who died who did 
have responses, whether the comparisons are made at Day 1 (p=0.20), or on 
Days 1-7 (p=0.40). 
3.7.11 The duration of stay in hospital after stroke 
The mean stay in hospital to death or discharge for all 118 patients was 
62.5 days. Patients who survived to 12 months had a mean stay of 67.2 days 
(Table 44). Patients with responses present on Day 1 or on Days 1-7 had shorter 
stays in hospital than patients with no responses on these days. 
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PATIENTS DAYS IN HOSPITAL 
Total number of patients (n= 118) 62.5 + 79.2 
Survivors at 12 months (n= 76) 67.2 + 85.7 
No response in thenar muscles at Day 1 (n = 44) 81.4 + 84.1 
Responses in thenar muscles at Day 1 (n = 74) 51.3 + 74.4 
Patients who die: 
total (n = 42) 72.5 + 80.3 
stroke-related death (n= 36) 57.9 + 72.7 
non-stroke death (n = 6) 157.7 + 73.7 
No response in thenar muscles Days 1-7 (n = 53)': 
stroke-related deaths (n = 28) 55.9 + 70.7 
survivors (n = 24) 109.6 + 83.4 
Responses present in thenar muscles Day s 1-7 (n = 65)2: 
stroke-related deaths (n = 8) 20.1 + 17.2 
survivors (n = 52) 47.7 + 80.2 
Table 44. The duration of stay in hospital (mean + S. D. ) for different groups of 
stroke patients. 
I One patient died of causes unrelated to stroke. 
Five patients died of causes unrelated to stroke. 
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The relationship of duration of stay in hospital after stroke to central motor 
conduction 
When the means for the number of days a patient remained in hospital were 
compared for different patient groups, the 24 surviving patients, who had no 
responses in the thenar muscles at any time on Days 1-7, remained in hospital for 
109 days, which was significantly longer than the 47 day period for the 52 
surviving patients from the Normal and Delayed Response Groups combined, who 
always had responses in the thenar muscles on Days 1-7 (Table 45). Surviving 
patients from the No Response Group at Day 1 had a considerably longer stay in 
hospital than patients with responses from the Normal and Delayed Response 
Groups combined at Day 1. Although this measure is influenced by many non- 
medical factors it reflects the incomplete recovery and loss of independence seen 
in the patients who had no responses following cortical stimulation. 
3.8 THE INFLUENCE OF STROKE PROGRESSION ON OUTCOME AT 12 MONTHS 
Although many physical signs develop rapidly after stroke, damage may 
progress over a number of days leading to further loss of function. With this in 
mind, it has been useful to refer to patients with no responses following cortical 
stimulation on one or more occasions in the period Day 1 to Day 7. This increased 
the number of patients in the No Response Group in the thenar muscles to 53 
patients by including those whose stroke had progressed and who subsequently 
lost responses following cortical stimulation. When patients in the Days 1-7 No 
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PATIENT GROUP DURATION IN SIGNIFICANCE 
HOSPITAL 
No response Days 1-7 109.6 + 83.4 
P=0.0001 
Responses present Days 1-7 47.7 + 80.2 
Table 45. The length of stay in hospital of patients with no response in the thenar 
muscles following cortical stimulation on Days 1-7 compared to patients with 
responses on Days 1-7 (Mann-Whitney). 
163 
Response Group are compared to patients with no responses following cortical 
stimulation at Day 1, the mean values for most outcome measures are less and 
there was an increase in the number of patients in the poor outcome groups. The 
correlations for some of the major outcome assessments are more significant for 
patients in the Days 1-7 No Response Group. These values are given in Table 46. 
In each case patients with responses were compared to those without responses. 
3.9 THE INFLUENCE OF THE NUMBER OF MUSCLES WITH NO RESPONSES 
FOLLOWING CORTICAL STIMULATION ON OUTCOME AT 12 MONTHS 
Poor outcome was related to the number of target muscles demonstrating 
absent responses - the more muscles with absent responses the less favourable the 
outcome. Table 47 shows the number of patients relative to the number of 
muscles with no responses following cortical stimulation. 
When the major outcome measures are compared for all the patients with 
absent responses in one or more target muscles on one or more occasions on Days 
1-7, some of the correlations were stronger (Table 48 - compare to Table 46). The 
number of muscles with absent responses is probably an indication of the extent 
of damage to the motor pathways. The more muscles with no responses following 
cortical stimulation at anytime on Days 1-7 post-stroke, the stronger the correlation 
to final poor outcome and the more accurate the prognostic value of evaluating 
central motor conduction. 
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12 MONTHS OUTCOME NO RESPONSE 
DAY I (n = 44) 
p VALUE NO RESPONSE 
DAYS 1-7 
(n = 53) 
p VALUE 
Motricity Index: 
(mean + S. D. ) 
Pinch grip 15.1 + 12.1 P<0.0001 14.9 + 11.3 P<0.0001 
Arm total 52.5 + 37.2 P=0.0001 51.7 + 35.0 P<0.0001 
Leg total 67.4 + 28.7 P=0.0001 68.0+ 27.1 P<0.0001 
Arm+leg total 59.9 + 32.0 P=0.0001 59.8 + 29.9 P<0.0001 
Peg test rate 0.06+0.14 p<0.0001 0.05 + 0.13 P<0.0001 
(mean + S. D. ) 
Barthel: 
median score 14.5 + 5.1 p<0.005 13.5 + 4.8 p<0.0001 
poor outcome 7 p<0.05 8 P<0.0001 
Rankin: 
poor outcome 15 P<0.001 19 P<0.0001 
Stroke-related 
deaths 23 P<0.001 28 p<0.001 
Table 46. The mean values + S. D. and the number of patients in each poor 
outcome group for patients with no response in the thenar muscles on Day 1 and 
also for patients with no responses on Days 1-7. The p values refer to the 
significance of the differences for the scores of those with no responses at Day 1 
compared to those with responses at Day 1, and the differences between those 
with no responses on one or more occasions on Days 1-7 compared to those who 
always had responses Days 1-7. 
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NUMBER OF MUSCLES WITH NO RESPONSES 
ON ONE OR MORE OCCASIONS DAYS 1-7 
NUMBER OF PATIENTS 
None 55 (46.6%) 
1 muscle 4 (3.4%) 
2 muscles 5 (4.2%) 
3 muscles 11 (9.3%) 
4 muscles 43 (36.4%) 
Table 47. Number of patients demonstrating muscles with no responses on one 




NO RESPONSE IN ONE OR 
MORE TARGET MUSCLES ON 
ONE OR MORE OCCASIONS ON 
DAYS 1-7 (n=63) 
RESPONSES IN ALL 
TARGET MUSCLES ON ALL 




(mean + S. D. ) 
Pinch grip 16.4 + 11.2 30.7 + 4.6 P<0.0001 
Arm total 54.0 + 33.0 94.7 + 10.8 P<0.0001 
Leg total 67.4 + 25.5 97.0 + 8.2 P<0.0001 
Arm+ leg total 60.7 + 27.8 95.9 + 8.6 P<0.0001 
Peg test rate 0.06+ 0.12 0.39 + 0.15 p<0.0001 
(mean + S. D. ) 
Barthel: 
median score 13.8 + 4.6 20.0 + 3.2 p<0.0001 
poor outcome 10.0 2.0 p<0.0005 
Rankin: 
poor outcome 23.0 8.0 P<0.0001 
Stroke-related 31.0 5.0 P<0.0001 
deaths 
Table 48. Mean outcome values (+ S. D. ) for patients with one or more muscles 
with no responses on one or more occasions on Days 1-7 compared to patients 
who always had responses in all muscles on Days 1-7. The p value refers to the 
significance when the two groups are compared for each outcome value. 
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3.10 THE RELATIONSHIP OF THRESHOLD TO ELECTROMAGNETIC 
STIMULATION ON OUTCOME AT 12 MONTHS 
Responses at Day 1 could be grouped as: 
1) Obtained in relaxed muscles. 
2) Only obtained with muscle contraction with maximum EMS. 
3) Absent despite maximum stimulation and muscle contraction. 
In many stroke patients responses could not be evoked in relaxed muscles 
and contraction was required to facilitate a response. The threshold for responses 
in stroke patients was graded not only by the level of output of the stimulator, but 
the need for contraction when responses were not present at maximum stimulator 
power output in relaxed muscle. This phenomenon was observed for all target 
muscles but was only documented for biceps brachii (Table 49). 
The outcome of patients in whom responses in biceps brachii were only 
possible with muscle contraction was compared with those with responses in 
relaxed biceps brachii. Patients who required muscle contraction at Day 1 to 
produce a response, had mean clinical and functional outcome scores slightly lower 
than patients with responses in relaxed muscle. If contraction was required to 
facilitate a response a larger proportion of patients either died or achieved poor 
outcome in terms of Barthel and Rankin outcome groups. However when the 
differences were analysed they failed to reach statistical significance. 
Analysis of the relationship to death revealed some interesting observations. 
Of the 23 stroke-related deaths that occurred within 28 days after stroke, 14 were 
patients with no responses recorded in the biceps brachii on Day 1. A further five 
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12 MONTHS OUTCOME RESPONSES IN 
RELAXED BICEPS 
BRACHII MUSCLE 
DAY 1 (n=53) 
RESPONSES ONLY IN 
CONTRACTED BICEPS 
BRACHII MUSCLE 
DAY 1 (n = 19) 
Motricity Index: 
(mean + S. D. ) 
Pinch grip 30.3 + 5.5 26.4 + 7.1 
Arm total 93.6 + 14.7 80.1 + 19.1 
Leg total 96.0 + 9.2 85.4 + 20.2 
Arm+ leg total 94.9 + 11.1 82.9 + 18.4 
Peg test rate 0.36 + 0.17 0.26 + 0.24 
(mean + S. D. ) 
Barthel: 
median score 20.0 + 2.5 20.0 + 5.1 
poor outcome 3.0 (5.6%) 2.0 (8.7%) 
Rankin: 
poor outcome 11.0 (20.4%) 5.0 (21.7%) 
Stroke-r lated death 7.0 (13.0%) 7.0 (30.4%) 
Table 49. The mean values and number of patients in outcome groups and number 
of stroke-related deaths for patients with responses obtained in relaxed biceps 
brachii muscles and those in whom responses could only be obtained in 
conjunction with contraction of the target muscle or the homologous muscle. 
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deaths occurred in those in whom responses could only be obtained at 100% 
electromagnetic output with the additional threshold-lowering effect of muscle 
contraction. Therefore, of the 23 stroke-related deaths occurring within 28 days 
of stroke, all except four patients had absent cortical responses following maximal 
EMS with biceps brachii in a relaxed state. At 12 months half the patients with 
responses following cortical stimulation (n= 14) who died of stroke-related death, 
were patients who required contraction to facilitate a response in biceps brachii. 
Note, however, most deaths occurred in patients in whom responses were not 
obtained on Day 1, even with muscle contraction (n = 22 for biceps brachii). 
When the period of stay in hospital for patients with responses in relaxed 
biceps brachii at Day 1 was compared to patients with responses in biceps brachii 
only with muscle contraction, the mean stay was slightly longer (Table 50). 
In conclusion, if responses can only be obtained at maximum levels of 
stimulation with the aid of muscle contraction, the outcome at 12 months is 
slightly less favourable than for patients with responses in relaxed muscles. 
3.11 REASSESSMENT OF SURVIVORS AT 18 MONTHS 
Functional and clinical assessments at 18 months after stroke of the 32 
survivors from the first 60 patients recruited did not reveal any further changes of 
significance from the results obtained at 12 months. Therefore any further 
improvement after 12 months was minimal and all major changes in central motor 
conduction and recovery of motor function were complete. The choice of 12 
months as the end point of the study appears to have been valid. 
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DAYS IN HOSPITAL 
Response obtained in relaxed biceps 49.1 + 80.2 
brachii 
Response obtained only with 51.0.: E 55.5 
contraction of biceps brachii 
No Response obtained despite 86.6 + 84.9 
con raction of biceps brachii 
Table 50. Relates the total length of time spent in hospital to ability to obtain a 
response in biceps brachii at Day 1 with the muscle relaxed or contracted (mean 
S. D. ). 
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3.12 VALIDITY OF CMCT AS A PREDICTOR OF OUTCOME. 
The sensitivity and specificity of using CMCT as a predictor of outcome after 
stroke and the positive and negative predictive values are given in Table 51. 
Sensitivity refers to the percentage of diseased subjects who have a positive 
test. In the context of this study, diseased subjects are the patients who have 
poor outcome at 12 months. The positive test refers to the patients with no 
responses following cortical stimulation i. e. the No Response Group. Specificity 
is the percentage of disease-free subjects who have a negative test. The 
disease-free subjects are those who have good outcome at 12 months with respect 
to particular outcome measures. The negative test refers to patients with 
responses following cortical stimulation i. e. the Delayed and Normal Response 
groups combined. 
The statistical indices of sensitivity and specificity are useful in assessing the 
validity and informational value of a diagnostic test. However, positive predictive 
value (PPV) and negative predictive value (NPV) are not true indices of validity, 
because they depend on the relative proportions of diseased and disease-free 
subjects being tested. They are governed by the ratio of true and false positives 
(PPV) or true and false negatives (NPV). A test with high specificity (few false 
positives among the disease-free) can have low positive predictive value, if the 
ratio of the disease-free to diseased subjects is high. Similarly, a test with high 
sensitivity (few false negatives among the diseased) can have negative predictive 
value if the ratio of disease-free to diseased subjects is low (a very unlikely testing 
situation). 
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The results of this study show that the measurement of CIVICT is a test of 
high specificity. The sensitivity is more variable for assessments at Day 1. The 
sensitivity was low for predicting poor outcome using the Barthel score and the 
probability of death. However, for most outcome measures identifying patients 
with no responses at Day 1 (positive test) had high positive predictive value. 
The result of low positive predictive value relating to the Barthel score may 
have been different if a different score had been chosen to divide the patients 
arbitrarily into the two outcome groups of poor and good outcome. The positive 
predictive value relating to death is low because even though the proportion of 
patients in the No Response Group who die is high (52% for patients with no 
response in the thenar muscles at Day 1), a large minority of patients with no 
responses survive to 12 months. Only the assessment of Peg Test rate and 
assessment of muscle strength using the Motricity Index did not have a high 
negative predictive value for patients with responses at Day 1 (negative test) who 
have good outcome (disease-free). This is due to the fact that it is unusual for 
patients to fully recover normal motor function after stroke. In this study very few 
surviving patients at 12 months recovered normal dexterity and full strength as 
measured by the Peg Test rate and the Motricity Index. The test therefore has only 
a low rate of false negative results and is moderately good at identifying true 
positive results with respect to specific outcome measures. 
In general the ability to identify two patient groups, those with responses 
(the Delayed and Normal Response Groups combined) and with no responses (the 
No Response Group) at Day 1 is a test with high specificity, with only a low rate 
of false negatives. (See: 4.8 Validity of CMCT as a predictor of outcome). 
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OUTCOME MEASURE SENSITIVITY % SPECIFICITY % PPV % NPV % 
Tone in arm - abnormal 52 91 79 75 
Tone in leg - abnormal 58 90 74 82 
Motricity Index: 
Pinch grip - weak 
Arm power - weak 
Leg power - weak 

















Peg test rate -< normal range 41 94 89 54 
Barthel score - 12 or less 27 97 60 87 
Rankin scale - dependent (3-5) 48 89 75 71 
Stroke-related death by 12 months 64 74 53 81 
All deaths by 12 months 57 74 55 76 
TABLE 51. Sensitivity and specificity of responses in the thenar muscles to EMS 
of the motor cortex at Day 1 for defining different outcome measures at 12 
months. PPV, positive predictive value; NPV, negative predictive value. In the 
Motricity Index weak is defined as any score less than full power for a particular 
movement or combination of movements. Values for the Nine-hole Peg Test are 
abnormal if they are outside the normal range defined by testing the 53 healthy 
subjects. 
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3.13 SUMMARY OF THE RESULTS RELATING TO THE PROGNOSTIC VALUE OF 
ASSESSING CENTRAL MOTOR CONDUCTION AFTER STROKE 
Electromagnetic stimulation of the brain to evoke motor responses in the 
corticospinal tracts represents a simple, non-invasive neurophysiological method 
of assessing the function of the central motor pathways. The technique can be 
safely used in the first few days following stroke. The present study has 
demonstrated clinical and functional recovery following stroke correlates with the 
neurophysiological observations performed in the immediate post-stroke period of 
12 -72 hours (median = 47.5 hours). The following observations were made: 
Central motor conduction 
1. In the period of 12 to 72 hours after stroke the integrity of the central motor 
pathways may be disrupted resulting in the absence of recordable responses 
following EMS of the motor cortex. If responses are obtained they may be delayed 
or within the normal CMCT range. Most patients who lack responses after stroke 
gain responses within three months. The latency of these responses is often 
prolonged but may eventually return to normal. Extension of stroke may lead to 
loss of responses. 
2. The changes in central motor conduction were seen in both proximal and distal 
muscles with no difference between antagonistic muscles. 
3. The durations of responses to cortical stimulation that appeared by 12 months 
were shorter than normal. 
4. The thresholds to cortical stimulation in the damaged hemisphere were initially 
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elevated but they decreased to significantly lower levels than normal by 12 
months. Similar, but less significant changes were seen for thresholds in the 
undamaged hemisphere. The threshold stimulation of both the damaged and 
non-damaged hemispheres for the thenar muscles was slightly lower than the value 
for biceps brachii. 
5. At 12 months all major changes in central motor conduction were complete and 
no further changes were observed at 18 months. 
Absentresponses 
1. Cortical responses were more likely to be absent in patients with infarctions, 
large lesions, lesions with mass effect or cortical lesions, as seen on CT scans. 
2. Absent responses were more common in patients with Total Anterior Circulation 
Syndrome and patients with the greatest initial impairment of function. 
3. Absent cortical responses indicated a poor prognosis leading to either death or 
incomplete functional recovery. 33 out of the 36 patients who died of stroke- 
related causes had some evidence of abnormal central motor conduction. The risk 
of death was greatest if responses were absent on Days 1-7 and if more than one 
muscle had absent responses. 
4. By comparison to patients with responses at Day 1, patients with no responses 
who survived achieved significantly lower scores for all outcome measures at 12 
months including abnormal tone and reflexes, muscle strength measured by the 
Motricity Index, hand dexterity measured by the Nine-hole Peg Test, activities of 
daily living measured by the Barthel score, functional independence measured by 
the Rankin scale and duration spent in hospital. 
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Delayed central motor conduction time 
Patients with delayed responses did not regain normal hand dexterity. 
However, the overall recovery of these patients was comparable to those with 
responses with normal CIVICT. 
Normal central motor conduction time. 
Patients with normal CIVICT had a good prognosis. The probability of death 
was low and most survivors achieved good functional recovery. 
The role of muscle contraction during the recording of responses. 
Patients in whom cortical responses could only be obtained at maximal 
stimulation with the threshold-lowering effect of muscle contraction were at 
slightly higher risk of poor outcome compared to patients with responses obtained 
in relaxed muscles. 
Specificity and sensitivity. 
The measurement of CMCT is a test of high specificity. The sensitivity is 
more variable but there are factors relating to the design of the study which may 
account for the low sensitivity of some outcome measures. 
Electromagnetic stimulation of the motor cortex in the immediate post-stroke 
period provides important prognostic information that relates to mortality and 
functional outcome at 12 months. The interpretation of the results, the possible 
mechanisms that might underlie the neurophysiological findings and the 
implications of these observations are discussed in the following chapter. 
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DISCUSSION. 
4.1 OBSERVATIONS IN NORMAL SUBJECTS 
The muscles studied included those acting at the shoulder, about the elbow 
and in the hand and involved spinal roots from C5 to T1. In the normal group of 
subjects the CMCTs calculated for each muscle were not significantly different, but 
the temporal distribution corresponded to the spatial cranio-caudal segmental 
distribution of the motor nuclei and therefore the conduction distance along the 
corticospinal pathway. When the values of CIVICT for the group of normal subjects 
and for the non-paretic side of the stroke patients were taken together no 
statistical correlation of CIVICT with age was found. The values are comparable to 
those observed in a cross-sectional study of children aged two years to adulthood 
(Eyre et al., 1991). The results of the present study support the observations 
made by Eyre et al. that CMCTs do not change in adult life. Therefore, when 
studying patients with stroke comparisons with normal adult subjects as a group 
are valid and there is no need to make any correction for age. 
Macdonell et al. (199 1), observed hemispheric threshold differences in MEPs 
produced by EMS. The threshold to stimulation of the left hemisphere projection 
to the muscles of the right hand was lower than that of the right hemisphere to left 
hand. It was proposed that the differences related to the asymmetry of 
corticornotoneuronal monosynaptic connections and the suggestion was made that 
a greater number project to the motor neurones of the right hand muscles than 
those of the left. The observations were made in only 19 right-handed normal 
subjects with recordings from the adductor digiti minimi and biceps brachii 
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muscles. In the present study handedness was not formally assessed and no 
hemispheric differences with respect to CMCT were discovered in the group of 53 
normal subjects. 
Macdonell et al. 0 99 1) also observed that the threshold to stimulation of the 
hand muscles (adductor digiti minimi) was slightly lower than that of biceps brachii. 
The present study found the same minor differences when comparing the threshold 
to stimulation of the thenar muscles compared to biceps brachii in normal subjects. 
4.2 OBSERVATIONS IN STROKE PATIENTS 
The neurophysiology of conduction in the motor pathways from the cortex 
to the spinal cord has been investigated sequentially over 12 months in a group of 
118 patients following stroke. At Day 1, defined as between 12 and 72 hours 
following the onset of symptoms, when the CIVICT of responses obtained in stroke 
patients were compared to values of CIVICT obtained from 53 healthy subjects, the 
patients divided into three groups those with normal CIVICT, delayed CIVICT and 
absent responses. All the target muscles investigated demonstrated a similar 
pattern of abnormality and recovery in terms of central motor conduction. In both 
normal subjects and stroke patients the target muscle was contracted or the 




4.2.1 Comparison to other neurophysiological studies after stroke 
Comparable neurophysiological observations after stroke have been made 
using SEPs (Larson et al., 1966; Kussofsky et al., 1982; La Joie et al., 1982; 
Macclonell et al., 1989; Zeman and Yiannikas, 1989) and using percutaneous ES 
of the brain (Berardelliet al., 1987; Thompson et al., 1987; Dominkuset al., 1990; 
Macclonell et al., 1989; Meyer et al., 1990; and Abruzesse et al., 1991). A 
number of studies have now been completed using EMS (Bridgers, 1990; Ferbert 
et al., 1992 [patients with pontine infarction only]; H6mberg et al., 1991; Kandler 
et al., 1991; Chu and Wu, 1992; Escudero et al., 1992). In these studies only 
small numbers of patients were tested in the immediate post-stroke period and no 
comparisons were made to outcome at 12 months. 
The present study observed changes in central motor conduction that had 
been reported in the studies cited above. Absent, delayed and normal responses 
were observed. The conduction abnormalities from dominant and non-dominant 
cerebral hemispheres were not significantly different. There was also no difference 
between CMCTs for distal compared to proximal muscles, and when the results of 
biceps brachii and its antagonist, triceps brachii were compared. 
4.2.2 The importance of identifying responses in the immediate post-stroke period 
It is significant that in approximately 15% of patients in the present study, 
responses could only be evoked by the facilitating action of muscle contraction. 
Escudero et al. (1992) made the same observation in some patients. Not all the 
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publications mentioned above include observations based upon responses recorded 
in contracted muscles. It is likely that the no response groups reported by 
1-16mberg et al. (199 1) and Kandler et al. (199 1), where recordings were made in 
relaxed muscles, included a number of patients who might otherwise have been 
classed as responders. The conclusions drawn from these studies might have been 
different if all the patients had been identified in whom responses could be 
obtained by recording from muscles with the aid of muscle contraction. 
Macdonell and Donnan (1992) found MEPs to be of prognostic value 
regardless of whether responses were obtained with or without contraction. The 
results of the present study suggest that it is essential to use muscle contraction 
during the recording of responses following cortical stimulation in order to identify 
all patients who are capable of responses. Our results suggest that patients with 
responses obtained only in the presence of contraction have a less favourable 
outcome compared to patients whose responses are present in relaxed muscles. 
However, the outcome of patients with no responses despite muscle contraction 
was considerably worse than patients with no responses in relaxed muscles but in 
whom responses could be evoked during muscle contraction. The results of the 
present study are therefore different to those reported by Macdonell and Donnan 
992). The authors did comment that if responses were only obtained with 
contraction the significance of the finding required further study. 
The results of the present study compare favourably with the results of 
previous studies regarding the significance of identifying responses in patients 
immediately after stroke. Macclonell et al. (1989), Domininkus et al. (1990), and 
Chu and Wu (1992) all observed that, if responses to cortical stimulation were 
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obtained, this correlated with good outcome. These authors, with the exception 
of Chu and Wu (1992), also concluded that the absence of responses suggested 
a poor outcome. The present study clearly demonstrates the significance of 
identifying responses and the relationship of this finding to good outcome and the 
association of absent responses leading to poor outcome. 
Chu and Wu (1992) observed a small number of patients who initially had 
no responses, but who regained them within a few weeks of stroke. The design 
of the present study allowed this phenomenon to be observed in close detail and 
clearly shows that most patients who had no responses immediately after stroke 
gain responses within three months. This is an important observation that casts 
doubt upon the validity of some of the conclusions made by Kandler et al. 1991; 
H6mberg et al. 1991; Ferbert et al. 1991; Chu and Wu 1992; Escudero et al. 
1992, regarding the correlation of neurophysiologicalfindings recorded many days 
or weeks after stroke with outcome. 
The studies cited above lacked information regarding the evolution of central 
motor conduction changes and included only small numbers of patients tested in 
the acute stroke period. This may have resulted in inaccurate grouping of patients. 
Patients with responses many days after stroke may originally not have 
demonstrated responses if they had been investigated in the immediate post-stroke 
period. If responses were recorded in an individual and it was unknown whether 
responses had previously been absent, then the results in these patients are of 
limited value. Also, a greater number of patients with delayed CIVICT were 
identified in many previous studies and this may indicate patients who originally 
had no responses but who have gained responses with delayed conduction. These 
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patients were therefore wrongly categorised as responders, which may explain the 
variable recovery of some patients in previous studies in whom responses were 
obtained and yet the outcome of the patient was poor. This weakens the 
conclusions made in previous publications regarding the prognostic significance of 
demonstrating responses after stroke. 
The present study identified clearly patients who first lost and later regained 
responses by commencing investigations within hours of the onset of stroke and 
then sequentially retesting at fixed time intervals over 12 or 18 months after 
stroke. Patients in the present study who regained responses were identified in the 
post-stroke period as non-responders and were found to have a poor outcome. 
The results of the present study show that it is essential to identify all patients 
who have no responses and the only way of doing this is to investigate all patients 
at the earliest possible opportunity. 
4.2.3 Responses with delayed CIVICT 
Escudero et al. (1992) found delayed responses were indicative of poor 
outcome. The present study identified only seven patients who initially had 
delayed CIVICTs. In general this group of patients had an outcome comparable to 
the patients with normal CMCTs. There was a tendency towards poor return of 
hand dexterity as measured by the Nine-hole Peg Test, but the number of patients 
in this group was small and therefore the present study has not clarified the 
significance of delayed CIVICT measures in the immediate post-stroke period. 
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4.2.4 Responses obtained following stimulation of the undamaged hemisphere 
When the results of CIVICT estimated from responses recorded in the 
non-paretic arm following stimulation of the undamaged hemisphere are compared 
to the results from normal subjects no differences were discovered. Therefore, the 
results of the present study agree with those of a number of authors (Thompson 
et al., 1987; Meyer et al., 1990; Beradelli et al., 1991; 1-16mberg et al., 1991; 
Escudero et al., 1992) who found responses in the paretic limb following 
stimulation of the non-damaged hemisphere had CMCTs within the normal range. 
The responses in the non-paretic limb can therefore act as controls for those of the 
paretic arm and indeed are indistinguishable from those of normal subjects. 
4.2.5 The significance of the present study 
The present study differs from those reported above in that the 
investigations were initiated within 12 to 72 hours after the onset of symptoms in 
a large and well-defined group of patients with first-ever stroke. The observations 
made in this study have helped to clarify a number of methodological features 
relating to the use of EMS following stroke. It is essential that investigations 
should commence as soon as possible after stroke in order to identify those who 
have no responses. Failure to do this leads to misleading results, if patients are 
first investigated a number of days after stroke when they may have regained 
responses. All cortical responses should be recorded during muscle contraction 
rather than in relaxed muscles in order to avoid inaccurate grouping of patients. 
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In some patients the clinical signs of stroke extend and become more widespread, 
often resulting in the subsequent loss of responses. Patients who originally 
demonstrate responses should therefore be retested seven days after the initial test 
in order to identify if there has been any subsequent loss of response. It is now 
clear why the initial observations of central motor conduction are so important. 
The absence of responses at any time carries the same poor prognosis as no 
response on Day 1 and leads to death or poor recovery. If responses are always 
present the functional prognosis is highly likely to be good. 
At 18 months, a final review of the survivors from the first 60 patients 
recruited did not reveal any further features suggesting that recovery of motor 
function and its central nervous control was complete by 12 months. 
4.3 THE REASONS FOR CHANGES IN CENTRAL MOTOR CONDUCTION 
4.3.1 The pathophysiology of absent responses 
The total absence of a response 12 months after stroke probably indicates 
the irreversible loss of the corticospinal projection to a particular motoneuronal cell 
group. It has been assumed that the responses are conducted by the corticospinal 
pathway projecting monosynaptically to spinal motoneurones. The arguments for 
corticospinal transmission are based upon the short latencies of the responses 
(Rothwell et al., 1991; Boyd et al., 1986) and observations in the monkey that 
EMS at levels above threshold excites corticospinal axons (Edgley et al., 1990b 
and 1992). In this study, if no response was recorded in one muscle in the upper 
limb, responses were often absent in other target muscles. This may result from 
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destruction of the corticospinal neurones or interneurones in the motor cortex, or 
damage to corticospinal axons in the pathway from the cortex to the synapse with 
a-motoneurones. In each case it is assumed that alternative pathways cannot be 
activated and that the threshold for corticospinal activation is not elevated above 
the output capability of the electromagnetic stimulator. 
In the No Response Group at Day 1 responses to cortical stimulation were 
gained in a small number of subjects within a few days. However, the majority 
who gained responses did so by one month or occasionally by up to three months. 
This raises the question why recovery takes so long in the corticospinal pathway 
and whether conduction appears in descending pathways other than the direct 
crossed corticospinal pathway from cortex to spinal motoneurones. The 
hypothesis that recovery in stroke may be due to ipsilateral corticospinal pathways 
(Palmer et al., 1992) has not been supported by the findings of this study. In the 
present study the stimulator coil was held over the vertex. Although the direction 
of current flow in the coil governs which hemisphere is preferentially stimulated, 
the coil is capable of stimulating either hemisphere. It was therefore not possible 
to be sure in which hemisphere the evoked potential was produced. Attempts to 
produce ipsilateral responses by placing the coil over the ipsilateral hemisphere did 
not alter the latency of responses. The design of the present study did not allow 
the identification of alternative crossed or ipsilateral pathways. 
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4.3.2 The anatomical basis of absent responses 
In the present study the correlations between the anatomical features of 
stroke visualised on CT scans and the underlying neurophysiology are of interest. 
The absence of responses correlated with large infarctions, lesions with mass 
effect and lesions involving the cortex. The CT scan results suggest lesions 
involving the cortex lead to loss of responses and purely subcortical damage was 
more probable to lead to retained responses, the reasons for this are unclear. ' 
However, the results from the present study agree with Escudero et al. (1992) who 
observed that responses were more likely to be absent if the lesion was cortical 
and large. Chu and Wu (1992) found cortical lesions to have a more variable 
association with absence of responses, but agreed with other studies that most 
delayed responses were associated with subcortical lesions (Abruzzesse et al., 
1991; Beradelli et al., 1987; Dominkus et al., 1990; Thompson et al., 1991). The 
small number of patients with delayed responses at Day 1 in the present study do 
not allow accurate comparisons to be made between delayed CIVICT and CT scans. 
The correlations between CT scanning features and CIVICT in the present 
study must be viewed carefully. It is not surprising that the correlations are not 
straightforward since the two techniques are evaluating very different aspects of 
the central nervous system. Scans provide anatomical information, whereas 
conduction studies are a measure of neurophysiological function of motor 
pathways. Also, the value of the CT scan is reduced by the fact that the 
investigation was not standardised. The scans were performed on two different 
machines. The procedure was performed whenever it was possible to scan the 
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patient, hence the scans did not take place at a fixed time after stroke, unlike 
cortical stimulation which was performed at fixed time intervals after stroke. 
There is also the difficulty of interpreting the scan findings. Some of the 
earliest scans with no visible abnormality may have subsequently developed 
identifiable lesions. Oedema is often difficult to distinguish from infarction early 
after stroke and estimation of the boundaries of an infarct and approximations of 
size are therefore highly subjective. The correlation of CT scan appearances with 
central motor conduction was not straightforward particularly regarding the 
influence of mass effect. It is interesting that lesions involving the cortex 
compared to purely subcortical lesions had a higher probability of absent 
responses. This suggests that central motor conduction may be more prone to 
disruption when there is damage to the cortex resulting in cortical cell loss and 
disruption of cortical interneuronal connections. 
4.3.3 The mechanisms underlying delayed central motor conduction 
Delayed responses fell under two categories. At Day 1a group of patients 
had delayed responses with relatively small discrepancies from the normal range. 
This was a small group with only seven patients with delays in the thenar muscles 
at Day 1 and only five survivors at 12 months. Patients with delayed central motor 
conduction had incomplete recovery of hand dexterity, but the significance of the 
observation remains unclear. A direct comparison of the outcome of the Delayed 
Response Group compared to the Normal Response Group failed to identify any 
significant differences despite the fact that the Delayed Response Group had a 
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lower mean outside the normal range. The size of the Delayed Response Group is 
too small and any statistical comparison with the other groups of patients may be 
inaccurate. A further group of patients with delayed tMCTs emerged in 
subsequent tests from amongst the non-responders at Day 1 who gained 
responses and from other individuals who extended their stroke, lost responses and 
then subsequently regained responses with prolonged CMCTs. Some patients who 
gained responses with delayed CIVICT later developed responses with normal 
CMCTs, an observation that was also made by Chu and Wu, 1990. 
Delayed responses in patients at Day 1 may reflect permanent loss of large 
diameter fast myelinated fibres in the corticospinal pathway. If the pathway was 
not destroyed, temporary slowing in the larger fibres may have been due to higher 
metabolic demands and a greater susceptibility to ischaemia (Branston et al., 
1988). The possibility of this being a real phenomenon is highlighted in a number 
of studies (Momma et al., 1988; Oro and Levy 1987; Simpson et al., 1987). 
Dominkus et al. (1990) suggested an alternative view that a form of central motor 
neuropraxia may exist analogous to that following peripheral nerve damage. The 
net result would be slowing of conduction in the larger fibres or it is possible that 
the cortical stimulus is only able to activate smaller, more slow-conducting fibres 
under conditions of ischaernia. 
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4.3.4 Altered excitability of corticospinal neurones following stroke 
In all stroke patients the threshold for eliciting responses from the damaged 
hemisphere was initially high, being greater than the range obtained in normal 
subjects, and decreased progressively during recovery. The thresholds fell over 12 
months and in many cases were below the normal range (Table 23). The 
pathophysiology underlying this observation is difficult to explain. By 12 months 
following stroke the excitability of the spinal motoneurones, particularly those of 
flexors of the upper limb, is likely to be raised. Other monosynaptic inputs such 
as the stretch reflex evoke responses at much lower intensities and contribute to 
the clinical state of spasticity (Ashby and McCrea 1987). Raised motoneuronal 
excitability could arise through the reduction in spinal inhibitory mechanisms 
(Yanagisawa et al., 1976; Plant and Miller, 1990; Ashby and McCrea, 1987). 
Conduction in the large myelinated fibres of the corticospinal pathway is 
thought to be responsible for the early component of the evoked motor responses 
following EMS of the motor cortex (Edgley et al., 1990b). These fibres may be 
more susceptible than small myelinated fibres to ischaemia. Since large myelinated 
axons in general have low thresholds to ES and fibre diameter in the corticospinal 
pathway is related to the threshold of EMS (Eyre et al., 1991), it would be 
expected that the threshold should rise following stroke. If the large myelinated 
fibres suffer partial and reversible conduction block following stroke, an initial 
increase and then decrease in the threshold of EMS would be expected. The 
temporary loss of large myelinated corticospinal fibres would also disrupt the 
temporal and spatial summation of direct and indirect volleys at the motoneurone 
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and contribute to the increase of threshold. 
The initial increase of threshold for motor responses in muscles of the non- 
paretic limb following stimulation of the undamaged hemisphere was not 
unexpected but is probably due to processes such as general brain oedema and 
anatomical displacement of the hemispheres. The observation that the threshold 
to stimulation later in recovery and up to the final test sessions at 12 months 
decreased was not anticipated. There could be an increase in the excitability of 
corticospinal neurones or spinal motoneurones, but the underlying mechanisms are 
hard to define, particularly since reciprocal inhibition has been reported to be 
normal in the non-paretic arm (Miller and Plant, 1991). 
The idea of altered excitability in the cortex is strengthened by the 
observation that some patients have responses only when facilitated with muscle 
contraction. This mechanism although thought to take place at the spinal level by 
some authors (Maertens de Noordhout et al., 1992) may still alter excitability of 
the pyramidal tract neurones or cortical interneurones at, or just before the 
initiation of movement. The lowering of cortical threshold by facilitation lowers the 
intensity of stimulation required to recruit multiple descending volleys and 
discharge motorneurones (Thompson et al., 1991). Altered excitability of the 
corticospinal neurones following stroke may explain why two patients in this study 
had movement in the pinch grip test in the Motricity Index assessment, despite the 
absence of responses in the thenar muscles on Day 1. On subsequent days these 
two patients hadrecordable responses and their outcome was better than patients 
with absent responses and no movement. The stimulus threshold to excite the 
cortex may have been exceptionally elevated above the maximum output intensity 
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of the stimulator. 
4.3.5 Why should responses reappear? 
A number of possibilities may explain why responses reappear. The first 
two mechanisms have already been discussed. Firstly, the corticospinal pathway 
may initially be refractory to the stimulus intensities used. The electrical currents 
induced in the cortex may not have been sufficient to excite the pathways in the 
damaged brain after stroke until, at a later date, the excitability of the cortex 
increased and the threshold to stimulation fell. A second possibility is that 
alternative motor pathways from the cortex to the spinal cord may have been 
activated particularly in the case of very prolonged responses that reappeared. 
These proposed pathways may be contralateral or ipsilateral. 
A third explanation for the reappearance of responses with delayed CIVICT 
could be the loss of myelinated fibres and dependency upon intact smaller fibres. 
There may have also been some clemyelination of large fibres. Some patients lost 
responses and this was followed by the tardy return of responses that were initially 
delayed and subsequently fell to close or within the normal range, therefore the 
concept of reinnervation in the corticospinal tract must arise (1-16mberg et al., 
1991; Escudero, 1992). These patients had poor outcome and did not regain 
normal motor function. If reinnervation did occur it was therefore incomplete or, 
if it was anatomically complete, the final functional result was different since 
normal neurological function was not restored. 
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4.4 ALTERATION IN THE DURATION OF RESPONSES IN PATIENTS WHO GAIN 
RESPONSES 
Patients who regained responses did so with shortened duration and usually 
of delayed CMCT. The measurement of duration from an average of single trials 
may possibly lead to a skew of the results by recording the shortest onset latency 
and the longest offset latency, but the inaccuracy is small in relation to the total 
duration. This phenomenon is possibly explained by the permanent loss of some 
of the fastest conducting fibres as a consequence of ischaemic damage. Their 
contribution to the response waveform is therefore the earliest and represents the 
initial component of the EMG response. Therefore if their function is impaired or 
lost or they undergo permanent conduction block, the initial component of the EMG 
response is late producing a delayed onset of the response and therefore delayed 
CMCT. The overall duration is less due to the loss of the contribution at the onset 
of the waveform assuming the slowest fibres continue to conduct normally. 
4.5 THE RELATIONSHIP OFABNORMALITIES IN CENTRAL MOTOR CONDUCTION 
AND INITIAL CLINICAL ASSESSMENTS 
It is interesting that the symptoms that correlated with absent responses 
(weakness of limbs, swallowing difficulty, perception of visual problems, and 
urinary incontinence) reflect signs that are all known clinical predictors of Poor 
outcome. There is an increased risk of death with dense limb paresis (Allen 1984) 
or leg weakness (Chambers et al., 1987), swallowing difficulty (Wade and Hewer 
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1987a), hemianopia (Gray et al., 1989), conjugate eye movement problems 
(Rankin, 1957; Oxbury et al., 1975) and urinary incontinence (Wade et al., 1985). 
The relationship of central motor conduction to initial clinical assessments 
appears to be relatively straightforward. The highest proportion of patients with 
no responses were those with extensive hemispheric damage classified as total 
anterior circulation syndrome (TACS) in the Bamford scale. Patients with this 
constellation of signs have been shown to have an increased risk of poor outcome 
(Bamford etal., 1991). Inpatients with no responses, useful motor function of the 
affected limb was severely affected being either lost, resulting in no movement, or 
only a flicker of movement in the target muscle. This resulted in the inability to 
perform dexterous movements of the hand leading to a reduction in performance 
of many of the motor-related activities measured by the Barthel score at Day 7. 
Electromagnetic stimulation of the motor cortex stimulates the corticospinal 
tracts. Therefore, if the normal function of the corticospinal tracts has been lost 
it is not surprising to find abnormalities in central motor conduction correlate with 
clinical signs of corticospinal tract damage in terms of changes in muscle power 
and tone, and abnormal plantar response. Delays in conduction, reflecting impaired 
function of the pathway were also accompanied by a reduction in the function of 
the target muscle with lower scores of power and dexterity. The lack of 
correlation of conduction abnormalities with initial examination of tendon reflexes 
probably is due to the effects of oedema and anatomical shift both of which may 
transiently produce these signs in the absence of permanent corticospinal damage. 
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4.6 THE PROGNOSTIC VALUE OF MEASURING CENTRAL MOTOR CONDUCTION 
AFTER STROKE 
Abnormal central motor conduction after stroke 
The main aim of this project was to evaluate the use of EMS of the brain to 
provide a numerical and objective method of providing an early prediction of motor 
outcome and mortality following stroke. The results strongly suggest that 
abnormal central motor conduction early after stroke is related to poor prognosis. 
Of the 36 patients who died of stroke-related causes, 31 had conduction defects 
producing absent responses in one or more muscles, on one or more occasions on 
Days 1-7 after stroke. In a further two patients with responses with normal 
CIVICT, responses could only be obtained during muscle contraction. Investigations 
on Days 1-7 after stroke therefore identified abnormal conduction in 33/36 patients 
whose deaths were stroke-related. By contrast, only 3/55 patients with entirely 
normal central motor conduction died of stroke-related causes. Of the 76 survivors 
at 12 months 48 always had responses on Days 1-7 after stroke. 28 patients who 
had absent responses in one or more muscles, on one or more occasion on Days 
1-7 survived. Only five of these 28 patients achieved independence as measured 
by the Rankin scale, the other 23 survivors all remained dependent. 
The absence of responses in one or more muscles in the upper limb within 
72 hours of stroke was an important observation. The greater the damage and the 
larger the number of muscles without responses, the greater the risk of poor 
outcome. An insult that can produce irreversible damage to the function of the 
corticospinal pathway represents a serious threat to the brain leading to incomplete 
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recovery of motor function or death. The fate of patients who lost conduction in 
the corticospinal pathway was profoundly worse than the patients with responses 
and they accounted for nearly all the stroke-related deaths. Therefore, the main 
discriminator relating to prognosis, is the ability to identify patients with responses 
compared to patients with no responses at Day 1. This is fortunate since it now 
provides the basis for an objective test. 
Normal or delayed CIVICT after stroke 
The presence of responses did not guarantee recovery. When responses 
could only be obtained at maximal stimulus using the threshold lowering-effect of 
muscle contraction, this lead to a less favourable outcome (but statistically not 
significant). If responses were present but if CIVICT was prolonged (Delayed 
Group), most of these patients survived but had incomplete return of hand 
dexterity. However, the outcome of this group of patients was not significantly 
different to the outcome of patients with normal CMCT. The vast majority of 
patients with responses survived. Their recovery was often incomplete, but the 
level achieved was considerably better than patients with no responses. 
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4.7 CLINICAL AND IMAGING METHODS OF PREDICTING OUTCOME COMPARED 
TO THE MEASUREMENT OF CENTRAL MOTOR CONDUCTION. 
Assessment of the neurophysiological function of the central motor 
pathways after stroke can be safely performed in the immediate post-stroke period 
to provide valuable prognostic information. The results have been shown to 
correlate with mortality and to a wide range of clinical and functional abilities that 
depend upon the recovery of motor function of the upper limb. Unlike clinical and 
radiological assessments, the evaluation of central motor conduction provides an 
objective test with highly predictive data within hours of stroke. 
The initial clinical signs, although relating to risk of death, can be ambiguous 
with respect to the recovery of motor skills. It is not until many days after the 
acute illness that the residual motor signs become accurate and predictive of 
functional outcome at 12 months. In comparison to clinical examination, 
assessment of central motor conduction was a more accurate method of predicting 
outcome. Clinical examination was able to identify patients with no movement in 
target muscles, suggesting a poor outcome. In most cases the absence of 
movement in a target muscle was associated with no recordable response to 
cortical stimulation thus suggesting a dense paresis and poor eventual outcome. 
However, within the group of patients with no movement in target muscles there 
was a subgroup of patients with recordable responses. The presence of responses 
with normal or delayed CMCTs implied that transmission in the corticospinal 
pathway was still present. The majority of patients with responses survived and 
had a high probability of a favourable functional outcome at 12 months. Predicting 
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the outcome for this group of patients would have been inaccurate using the 
findings from clinical examination. 
Although CT scanning provides pathological and anatomical information that 
may be of prognostic value with respect to risk of death, it is not highly predictive 
of outcome of upper limb function. The investigation can not be performed by the 
bedside and therefore involves some discomfort to patients who are acutely ill. In 
the immediate post-stroke period there may be no visible lesion on the scan despite 
clinical signs suggestive of extensive damage. Even when lesions are visible on 
scans within hours of stroke they are often at an early stage of evolution and due 
to the influence of mass effect and oedema, measurements are often subjective 
leading to inaccurate and misleading prognosis. 
The present study has shown that EMS of the brain is a valuable method of 
assessing the neurophysiological function of the corticospinal tracts after stroke. 
By combining the neurophysiological information with clinical assessments of 
function and anatomical and pathological data available from CT scanning it now 
possible to provide a more accurate and earlier prognosis for individual patients. 
4.8 VALIDITY OF CMCT AS A PREDICTOR OF OUTCOME 
The high values for specificity in Table 51 imply that those patients with 
responses at Day 1 (Normal and Delayed Response Groups) have a greater 
probability of survival and good functional outcome at 12 months. This 
observation is supported by the tests of return of muscle power, manual dexterity, 
Barthel scores, Rankin scale and by mortality indices. Furthermore, the negative 
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predictive values (Table 51) emphasize that these patients are highly likely to 
achieve independence in activities of daily living, as judged by the Barthel and 
Rankin assessments and they are unlikely to die before 12 months. 
The low values for sensitivity in Table 51 require more detailed explanation. 
At face value the figures imply that patients with no response at Day 1 have a 
mixed outcome, the majority having poor functional outcome at 12 months (See: 
Odds ratios - Fig. 14), but with some achieving good functional outcome and 
independence. In particular, it should be noted that the sensitivity is highest for 
death by 12 months and that it is the patients with no responses who account for 
most stroke-related deaths by 12 months. The sensitivity of measurements of 
CIACT in predicting functional outcome can be increased, when further tests are 
performed within the following seven days. For example, the sensitivity for tests 
performed at Day 1 with respect to stroke-related death at 12 months is 63.9% 
(specificity = 73.7), which rises to 77.8% (specificity = 68.4%), by expanding 
the No Response Group on Day 1, and including those who lose responses and 
therefore have no response on Day 3 or on Day 7. A similar improvement in 
sensitivity at the expense of specificity is seen for all the outcome measures. The 
net result is that the number of false negative results is reduced as the 
identification of patients with true positive results improves. 
The low positive predictive value relating to the Barthel score might have 
been different if a different score had been chosen to divide the patients arbitrarily 
into the two outcome groups of poor and good outcome. A further reason may 
have been due to the fact that 12 patients died by Day 7 when the first Barthel 
scale was assessed. These 12 patients were therefore excluded from all 
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assessments using the Barthel score. The low positive predictive value relating to 
death is because even though the majority of patients die in the No Response 
Groups at Day 1 and Days 1-7, many patients with no responses survive to 12 
months. 
Only hand dexterity measured by the Nine-hole Peg Test and assessment of 
muscle strength using the Motricity Index did not have a high negative predictive 
value for patients with responses at Day 1 who have good outcome. This is due 
to the fact that very few stroke patients can be expected to regain normal motor 
function. Very few patients in this study at 12 months recovered normal dexterity 
and full strength as measured by the peg test rate and the Motricity Index. 
4.9 THE USE OF THE THENAR MUSCLES FOR EVALUATION OF CORTICOSPINAL 
INTEGRITY 
The function of the thenar muscles was assessed in terms of hand dexterity 
in the Nine-hole Peg Test, the strength of index finger to thumb pinch grip in the 
Motricity Index and indirectly assessed in a variety of manipulative skills assessed 
by the Barthel score and the Rankin scale. The function of the thenar muscles was 
therefore more comprehensively assessed than any other target muscle in terms 
of comparing how central motor conduction related to clinical function. The use 
of the thenar muscles in manipulation skills of the hand clearly identify them as a 
very important muscle group, the recovery of which is of the greatest importance 
to the patient. In the monkey, pinch grip appears to require the integrity of the 
corticospinal pathway (Lawrence and Kuypers, 1968). This is a highly evolved 
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action that is often observed clinically to be one of the most resistant parts. of 
upper limb function to recover following stroke. It is therefore an important 
reflection of corticospinal function and motor recovery after stroke. 
The sensitivity of assessing central motor conduction as a predictor of 
outcome can be sharpened by making observations in many muscles of the upper 
limb (See: Odds ratio for death - Fig. 14). However, if responses were to be 
recorded in only one muscle, the thenar muscles provide the best index, as can be 
judged from the tests of manual dexterity (Nine-hole Peg Test), activities of daily 
living (Barthel test), functional outcome (Rankin scale) and probability of death. 
This observation would be expected on the basis of functional testing in 
non-human primates, where lesions of the corticospinal pathway lead to permanent 
impairment of manipulative skills in adult and infant animals (Lawrence and 
Kuypers, 1968, Lawrence and Hopkins, 1976). 
4.10 SAFETY OF ELECTROMAGNETIC STIMULATION AFTER STROKE 
The possibility Of EMS increasing the incidence of subsequent epileptic 
seizures in patients following stroke, was seriously considered at the onset of the 
study. The reported incidence of epilepsy following stroke varies in different 
studies, from 4.4% to 15% (Kilpatrick et al., 1990; Shinton et al., 1988; Louis and 
McDowell, 1967; Olsen et al., 1987; Black et al., 1983; Hauser et al., 1984), 
being highest (17%) for intracerebral haemorrhage (Berger et al., 1988). Isolated 
seizures following EMS in stroke patients with large areas of infarction have been 
reported (H6mberg and Netz, 1989; Fauth et al., 1992). These were likely to have 
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been incidental occurrences. 
Only 2 (1.7%) patients in the present study had a seizure. This low 
incidence reflects the safety of the procedure and the inclusion criteria for the 
study, i. e. no patients had any known neurological disease including previous 
epilepsy and stroke. The Human Movement Research Group in Newcastle upon 
Tyne has wide experience in the use of EMS in children, including patients with 
epilepsy. Their results strongly suggest that the technique is safe, with no 
increased incidence of epilepsy despite years of follow-up (Miller and Eyre - 
personal communication). The experience based upon the present study using 
maximal EMS within the first few hours following stroke and repeatedly in patients 
with extensive cerebral damage, supports the view that the procedure is safe and 
does not provoke epilepsy. The technique is well-tolerated by ill patients and no 
adverse affects were reported during or after stimulation. 
4.11 A PRACTICAL APPROACH TO THE USE OF EMS AFTER STROKE 
The results of this study provide guidance for the future use of EMS in 
stroke patients. The safety restrictions used in this study should be applied, but 
epileptic seizures need not be regarded as an absolute contraindication for EMS in 
the light of its safe use in the patients with seizures or conditions associated with 
seizures. All potential subjects must be questioned about shrapnel injuries or other 
accidents leading to the presence of metal fragments in their face, eyes or brain. 
The risk of anatomical damage during EMS appears low, but the advent of more 
powerful and focused stimulators may possibly require a reassessment of the risks. 
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Responses should be recorded from a number of different muscles to provide 
a comprehensive record of corticospinal tract damage. However, recordings from 
the thenar muscles alone confer a high degree of prognostic information. The 
recording of responses should be assisted by muscle contraction. Initial 
investigations can be safely commenced immediately after stroke. Patients with 
no responses have a high probability of either death, or incomplete recovery of 
function. If responses are present the chance of survival and good functional 
outcome is good, but investigations should be repeated seven days after the first 
test to assess if the damage has progressed resulting in a poor prognosis if 
responses are subsequently lost. An alternative would be to reinvestigate only 
patients who clinically extend their stroke. If responses are present throughout the 
first seven days after stroke the prognosis is good. Responses in the paretic limb 
should be compared to normative data and can be compared to data recorded from 
the non-paretic limb, since the CMCTs do not differ from the range in normal 
subjects. There is no need to relate the CIVICT results to the age of the patient in 
view of the consistency of CIVICT throughout adult life. 
4.12 CONCLUSIONS. 
Measurement of central motor conduction is a safe test that provides 
important prognostic information. Two groups of patients can be easily identified 
within hours of stroke, those whose prognosis is exceptionally poor leading to 
death or at best, survival with major disability and long hospitalisation, and a 
second group whose chance of survival is high and whose recovery is likely to be 
203 
good. Neurophysiological assessment of central motor conduction using EýAS 
provides information concerning the functional integrity of the corticospinal 
pathway which compliments clinical assessment of the patient and anatomical 
information from imaging of the brain. Combining the results of 
neurophysiological, clinical and anatomical assessments improves prognostication 
of an individual's prospects for survival and recovery following stroke. The 
implications of this are many. 
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4.13 THE FUTURE USE OF EMS FOLLOWING STROKE 
Further studies to evaluate the use of this technique as an adjunct to clinical 
measures for predicting mortality and motor recovery after stroke are required. The 
findings of the present study should be verified by a similar independent large 
longitudinal study. There remains scope for further clarification regarding the 
importance of delayed CIVICT immediately after stroke and the significance of 
responses that can only be obtained during muscle contraction. The value of 
measuring the amplitude of responses after stroke remains unclear and may merit 
further investigation. The use of EMS for predicting the outcome of lower limb 
function needs to be assessed now that more focused stimulator coils are available 
to evoke responses from leg muscles. The recovery of function in upper and lower 
limbs and mortality needs to be assessed for patients who have experienced 
multiple strokes. 
Some patients with stroke have motor problems due to dyspraxia of motor 
function, incoordination from cerebellar dysfunction and sensory loss affecting 
motor activity. The role of EMS of the motor cortex and cerebellum after stroke 
in these very interesting groups of patients with motor impairment has not been 
established. The same procedures need to be assessed for patients with motor 
problems resulting from other forms of cerebral ischaemia in the form of 
subarachnoid haemorrhage and possibly patients with subdural haematomas. 
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The possibility that some recovery of motor function following stroke may 
be due to ipsilateral or other crossed motor pathways remains unknown. The 
activity of ipsilateral sensorimotor pathways may influence changes in central 
motor conduction and influence tone and reflexes following stroke. The 
development of spasticity may inhibit the recovery of normal motor function and 
it may be possible to investigate these changes in humans using EMS. It is also 
a possibility, given ethical approval, to investigate the influence of other motor 
pathways after stroke. Investigation of extrapyramidal pathways such as the 
vestibulospinal, rubrospinal and reticulospinal pathways in animal models of 
ischaemia using EMS in combination with direct and indirect ES of the brain may 
provide further information that can be applied to man. 
The ability to identify patients with poor prognosis at a very early stage after 
stroke needs to be extended to assess how far the principles still hold if patients 
are investigated at the earliest possible time upon arrival in hospital, i. e. at 1-12 
hours after stroke. Investigating patients at such an early stage after stroke would 
be a challenge and would present many procedural problems. However, if it could 
be confidently shown that a group of patients with exceptionally poor prognosis 
can be reliably identified within 1-12 hours of stroke then this could have major 
implications for drug trials. Whilst the efficacy of a drug needs to be evaluated 
using well-designed trials with very large numbers of subjects to provide clear 
results, there is still a need for pilot studies. Identifying a group of patients with 
little prospect of recovery and high risk of death could be used in pilot studies of 
ischaemia-protective drugs. Identifying patients within hours of stroke would be 
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within the therapeutic window of many proposed stroke treatments such as 
thrombolytic agents, calcium antagonists and glutamate receptor blockers, where 
treatment must be initiated within 12 hours or possibly as short as six hours after 
the onset of the stroke. Electromagnetic stimulation of the brain to provide 
information about the function of the corticospinal tracts could then be evaluated 
as a method of monitoring the therapeutic efficacy of ischaernia-protective drugs. 
The action of a drug to produce the return of normal central motor conduction and 
voluntary motor function in patients could be compared to an untreated group of 
patients. We already know the natural history of changes in central motor 
conduction and motor recovery of the untreated group from the results of the 
present study. If the recovery of the treated group was different and resulted in 
better outcome in terms of survival and recovery of motor function, EMS might 
prove to be useful in monitoring the efficacy of drugs used in stroke. 
Studies are already underway to assess the use of monitoring central motor 
conduction during a variety of cerebral and spinal neurosurgical procedures. This 
concept of monitoring the corticospinal pathways during high-risk procedures that 
may lead to cerebral ischaernia could also be used in the context of coronary 
bypass, cerebrovascular or tumour surgery, or neuroradiological interventive 
therapy for the treatment of aneurysm or arteriovenous malformation. In all these 
procedures there is a major risk of stroke during the procedure. Intermittent 
monitoring of CIVICT during the operation may provide additional information that 
would make the procedure safer. 
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The value of EMS in the context of rehabilitation following stroke is 
presently unknown. It is unknown how physiotherapy and other forms of therapy 
enhance relearning of motor skills. It may be possible using EMS to monitor the 
recovery of motor skills and to define whether such forms of physical therapy are 
of definite value. Studies are needed to identify whether more intensive therapy 
should be directed at patients with no responses following EMS in the hope of 
maximising what little improvement they achieve. One might argue that limited 
health care resources might be better employed by focusing upon those patients 
with responses following cortical stimulation since they appear to have the greatest 
potential for improvement. This would be at the expense of reducing the 
rehabilitation input to the patients with no responses following cortical stimulation. 
This controversial ethical question is worthy of further investigation. 
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